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Abstract 
MicroRNAs (miRNAs) are small non-coding RNAs that enable post-transcriptional 
gene regulation through RNA interference (RNAi). The biogenesis of miRNAs 
involves distinct enzymatic processing steps, each of which requires a specific set 
of proteins. The processing of precursor miRNAs (pre-miRNAs) is performed by 
the endoribonuclease Dicer. Dicer enzymes are conserved in all organisms that 
utilise RNAi and they always associate with a double-stranded (ds) RNA-binding 
protein. In mammals, Dicer associates with TAR element binding-protein (TRBP) 
but the precise role of TRBP in miRNA biogenesis remains unclear. Research 
over the last 15 years has suggested that TRBP aids Dicer substrate recognition, 
facilitates diffusion of Dicer along dsRNA substrates, influences the length of 
Dicer products, and regulates Dicer activity or stability. Human TRBP is a 366-
residue protein that comprises three dsRNA-binding domains (dsRBDs) 
separated by long unstructured linkers. The two N-terminal Type-A dsRBDs bind 
dsRNA while the C-terminal Type-B domain mediates protein-protein interactions. 
The goal of this thesis is to explore the structure-function relationship and RNA-
binding properties of TRBP. DsRBDs recognise dsRNA via three interaction 
surfaces: Regions 1-3. Previous research has highlighted the contribution of 
Region 2 and suggested that the sequence and molecular dynamics of this loop 
may tune the dsRNA-binding affinity of the domain. Here, nuclear magnetic 
resonance (NMR) spectroscopy was used to evaluate the structure and ps-ns 
backbone dynamics of the two Type-A dsRBDs of TRBP, with particular focus on 
RNA-binding region 2. Analysis of 15N NMR relaxation parameters and residue 
composition of this region revealed differences between the two dsRBDs. A series 
of single and double mutant variants were made in single and tandem dsRBD 
constructs, and their dsRNA-binding properties were tested using several pre-
miRNAs. A previously reported difference in binding affinity between dsRBD-1 
and 2 was shown to be dependent on pH, which was also shown to affect the 
foldedness of dsRBD-1. Single-site mutations were shown to alter the dynamics 
of Region 2 and to affect RNA-binding affinity. These analyses suggested that 
Region 2 may be required for sensing the presence of non-Watson-Crick features 
in a pre-miRNA. The implications of these results on Dicer activity are unclear, 
but the characterisation of binding properties and backbone dynamics reported 
here provide further insight into pre-miRNA recognition by TRBP and proteins with 
multiple dsRBD more generally. 
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Chapter 1- Introduction  
 
1.1 MicroRNAs; Introduction, discovery and role 
 
MicroRNAs (miRNAs) are small non-coding RNAs that can regulate the 
expression of genes at the post-transcriptional level. In humans, miRNAs 
are the principal mediators of RNA interference (RNAi), a process in which 
small regulatory single-stranded (ss) RNAs base pair with complementary 
sequences on target mRNA, which in turn leads to the degradation and/or 
translation repression of the mRNA (Bartel 2004; 2009; Friedman et al. 
2009). 
 
The discovery of miRNAs began with an investigation carried out on the 
gene lin-4. This specific gene was shown to control the development of C. 
elegans larvae. It did not code for a specific protein but still carried a 
functional role (Lee et al. 1993). Two small non-coding RNAs derived from 
the lin-4 gene. The sRNAs varied in size and one was seen to fold into a 
stem loop and proposed to be the precursor of the other shorter RNA. 
Later, it was determined that the lin-4 RNAs had an antisense 
complementarity to various sites in the 3’ untranslated region (UTR) of the 
lin-14 mRNA (Wightman et al. 1993). This region was previously identified 
to be required for the repression of lin-14. The sites of interaction found on 
both lin-4 and lin-14 were probed by a series of molecular and biochemical 
experiments. This highlighted that the direct but imprecise base pairing of 
the sRNA and mRNA is important for the regulation of Lin-14 protein 
expression (Wightman et al. 1993). 
 
The discovery and investigation into the lin-4 RNA hypothesised a model 
where by lin-14 gene expression is regulated by the RNA as part of 
regulatory pathway which triggers the transformation in cell divisions of the 
first larval stage to those of the second. Which is instigated by the 
downregulation of the nuclear protein Lin-14 (Lee et al. 1993; Wightman et 
al. 1993). This information hinted at a new mechanisms of gene regulation, 
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but it was only seven years later when a second RNA was identified to 
control genes in this manner, let-7 (Reinhart et al. 2000). It was shown that 
let-7 and lin-41 were evolutionarily conserved throughout metazoans and 
homologues were found in molluscs, sea urchins, flies and humans  
(Pasquinelli et al. 2000).  This group of sRNAs involved in gene regulation 
through RNA interference have since been termed microRNAs. 
Computational predictions of miRNA target sites indicate that miRNAs may 
be involved in a broader network of gene regulation (Lewis et al. 2003). 
 
As described, the first miRNAs discovered in C. elegans lin-4 and let-7 
carry functional roles in controlling development, mutated lin-4 cells were 
unable to make the transition from the first to the second larval stage (Lee 
et al. 1993). In adult C. elegans, lin-4 has been shown to be required for 
the down regulation of lin-14 and the life-span regulation of the worm 
(Boehm and Slack 2005). Let-7 has also been shown to be important for 
the larval to adult transition as it regulates the expression of several 
developmental genes (Reinhart et al. 2000). In vertebrates, miR-124 has 
been shown to play a role in regulating neural development, it was shown 
through in vitro assays where miR-124 overexpression triggered, and 
knockdown assays prevented neural development (Gao 2010). 
 
The expression levels of miRNAs have been studied in various tumours 
and identified to be significantly altered (Lu et al. 2005; Jansson and Lund 
2012; Peng and Croce 2016). Lu et al (2005) identified that the global 
miRNA expression was lower in cancer cell tissues compared with normal 
tissue. The expression of 217 mammalian miRNAs was investigated using 
bead-based flow cytometric expression profiling (Lu et al. 2005). It was 
concluded that the downregulation of some miRNAs might play a crucial 
role in the generation or maintenance of tumour cells. The loss of miRNAs 
in tumour cells suggests that certain miRNAs play a role in tumour 
repression. However, it has been shown that miRNAs from the miR17-92 
cluster act with oncogenic potential (He et al. 2005; Olive et al. 2010). MiR-
155 has been shown to be sufficient to induce tumorigenesis, experiments 
in transgenic mice where miR-155 had been overexpressed showed pre-
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leukemic pre-B cells which proliferate to B cell leukaemia (Costinean et al. 
2006). 
 
Let-7 one of the first miRNAs discovered has also been shown to have a 
role in cancer as the expression of this miRNA was found to be decreased 
in lung tumours compared to normal lung tissue and overexpression of let-
7 was able to suppress cancer cell growth, shown in both in vitro and in 
vivo studies (Johnson et al. 2007; Kumar et al. 2008). The production of 
miRNAs is under heavy control which will be discussed further below. The 
dysregulation of miRNA production has been associated with disease 
progression and cancers (Melo et al. 2009; 2010; Gurtner et al. 2016). 
 
1.2 MiRNA biogenesis 
 
The production of miRNAs relies on several processing steps within cells 
(Lee et al. 2002). The primary transcript of miRNAs produced by RNA 
polymerase II can contain multiple hairpins, each of which can give rise to 
a different miRNA.  MiRNAs are generated from these primary RNA 
transcripts in a two-step process (Figure 1.1). The initial primary miRNA 
(pri-miRNA) is a 1-2 kilobase nuclear transcript, which possesses a short 
imperfect stem loop structure. This pri-miRNA is recognized by the nuclear 
“Microprocessor” complex, which is made up of the nuclear protein Di 
George Syndrome Critical region 8 (DGCR8) and the RNase III enzyme 
Drosha (Han et al. 2004). The Microprocessor excises the imperfect stem 
loop from the pri-miRNA (Lee et al. 2003; Denli et al. 2004). The cleavage 
product, which is termed the precursor miRNA (pre-miRNA), has a hairpin 
structure with a two nucleotide (nt) 3’-overhang (Bartel 2009). The pre-
miRNA is assembled into a complex with the nucleocytoplasmic 
transporter factor Exportin-5 and RanGTP, which facilitates the 
translocation of the pre-miRNA into the cytoplasm (Bohnsack et al. 2004; 
Lund et al. 2004). To produce the final miRNA for RNAi one more 
processing step is required where the 60-70 nt pre-miRNA is processed in 
the cytoplasm and is cleaved by a second RNase III enzyme called Dicer 
(Bernstein et al. 2001; Feng et al. 2012). The structure of Dicer has been 
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elucidated to give further insight on the mechanisms of pre-miRNA 
processing (MacRae et al. 2006; Lau et al. 2009; 2012). The processing 
step by Dicer has been revealed to be aided by a class of proteins known 
as double-stranded RNA binding proteins (dsRBPs) (Koscianska et al. 
2011; Ha and Kim 2014). The product of Dicer cleavage is a 20-25 bp 
duplex, which contains the functional miRNA guide sequence (Kim et al. 
2009). One strand of the miRNA/miRNA* duplex is transferred to the RNA-
induced silencing complex (RISC), which is responsible for miRNA-
directed RNAi in humans (Pratt and MacRae 2009). The intermediate 
protein complex made up of TRBP, Dicer and Argonaute, part of the RISC 
loading complex (RLC) is potentially responsible for assisting the transfer 
of the correct guide strand miRNA from Dicer to RISC (MacRae et al. 
2008). 
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1.3 The role TRBP and PACT play in facilitating Dicer processing 
of dsRNA 
 
As described, miRNAs are produced from long RNA transcripts, and 
require several regulated enzymatic processing steps during their 
maturation (Bartel 2009). Two multi-domain dsRBPs, TAR element binding 
protein (TRBP) and the Protein activator of PKR (PACT) have been 
identified to interact and aid Dicer in the processing of pre-miRNAs 
(Chendrimada et al. 2005; Haase et al. 2005; Lee et al. 2006; Lee and 
Doudna 2012; Lee et al. 2013). Biochemical and structural studies have 
Drosha 
DGCR8&
Expor,n
.5&
Ran&
GTP&
Dicer&
TRBP/
PACT&
Nucleus 
Preliminary-
miRNA 
 
Primary-
miRNA 
 
Preliminary-
miRNA 
 
Cytoplasm 
RISC&
miRNA duplex miRNA 
Figure 1.1 Overview of the miRNA biogenesis pathway.  
Pre-miRNAs are RNA hairpins produced in the nucleus from primary miRNA and 
exported to the cytoplasm. The endoribonuclease Dicer then processes pre-miRNAs to 
remove the terminal loop to produce a RNA duplex, this duplex contains the miRNA 
sequence which gets loaded onto the RISC. 
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shown that TRBP and PACT associate with Dicer (Kok et al. 2007; Laraki 
et al. 2008; niels et al. 2009; Wilson et al. 2015).  
 
In vivo studies of TRBP have identified that presence of this dsRBP can be 
crucial for RNAi activity, with knockout studies showing a loss of RNAi 
activity (Chendrimada et al. 2005; Haase et al. 2005; Lee and Doudna 
2012; Lee et al. 2013). This was tested by investigating mRNA silencing 
by short hairpin RNA (shRNA), when TRBP and PACT were depleted. The 
shRNA requires processing by Dicer and this identified that both proteins 
contributed to Dicer processing as its mRNA silencing was affected by the 
depletion of TRBP and PACT. Another study contradicted these claims and 
identified that siRNA-mediate silencing was not affected by the depletion 
of TRBP and PACT (Kok et al. 2007).  However, the effectiveness of the 
knockdown was not measured and knockdown of TRBP and PACT were 
carried out using siRNAs. As effectiveness of the siRNA knockdown 
technique can depend on the presence and activity of TRBP and PACT, 
this is not the best technique to knockdown these dsRBPs. 
 
In vitro binding studies have revealed that Dicer in complex with either 
TRBP or PACT can bind to dsRNA with a higher affinity relative to Dicer 
alone (nivas Chakravarthy et al. 2010; Lee and Doudna 2012; Lee et al. 
2013). This dsRNA binding affinity enhancement suggests that these 
dsRBPs may be required for the initial recruitment of dsRNA to Dicer.  
 
1.3.1 Altering the processing rate of Dicer 
 
Existing explorations into TRBP and PACT have underlined that the two 
dsRBPs impose different effects on Dicer for the processing of dsRNA (Lee 
et al. 2013). One role that has been proposed for TRBP is that it can affect 
the Dicer processing rate of dsRNA. Several in vitro studies have shown 
TRBP can either increase the processing rate of dsRNA by Dicer or have 
a conflicting function and decrease the rate of Dicer processing, dependent 
on the dsRNA and its respective structure (Lee and Doudna 2012; Lee et 
al. 2013). In vitro dicing experiments identified that the rate change TRBP 
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imposes on Dicer processing can be affected by structural elements of the 
dsRNA, such as an unpaired nucleotide at the Dicer cleavage site, which 
was shown to inhibit processing rate of Dicer bound TRBP. In contrast to 
TRBP, PACT in complex with Dicer has not been shown to increase the 
rate of processing of Dicer. However, where TRBP has been shown to 
increase the rate of Dicer processing for pre-siRNAs, PACT has been 
identified to severely decrease the rate of pre-siRNA processing compared 
to a Dicer-TRBP complex or Dicer alone (Lee et al. 2013). 
 
1.3.2 Facilitation of iso-miR production by Dicer cleavage of 
pre-miRNAs 
 
Variations in the length of the miRNA product (iso-miRNAs), which are 
derived from the processing of a single pre-miRNA by Dicer, can play a 
role in finding downstream miRNA targets (Cloonan et al. 2011). Thus, the 
mechanism behind the production of iso-miRs is important. TRBP and 
PACT have been shown to have differing effects on Dicer production of 
iso-miRs with product lengths differing in one nucleotide (Figure 1.2). 
TRBP has been shown to stimulate iso-miR production and alter the 
number of iso-miRs produced by Dicer. On the other hand, a Dicer-PACT 
complex produces the same number of iso-miRs as Dicer would alone 
suggesting PACT does not influence iso-miR production of Dicer 
(Fukunaga et al. 2012; Wilson et al. 2015). Knockout (KO) studies involving 
TRBP and PACT showed a similar trend in iso-miR production. TRBP KO 
studies in HeLa cells revealed altered levels of iso-miR expression, which 
was not seen for PACT KO studies. The effect that TRBP has on Dicer 
cleavage site selection and therefore iso-miR production suggests that this 
dsRBP may facilitate the positioning of the dsRNA on Dicer (Ha and Kim 
2014; Kim et al. 2014). The PACT-Dicer complex not being able to produce 
iso-miRs could suggest PACT may interact with Dicer for the processing of 
certain pre-miRNAs to hinder the production of iso-miRs.  
 
In a recent study Dicer partner proteins TRBP in humans and Loquacious-
PB (Loqs-PB) in Drosophila were shown to be required for tuning the length 
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of miRNAs produced by Dicer (Zhu et al. 2018). They identified that base-
mis-matches in the pre-miRNA stem can alter the length of miRNAs 
produced by Dicer with its partner proteins TRBP and Loqs-PB.  
 
1.3.3 Substrate gatekeeper for Dicer in an RNA-rich 
environment 
 
A recent study described that TRBP acts as a “gatekeeper” for Dicer in 
finding correct dsRNA substrates (Fareh et al. 2016) (Figure 1.2). It was 
determined that TRBP was able to ensure the efficient processing of pre-
miRNAs by Dicer in an RNA crowded environment.  Using tRNA as a 
competitor molecule revealed that the rate of processing of pre-miRNA was 
severely inhibited when Dicer was unaccompanied by TRBP. However, a 
Dicer-TRBP complex remained unaffected to an RNA crowded 
environment. Competition RNA binding assays showed that the binding 
affinity of Dicer to the pre-miRNA was severely reduced with a 1000-fold 
excess of tRNA present but with Dicer in complex with TRBP the presence 
of tRNA did not present any pre-miRNA binding inhibition. This newly 
identified role of TRBP further highlights the significance of TRBP in the 
miRNA biogenesis pathway, whether this phenomenon is present within 
PACT is yet to be investigated.  
 
1.3.4 Facilitating diffusion of Dicer along dsRNAs 
 
Both TRBP and PACT have been shown to have an ATP-independent 
diffusion property on dsRNA (Koh et al. 2013; 2017) (Figure 1.2). The exact 
role this diffusion property plays on dsRNA processing has yet to be 
elucidated but Dicer-TRBP diffusion activity does correlate with dsRNA 
cleavage. A possible motivation for this diffusion mechanism to exist can 
be to allow the dsRBPs to scan the overall structure of the dsRNA and in 
turn find the correct cleavage site for Dicer. The diffusion mechanism could 
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also be required for selection of appropriate substrates by scanning the 
dsRNA substrate.  
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Figure 1.2 Impact of TRBP and PACT in Dicer processing of pre-miRNA. 
Model of TRBP and PACT function in miRNA biogeneis. TRBP and PACT facilitate 
the “selection” specificity of Dicer for correct dsRNA substrates. “Diffusion” by Dicer 
on dsRNA is independent of ATP and is facilitated by TRBP.  “Positioning” of Dicer 
on the dsRNA to produce iso-miRs with differing lengths is facilitated by TRBP and 
PACT. TRBP and PACT both affect the “rate” of dsRNA cleavage by Dicer.  
 
 
 
21 
1.3.5 Post-transcriptional regulation of Dicer cofactors and 
its subsequent consequence on miRNA processing 
 
It has been reported that both TRBP and PACT undergo phosphorylation 
at several sites, but the effect post-translational modification has on 
regulating miRNA biogenesis has only been studied for TRBP (Paroo et al. 
2009; Warner et al. 2016). Phosphorylation of TRBP has been shown to 
increase stability of the protein but also the stabilization of the miRNA-
processing complex (Paroo et al. 2009). Phosphomimic TRBP transfection 
into human cell lines showed an increase in miRNA production relative to 
the controls (Paroo et al. 2009). This was credited towards the increased 
stability of the TRBP-Dicer complex as in vitro studies showed no 
differences in Dicer processing when complexed with wild-type or 
phosphor-mimic TRBP (Chakravarthy et al. 2010). A variety of kinases 
have been shown to modulate TRBP phosphorylation. Increasing the 
stability of the Dicer-TRBP complex through phosphorylation of TRBP, 
showed an increase in miRNA production and in turn the downstream 
miRNA silencing function.  
 
1.4 The RNA Induced Silencing Complex (RISC)  
 
The RNA induced silencing complex is made up of by a family of 
ribonucleoproteins that target genes for silencing, RNA interference is a 
powerful mechanism of gene silencing required by many organisms. It was 
identified when the mechanisms involved in the RNA interference pathway 
were investigated (Hammond et al. 2001; Pratt and MacRae 2009). 
 
The RNA induced silencing pathway requires one of two types of RNAs to 
target specific genes, miRNAs and small interfering RNAs (siRNAs). 
SiRNAs are a class of double-stranded RNA molecules, which like miRNAs 
can regulate the expression of genes using RNAi.  Unlike miRNAs, siRNAs 
are processed from long, fully complementary dsRNAs (Tomari and 
Zamore 2005). The mechanism of RNAi regulation requires various 
proteins in the complex to form the RNA induced silencing complex (RISC), 
which uses the guide RNAs to control the regulation of genes. Argonaute 
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was identified to be part of the RISC and the first biochemical evidence for 
it was shown through a purification of pre-loaded RISC from Drosophila S2 
cells (Hammond et al. 2001). Biochemical and structural studies have 
shown Argonaute proteins to be the catalytic core of the RNA effector 
complex (Liu et al. 2004). Therefore, Argonaute proteins are abundant in 
nature and found in plants, animals, fungi and protist (Carmell et al. 2002). 
The number of Argonaute genes present vary in different organisms for 
example C.elegans carry 27 whereas humans only contain 4 (Grishok et 
al. 2001). 
 
Argonaute proteins form the core of the RISC and contain a PIWI domain 
which has been implicated to be the required for mRNA cleavage. In some 
Argonaute proteins this domain has been shown to have a fold similar to 
that of RNAse H (Song et al. 2004; Yuan et al. 2005). Insight into the 
function of Argonaute has shown the PAZ domain found in Argonaute has 
a fold sufficient for oligonucleotide binding. This domain has the ability to 
anchor the single stranded 3’ end of the ssRNAs (Lingel et al. 2004). 
Further structural studies into archaeal Argonaute proteins identified that 
the PIWI domain has a conserved binding region for the 5’phosphate of 
sRNAs. This hypothesizes a model where the sRNA is lodged between the 
PAZ and PIWI domains of the protein and therefore positions the target 
mRNA near the catalytic centre (Peters and Meister 2007). All human Ago 
proteins have been shown to bind to microRNAs but only complexes 
containing Ago-2 support mRNA cleavage. The catalytic activity of 
Argonaute was identified by mutations carried out on three amino acids 
(DDH) found in the PIWI domain (Liu et al. 2004). 
 
The loading of the RISC complex in humans depends on key proteins, such 
as Dicer and dsRNA binding proteins TRBP in humans, which makes up 
the RISC loading complex (RLC). These three proteins are highly 
conserved across eukaryotes and represent the minimal components 
required for a functioning RISC. TRBP has been shown to form a complex 
with Ago2 in the presence of Dicer identified by immunoprecipitation 
experiments (Chendrimada et al. 2005; Haase et al. 2005; Lee and Doudna 
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2012; Lee et al. 2013). In vitro constitution of the RISC with TRBP, DICER 
and Ago2 has shown that it is capable of processing pre-miRNAs and 
cleaving target mRNAs (MacRae et al. 2008). For precise mRNA target 
inhibition, the correct complementary miRNA must be loaded onto RISC. 
Reconstituted RLC with DICER, TRBP and Ago2 displayed loading activity 
by unwinding of the miRNA/miRNA* duplex and selection of the correct 
guide strand dependent on the thermodynamic asymmetry property of 
processed pre-miRNAs (Khvorova et al. 2003). In Drosophila, selection of 
the miRNA guide strand has been shown to be mediated by the dsRNA 
binding protein R2D2, which was shown to sense the relative stability 
between the two ends of the siRNA. TRBP has been shown to bind siRNA 
in vitro and sense the asymmetry of dsRNA siRNAs by binding 
preferentially to one end of asymmetric siRNAs. This could potentially 
control the loading of the guide strand into Ago2 (Gredell et al. 2010).  
 
1.5 Double stranded RNA binding domains (dsRBDs) 
 
The double-stranded (ds) RNA binding domain (dsRBD) is a protein 
domain between 65-70 amino acids in length. One of the first identified role 
of the domain is to specifically bind to double stranded RNA (dsRNA) 
(Krovat and Jantsch 1996; Ramos et al. 2000). However, this is not a 
necessary property required for the definition of this domain as they have 
also been shown to interact with other protein domains (Krovat and Jantsch 
1996; Gleghorn and Maquat 2014).  DsRBDs can be found in eukaryotes, 
prokaryotes and have been shown to be present in the last common 
ancestor of metazoans (Kerner et al. 2011). DsRBD harbouring proteins 
have been implicated in many roles ranging from antiviral response to RNA 
transport and RNA silencing (Masliah et al. 2013). MiRNA biogenesis 
across most organisms has a minimum of one RNaseIII enzyme and 
usually multiple dsRBD containing proteins to aid with the recognition of 
dsRNA.  
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1.5.1 Discovery of dsRBDs 
 
The first discovery of dsRBDs started with the identification of this domain 
in two specific proteins: Staufen found in Drosophila required for the 
localization of maternal RNAs; and Xlrbpa in Xenopus which has been 
identified as a homologue of the TRBP (Johnston et al. 1992). A 76-amino 
acid region in Xlrbpa was identified to be sufficient in binding to dsRNA. 
Through sequence searches it was identified that Xlrbpa shares high 
similarity with regions found within TRBP and shares sequence similarity 
to three regions found in the Drosophila protein Staufen, which was not 
known to be a dsRNA binding protein. Using Xlrpba and a region of Staufen 
with high sequence conservation to the RNA binding domain of Xlrpba, 
binding assays were carried out with several RNA probes and identified 
protein constructs bound strongly to only RNAs with a double-stranded 
secondary structure (Johnston et al. 1992). 
 
 
1.5.2 The basic fold of a dsRBD 
 
The first three-dimensional structures of dsRBDs were solved by solution 
NMR and identified a conserved protein fold in both E. coli RNase III 
dsRBD and the third dsRBD of Drosophila Staufen (Bycroft et al. 1995; 
Kharrat et al. 1995). An α-β-β-β-α topology was uncovered where two α 
helices are packed against a three stranded anti-parallel β sheet (Figure 
1.3). To date, X-ray crystallography and NMR studies have determined 
structures of more than 30 dsRBDs (Masliah et al. 2013). 
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The conserved residues across dsRBDs have been shown to be 
individually important for the specific conformation of the dsRBD. 
Hydrophobic residues present in α1, β1, β2 and α2 of most dsRBDs help 
give the canonical α-β-β-β-α fold of dsRBDs. In addition to conserved 
hydrophobic residues there are two aromatic side chains, which are nearly 
absolutely conserved between most dsRBDs, a tyrosine residue found in 
the β1 strand (19th residue of most dsRBDs) and a phenylalanine residue 
in the β2 strand (residue position 34 of most dsRBDs) (Figure 1.4A).  The 
importance of their conservation can stem from their role of being indirectly 
involved in the binding of dsRNA by maintaining the correct orientation of 
the positively charged residues on the RNA binding regions. Furthermore, 
the position of these aromatic rings plays a role in the structure of the 
domain as they lie on the edge of the dsRBD to contribute to the overall 
stability of the domain (Ryter and Schultz 1998). 
 
Figure 1.3 Secondary structure of a typical dsRBD.  
Taken from a dsRBD found in Staufen (PDB accession code 1STU). The 3D 
structure holds the typical α-β-β-β-α fold. Alpha helix in red and beta sheet in 
yellow. The protein structure was visualised using Pymol. 
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1.5.3 Double stranded RNA recognition regions of Type-A 
dsRBDs 
 
Mutational analysis of dsRBDs identified three regions required and 
conserved for the interaction with dsRNA (Krovat and Jantsch 1996; Erard 
et al. 1998; Ryter and Schultz 1998; Ramos et al. 2000; Chang and Ramos 
2005). Region 1 is located in the first alpha helix with the Region 2 in the 
loop linking strand β1 and β2 and the Region 3 at the N-terminus of helix 
α2. Each of these regions contains high conservation across most 
dsRBDs, specifically the conserved glutamic acid residue found at the N-
terminal end in helix α1, the GPxH motif conserved in β1- β2 loop and the 
positively charged residues in the KKxAK motif at the N-terminal end of 
helix α2, conserved with only slight variations between dsRBDs (Figure 
1.4A). 
 
DsRNA recognition by dsRBDs is highly specific due to the dsRBDs ability 
to discriminate between dsRNA from other nucleic acid polymers (dsDNA, 
ssRNA and DNA/RNA hybrids) (Masliah et al. 2013).The conformation 
adopted by dsRNA is characterized as A-form helix, which is significant for 
dsRBD recognition. The A-form dsRNA double helix is described by a deep 
and narrow major groove, and a wide and shallow minor grove (Saenger 
and Saenger 1984). Another characteristic that should be highlighted is the 
presence of 2’-OH functional groups on the ribose sugar not present in 
dsDNA, 2’-OH groups line the entire minor groove, and this may favour the 
binding of dsRBDs to dsRNA over dsDNA. In summary dsRBDs have the 
ability to distinguish dsRNA from other molecules by probing the presence 
of 2’-OH on the dsRNA and the unique structure of the A-form helix and 
bind across successive minor grooves and the intervening major groove 
on the dsRNA helix. 
 
NMR spectroscopy and X-ray crystallography have given high-resolution 
and atomic resolution structures of dsRBDs in complex with various types 
of RNA molecules (Ramos et al. 2000; Wang et al. 2011; Yamashita et al. 
2011). The high-resolution structures have highlighted the RNA binding 
interface of dsRBDs and exposed the various parts of the domain which 
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combine to present a surface with the ability to bind to the A-form helix 
structure that the dsRNA hold (Chang and Ramos 2005; Masliah et al. 
2013). The recognition is carried out by the several regions of the domain 
contacting the bases located at the minor grooves and the phosphate 
backbone of the major groove (Figure 1.4B) 
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Figure 1.4 DsRNA interaction by a type-A dsRBD  
(A) Sequence alignment of type-A dsRBDs found in various organisms and dsRBPs                 
RNA binding regions highlighted. Sequences were aligned using T-coffee (Notredame et al. 
2000) and rendered using ESPript (Gouet et al. 2003).(B) Structure of TRBP-D1 with RNA 
binding regions highlighted (RED) interacting with dsRNA . Edited using Pymol (PDP accession 
code 5N8L) 
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In region 1 of most dsRBDs there are around 4 residues, which produce 
the interaction surface, one of which is a highly conserved glutamate 
(Figure 1.4A). The other 3 residues lack conservation between dsRBDs of 
different proteins, which could be an explanation for the difference in RNA 
binding properties of various dsRBDs. The residues required for dsRNA 
interaction in region 1, range from bulky and hydrophobic amino acids (e.g. 
valine or isoleucine) to amino acids whose side chains are capable of 
hydrogen bond interactions. They have roles in either interacting with the 
ribose and bases of the dsRNA or interacting with other amino acids in the 
dsRBD for correct folding leading to successful RNA binding interaction. 
The highly conserved RNA binding residue glutamate found in region 1 has 
been shown to be required for RNA binding as mutating this residue has 
shown to abolish RNA binding (Ramos et al. 2000). The carboxylic group 
of this glutamate makes a hydrogen bond with the 2’-OH group of a ribose 
sugar of the RNA.  
 
RNA binding region 2 found in the loop between β1- β2, has been shown 
to interact with the minor groove of the dsRNA, one helix turn away from 
the minor groove interacting with RNA binding region 1 (Figure 1.5). The 
conserved amino acids in this region match the trend of GPxHxx across 
most dsRBDs, this region relies on interactions conserved and seen in 
structures of most dsRBDs. The carbonyl group of the peptide backbone 
of the histidine residue makes a hydrogen bond to a 2’OH group of one 
strand of the dsRNA with the imidazole ring of the residue making a 
hydrogen bond to the 2’OH of the previous ribose on the other strand. The 
histidine residue has been shown in various structures to be central in RNA 
binding of this region and the importance of this residue has been shown 
with mutations of this residue knocking out RNA binding (Krovat and 
Jantsch 1996; Yamashita et al. 2011). There are slight sequence variations 
in RNA binding region 2 between dsRBDs. For example, the presence of 
two histidine residues in RNase III or two proline residues in Xlrpba 
preceding the RNA binding histidine. Nonetheless, in all three structures 
the side chain imidazole ring of a histidine makes contact with the 2’OH of 
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the dsRNA (Figure 1.5).  Comparing region 2 of various dsRBDs has also 
shown a disparity in amino acid composition of this loop region between 
dsRBDs of different proteins and dsRBDs within the same multi-domain 
protein. 
 
 
 
Figure 1.5 High-resolution X-ray structures of the RNA binding region 
2 interacting with dsRNA in various dsRBDs. 
Crystal structures of dsRBDs interacting with dsRNA with RNA binding 
region 2 highlighted (A) TRBP-dsRBD2 interaction with a dsRNA 
(PDB:3ADL). Interaction of His188 in RNA binding region 2 of TRBP 
dsRBD2 with dsRNA. (B) Xlrbpa dsRBD2 interaction with dsRNA 
(PDB:1DI2). Interaction of His180 in RNA binding region 2 of Xlrbpa 
dsRBD2 with dsRNA. (C) RNase III dsRBD interaction with dsRNA 
(PDB:4m2z). Interaction of His 141 in RNA binding region 2 interacting with 
dsRNA. Pymol was used to visualize the structures.  
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RNA binding region 3 found in the N-terminal tip of helix α2, consists of a 
well conserved amino acid motif of KKxAK, with this surface interacting 
with the width of the major groove. This region has been shown to contact 
the negatively charged phosphodiester backbone of both RNA strands. 
The side chains of the first and the third lysine of the motif interact with one 
strand with the second lysine interacting with the other strand forming an 
arch shaped structure. A dsRBD found in Drosha has been shown to not 
interact with dsRNA as it lacks amino acids found in the three RNA binding 
regions. However, Kranick et al (2017) were able to engineer dsRNA 
binding activity into this dsRBD through site directed mutagenesis at the 
canonical RNA binding region 3. This region alone was able to facilitate the 
interaction of the dsRBD with dsRNA, which highlights the importance of 
this RNA binding region (Kranick et al. 2017). 
 
Although there is not much evidence in the literature that dsRBDs have a 
sequence specific interaction with dsRNA, solution structure and 
mutational studies of ADAR2 have highlighted the sequence specific 
interaction of some dsRBDs (Stefl et al. 2010).  However, most structural 
and biochemical information suggests that dsRBDs do not favour specific 
dsRNA sequences and dsRBDs mainly interact with non-sequence 
dependent parts of the dsRNA, such as the phosphate backbone and the 
2’OH groups of the ribose. 
 
1.5.4 Type-B dsRBDs 
 
As described previously the canonical dsRBD is structured with an α-β-β-
β-α fold which a gives a specific secondary structure with the ability to 
recognize and bind dsRNA. However, further research into dsRBDs 
identified several domains which still hold the canonical fold but lack the 
key property of binding dsRNA. These domains termed type-B dsRBDs, 
have been discovered to form homodimers or even heterodimers with other 
dsRBDs containing proteins. This feature adds to the function of dsRBPs 
past the obvious dsRNA binding property.  
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Human Staufen 1 contains one dsRBD, which follows the type-B rule 
(dsRBD5) (Gleghorn et al. 2013).  There are a variation of ways a dsRBD 
can have the classic α-β- β-β-α fold without the ability to bind to dsRNA. 
For example, in the (DUF)283 domain of Dicer and Dicer-like proteins the 
extension of the loop between α1 and β1 causes α1 to cross at α2 in type-
B dsRBDs, this hinders the alignment of α1 with the dsRNA minor groove 
for the interaction of RNA binding region 1 to dsRNA (Qin et al. 2010). 
Positioning of amino acids in the B-type dsRBDs can also play a role in 
knocking out dsRNA binding as can be seen in the two isoforms of STAU1 
where they differ by an additional 6 amino acids in the β1 sheet, the 
addition of these 6 residues was shown to inhibit RNA binding by 
repositioning the key RNA binding motif found in the loop between β1 and 
β2 (Bycroft et al. 1995). 
 
Variations in sequence within the actual RNA binding regions could also 
occur in type-B dsRBDs. In the X-ray crystal structure of human Stau1 
dsRBD5 it was shown that it lacked the conserved glutamate required for 
RNA binding of region1, region 2 was shown to be shorter and therefore 
lacks the GPxH motif and region 3 lacks the KKxAK motif which is replaced 
by negatively charged residues which repel dsRNA (Gleghorn and Maquat 
2014). TRBP and PACT also contain one type-B dsRBDs that rather than 
containing dsRNA binding properties, is required for the interaction with 
protein cofactors (Laraki et al. 2008; Heyam et al. 2015). 
 
1.6 Multi-domain significance of double stranded RNA 
binding proteins 
 
Although structural biology has highlighted atomic resolution detail of 
individual dsRBDs, the interplay of dsRBDs with each other in a multi 
domain protein hasn’t been studied in detail (Lunde et al. 2007). RNA 
recognition by dsRBPs can range in various ways using single or multiple 
dsRBDs; the domains can independently bind to dsRNA and have little or 
no contact between them. Alternatively, they can interact with each other 
to produce a structural conformation required for dsRNA recognition and 
binding (Tian et al. 2004). 
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The need for a multi-domain dsRBP can be due to individual dsRBD 
demonstrating a weak specificity and affinity for the dsRNA and the 
combination of multiple domains can give high affinity and specificity for 
dsRNAs. For example, in the interaction of TRBP and protein kinase R 
(PKR) with dsRNA, each dsRBD domain binds with lower affinity to the 
dsRNAs compared to the multi-domain protein (Ucci et al. 2007; Yamashita 
et al. 2011; Benoit et al. 2013). 
 
The interplay of separate domains on a dsRBP can be dependent on the 
linker region connecting the dsRBDs and therefore the linker may also a 
play a role in the dsRNA interaction of the protein. The linker can be 
important in the formation of dsRBP/dsRNA complex as in some cases the 
linker plays a role in forming the binding surface of the dsRBD by 
specifically folding to form inter-domain contacts (Teplova et al. 2011; 
Mackereth and Sattler 2012).  However, in other cases the linker can be 
intrinsically disordered and flexible and in this case the length of the linker 
may be important rather than the conserved sequence. The flexible long 
linker can also act as a tether by increasing the local concentration of one 
dsRNA-binding domain upon the binding of the other, however this is 
dependent on the length of the linker. In the case of TRBP and ADAR2 
they present examples where the two domains interact with their target 
dsRNAs independently and no physical interaction can be seen between 
the two domains, this can be due to the flexibility and the length of the linker 
connecting the domains (Stefl et al. 2010; Benoit et al. 2013). 
 
1.7 Structure of precursor microRNAs 
 
The role of the structure of pre-miRNAs in recognition by dsRBP still 
remains unclear. Pre-miRNAs have an A-form helical structure and dsRBD 
interaction has been identified to be non-sequence specific. This proposes 
that structural features within pre-miRNAs such as bulges, internal loops 
and non-Watson-crick base pairing may play a role in dsRNA recognition 
by dsRBPs (Figure 1.6) (Krol et al. 2004). In a study on pre-microRNA 
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structure and its effect on binding various dsRBPs it was shown that 
ADAR2 and Staufen1 showed a higher affinity for structured RNAs (pre-
let7 and TAR RNA) (Bevilacqua et al. 1998). However, pre-let-7A and TAR 
RNA only contain some structural defects and not the whole spectrum of 
structural features that pre-miRNAs can exhibit.  The two dsRBDs of PKR 
have also been shown to bind to dsRNAs which contain bulges and internal 
loops (Bevilacqua et al. 1998). PKR dsRBD-1 is capable of binding to 
structurally different dsRNAs much more favourably than PKR-dsRBD2 
(Bevilacqua et al. 1998; Heinicke et al. 2011). 
 
 
 
 
Figure 1.6 Structural features found in pre-miRNAs. 
Structures of pre-miRNAs were created using mfold (Zuker, 2003) . Non 
Watson-Crick base pairs are annotated in black boxes. (A) Structure of Pre-let-
7a-1 (B) Structure of Pre-miR-16-1. 
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1.8 Structure of TRBP and PACT 
 
TRBP and PACT are multi-domain proteins with three dsRBDs, two N-
terminal type-A dsRBDs, which bind to dsRNA and one type-B dsRBD 
found at the C-terminus, which mediates protein-protein interaction (Laraki 
et al. 2008; Yamashita et al. 2011; Benoit et al. 2013; Wilson et al. 2015). 
Comparison of the linker regions between TRBP and PACT show that the 
linker regions are not as highly conserved as the dsRBDs and the length 
of the linker region differs substantially between TRBP and PACT (Figure 
1.7B). 
 
 
 
In both TRBP and PACT, domains 1 and 2 are type-A dsRBDs and have 
been shown to have the ability to bind to dsRNA non-specifically 
(Yamashita et al. 2011; Benoit et al. 2013). When TRBP was first 
discovered it was thought to specifically recognise structured RNAs such 
Figure 1.7 Sequence conservation and domain structure and interaction 
regions of TRBP and PACT 
(A)Sequence conservation of the dsRBDs found in TRBP and PACT. Aligned 
using T-Coffee and rendered using ESPript. 
(B)Schematic of the structure of both dsRBPs which contain 3 dsRBDs. Two 
type-A dsRBDs at the N-terminal with one type-B dsRBD at the C-terminal. The 
third dsRBD has a N-terminal extension for both TRBP and PACT.   
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as HIV-1 trans-activation response (TAR) RNA (Gatignol et al. 1991; 
1993).  But since then both TRBP and PACT have been shown to interact 
with a broad range of dsRNA targets. A linker region in both TRBP and 
PACT separates the two N-terminal dsRBDs. The linker region between 
TRBP-D1 and TRBP-D2 has been shown to be highly flexible and the 
dsRBDs have been shown to not interact with each other in complex with 
dsRNA or in a free conformation, which could be due to the length and 
flexibility of the linker region (Benoit et al. 2013). The effect of the short 
linker between the two dsRBDs in PACT in dsRNA binding remains to be 
elucidated. 
 
The first and second dsRBD structures of TRBP solved by X-ray 
crystallography have shown only minimal differences between the dsRBDs 
with a small shift of the first α-helix (Figure 1.8) (Yamashita et al. 2011). 
Yamashita et al, identified a difference in the domains at the loop between 
α1 helix and β2 strand, which in dsRBD2 possesses an extra tryptophan 
residue (Trp152) (Yamashita et al. 2011). The side chain of this tryptophan 
protrudes into the hydrophobic pocket made up of Lys150 and other 
residues. The interaction between the aromatic ring of Trp152 and the 
positively charged lysine side chain on the opposite side of the dsRNA 
binding surface has been said to contribute to the further stabilization of 
the domain structure.  
 
Structures of TRBP and its binding partners have been studied and 
elucidated. The RNA binding portion of TRBP, TRBP-D1 and TRBP-D2 
have been shown to confer the canonical α-β-β-β-α fold. Interestingly 
TRBP-D1 contains an additional small alpha helix at the N-terminal end 
(α0) (Masliah et al. 2018; Paithankar et al. 2018). This α-helix has been 
shown to fold back on the cleft between α1 and α2 and is stabilized by 
several side chain hydrophobic interactions between α0 and α1 (Figure 
1.8F).  The only structure at the time of writing for PACT is the N-terminal 
type A dsRBD, PACT-D1 (Figure 1.8C). The solution structure highlights 
this dsRBD does not digress from the canonical dsRBD fold. Structures of 
the type-A dsRBDs of TRBP have been elucidated in complex with 
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dsRNAs, a crystal structure of TRBP-D2 with a dsRNA and solution 
structures of TRBP-D1 and TRBP-D2 in complex with a 19 bp siRNA (Yang 
et al. 2010; Masliah et al. 2018). These structures identify that the type-A 
dsRBDs of TRBP interact with dsRNA with the three canonical dsRBD 
interaction regions (Figure 1.8E &F). 
 
The C-terminal domains of TRBP and PACT (TRBP-D3 and PACT-D3) do 
not bind to dsRNA but are required for the interaction with other proteins, 
the presence of a type-B dsRBD is common among dsRNA binding 
proteins (Gleghorn and Maquat 2014). Both TRBP-D3 and PACT-D3 have 
been shown to bind to Dicer and PACT-D3 has also been shown to interact 
with Protein kinase R (PKR) (Park et al. 1994; Heyam et al. 2015) .  There 
is also evidence that both TRBP-D3 and PACT-D3 can homodimerize and 
heterodimerize (Laraki et al. 2008; Singh et al. 2011; Heyam et al. 2018). 
3.2 Å crystal structure of TRBP-D3 binding with the N-terminal helicase of 
Dicer, a four-helix bundle of 97 residues, highlights an interface, which 
comprises a hydrophobic core surrounded by electrostatic interactions 
(Wilson et al. 2015). 
 
 
 
 
38 
 
Figure 1.8 3D structures of TRBP and PACT dsRBDs individually and 
interacting with their respective binding partners. 
(A) Solution structure of TRBP-D1 (PDB: 3LLH) (B) Solution structure of TRBP-
D2 (PBB: 2CPN) (C) Solution structure of PACT-D1 (PDB: 1DIX) (D) Crystal 
structure of TRBP-D3 interacting with part of the Dicer helicase (PDB:4WYQ) 
(E) Crystal structure of TRBP-D2 interacting with a nicked dsRNA (PDB: 
3ADL). (F) Solution structure of TRBP-D1 and TRBP-D2 interacting with a 
19bp siRNA. Structures were visualized using Pymol. 
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1.9 Interaction of TRBP with dsRNA 
 
The RNA binding properties of TRBP have been studied and the two N-
terminal dsRBDs have been shown to interact with dsRNA independently. 
RNA binding affinity studies have suggested that the two dsRBDs bind to 
dsRNA with differing affinities (Table 1.1). However, the difference in 
affinity ranges from low to high depending on the experimental technique 
and the dsRNA used (Table 1.1). Two methods have been used to study 
the interaction of TRBP dsRBDs with dsRNAs, isothermal calorimetry (ITC) 
and electrophoretic mobility shift assays (EMSAs). A difference in binding 
affinity between dsRBDs in multi-domain proteins has been elucidated for 
other proteins such as PKR, HYL1 and ADAR1 (Gabel et al. 2006; Rasia 
et al. 2010). Structural, dynamic and sequence differences have been 
proposed to explain the difference in affinities seen in dsRBDs in proteins.  
 
Table 1.1 Binding affinities of TRBP-D1 and TRBP-D2 with various 
dsRNAs 
RNA Domain KD (µM) Error 
(µM) 
Technique Reference 
Pre-miR-155 D1 15.4 0.8 ITC Benoit et 
al., 2013  D2 3.7 0.5  
21 bp duplex D1 0.22  ITC Yamashita 
et al., 2011  D2 0.11   
TAR RNA D1 8  EMSA Daviet et 
al., 2000  D2 0.06   
22 bp duplex D1 3.5 0.3 EMSA Acevedo 
et al., 2015  D2 1.7 0.1  
33 bp duplex D1 0.9 0.3 EMSA Acevedo 
et al., 2015  D2 1 0.08  
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As mentioned previously, the dsRBDs of TRBP have been shown to bind 
dsRNA non-sequence specifically, however there is evidence for TRBP in 
recognising structural imperfections in pre-miRNAs to the extent of it being 
unable to bind efficiently to imperfections in the dsRNA stem (Takahashi et 
al. 2013). TRBP was seen binding to a dsRNA with a 1x1 nt A.A mismatch 
in the stem with a weaker binding affinity than a perfect dsRNA duplex.  
 
Full length TRBP and PACT have been shown to bind dsRNA with different 
modes of interaction. EMSA and size exclusion chromatography (SEC) 
showed that two molecules of TRBP or PACT bound to one siRNA. 
However, TRBP binds to the siRNA in two sequential steps (Takahashi et 
al. 2013). Whereas, PACT bound to siRNA in one step and the deletion of 
PACT-D3 disrupted this binding mode and the final protein complex was 
formed in two steps. This indicates that PACT dimerization affinity is 
stronger than the siRNA binding affinity and TRBP has a much weaker 
dimerization affinity compared to dsRNA binding affinity. This has been 
further suggested with NMR studies of the third domain of TRBP and 
PACT, PACT-D3 was shown to homodimerize much tighter than TRBP-D3 
with a difference in amino acid composition between the two dsRBDs at 
the dimerization interface being the cause of this difference in 
homodimerization properties (Heyam et al. n.d.). These differences seen 
in the homodimerization and in the interaction of TRBP and PACT with 
dsRNA could allow for Dicer to discriminate between dsRNAs dependent 
on which cofactor of Dicer it is bound.  
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1.10 The properties of RNA binding region 2 in dsRNA 
recognition of dsRBDs 
 
NMR analysis of the two dsRBDs found in HYL1 and their RNA binding 
properties showed that the first dsRBD (HYL1-1) bound to dsRNA with a 
much higher affinity compared HYL1-2. This difference in binding was 
attributed to RNA binding region 2 on both dsRBDs, as the second domain 
showed no interaction of this region with dsRNA in the NMR analysis 
(Rasia et al. 2010). The lack of a histidine residue in the β1-β2 loop of 
HYL1-2 could be a main contributor in the non-interaction of this region, 
however the structural properties of the loop region could also have been 
a contributing factor. The flexibility of loop 2 (RNA binding region 2) has 
been studied for several dsRBDs using NMR relaxation studies, in the apo 
and RNA bound state of dsRBDs (Wostenberg et al. 2010; 2012).  
 
Interestingly analysis of dynamics through (1H-15N) Heteronuclear NOE 
experiments of the two N-terminal dsRBDs of TRBP identified a difference 
in flexibility in the β1-β2 loop region between the two dsRBDs. TRBP-D1 
contained a more flexible loop region compared to TRBP-D2 (Benoit et al. 
2013). The importance of this difference in dynamics for dsRBD function 
has yet to be elucidated; additionally, how this difference in dynamics exists 
between the two dsRBDs has not yet been identified.   
 
Crystal structures of dsRBDs with dsRNA have highlighted that many of 
the dsRNA binding residues use both the backbone and side-chain groups 
to interact with dsRNA. Therefore, the protein backbone flexibility of these 
regions is likely important in playing a role in fine-tuning the dsRNA binding 
interaction of dsRBDs. The importance of amino acid composition and 
length of RNA binding region 2 in dsRBDs has been highlighted in the 
dsRBDs of RDE-4, the β1-β2 loop region is much shorter compared to 
other dsRBDs and lacks important dsRNA binding residues accounting for 
the proteins relatively weak dsRNA binding affinity. 
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1.11 Aim of this study 
 
It has been identified that TRBP is important in the processing of miRNAs 
by Dicer and the loading of the RISC. However, the dsRNA interacting 
properties of TRBP have yet to be fully elucidated. The interaction of the 
individual dsRBDs of TRBP has been somewhat studied but the 
differences in the dsRNA binding properties, amino acid composition and 
motional dynamics in the important dsRNA interacting regions have not 
been as extensively studied compared to other dsRBDs. 
 
Previous studies into the RNA binding regions of the type-A dsRBDs of 
TRBP have only targeted RNA binding region 3. Mutagenesis of this region 
identified its importance in RNA binding of the dsRBDs. Therefore, this 
study will focus on RNA binding region 2 in the β1-β2 loop of the two N-
terminal dsRBDs and determine the role of this region in the specific 
dsRNA recognition of each dsRBD.  
This study will focus on: 
• The amino acid composition of RNA binding region 2 of TRBP-D1 
and TRBP-D2 and how they play a role in dsRNA binding 
o Identification of the residues required for dsRNA binding. 
o Differences in this region between the two dsRBDs. 
• The difference in dynamics of the β1-β2 loop between TRBP-D1 and 
TRBP-D2 
o Further analysis of the difference in loop dynamics 
o The cause of the difference in loop dynamics 
 
This study should elucidate the importance of amino acid composition of 
RNA binding region 2 in the dsRBDs of TRBP. Additionally, investigating 
motional dynamics of dsRNA binding region 2 should highlight the 
importance of structural features of dsRNA binding regions in dsRNA 
interactions.  
 
Investigating RNA binding properties of the dsRBDs in TRBP can help to 
further elucidate how TRBP facilitates Dicer in processing of pre-miRNAs, 
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such as iso-miR production, rate of dicer production, diffusion ability of 
TRBP domains and dsRNA specificity.  
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Chapter 2- Materials and Methods 
 
2.1 Protein production methods 
 
2.1.1 Vector preparations 
 
Codon optimized DNA sequences (Eurofins Genomics) were cloned into a 
pETFPP expression vectors produced by the University of York 
Technology Facility (TF). This vector contained a gene for the resistance 
to kanamycin, an open reading frame coding for a maltose binding protein 
(MBP) solubility tag flanked by a 6xHis tag and a protease cleavage site 
(GLEVLFQ/GPAM) for human rhinovirus (HRV) 3C protease (produce by 
York TF). Due to the cleavage site of 3C protease present between the 
glutamate and glycine, all protein constructs of interest have a non-native 
sequence of GPAM at the N-terminus. List of plasmids can be found in the 
appendix. 
 
The protein of interest used in this study was cloned after the 3C cleavage 
site, the cloning was performed by the University of York TF. A T7 promoter 
and a lac operator element required for protein expression is upstream of 
the ORF. This allowed protein expression to be induced by isopropyl β-D-
1 thiogalactopyranoside (IPTG).  
 
2.1.2 Transformation into E. coli  
 
Transformation of the vector was carried out in the BL21 (DE3) strain of 
Escherichia coli (E. coli). An advantage of this strain is that the genes 
encoding proteases have been removed to prevent degradation of the 
overexpressed protein of interest.  
 
Transformation was carried out with 50 µL of chemically competent E. coli 
cells incubated on ice for 30 minutes with 2 µL of plasmid in a 1.5 mL 
microcentrifuge tube. The mixture was then heat shocked with 45 seconds 
at 42°C followed by incubation on ice for 2 minutes. The mixture was then 
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added to 450 µL of Lysogeny broth (LB) media and incubated at 37°C for 
1 hour with agitation.  The cell mixture was then plated on LB/agar plates 
containing 50 µg/mL of kanamycin and incubated overnight at 37°C. 
2.1.3 Site directed mutagenesis 
 
Primers for site directed mutagenesis of protein constructs were designed 
using PrimerX (http://www.bioinformatics.org/primerx/). Primers were 
designed with specific properties such as length of primer (25-45 nt), 
melting temperatures of < 78°C and GC content was required to be 
between 40%-60%. Mutagenesis was carried out on freshly prepared DNA 
plasmid (100 ng) using the QuickChange lightning mutagenesis kit, the 
reaction was carried out according to the manufactures protocol.  
 
2.1.4 Sequencing of mutant constructs 
 
5 single colonies were picked from LB agar plates for each mutant protein 
construct and used to inoculate 5 mL of LB for 16 hours at 37°C. The 5 mL 
cultures were centrifuged and the extraction of the plasmid was carried out 
using a Miniprep kit (QIAprep Spin Miniprep Kit) according to manufactures 
protocol. Plasmids were then sent off for sequencing (Eurofins genomics). 
The sequenced plasmids were then compared with the WT protein DNA 
sequence and effectiveness of protein mutation was checked.  
 
2.1.5 Protein expression for NMR studies 
 
The same conditions and protocol were used for the expression of all 
labelled protein constructs in this study. 10 mL of LB with 50 µg/mL of 
kanamycin was inoculated with a single colony and grown for 6 hours at 
37° C with shaking at 120 rpm. The optical density at 600 nM (OD600) was 
measured and a volume (V) calculated to give a cell OD600 of 0.05 for the 
new media was extracted and centrifuged. The cells were then 
resuspended in 50 mL M9/kanamycin minimal medium. 
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𝑉 = 𝑂𝐷%&& × 𝑁𝑒𝑤	𝑣𝑜𝑙𝑢𝑚𝑒𝑅𝑒𝑞𝑢𝑖𝑟𝑒𝑑	𝑂𝐷%&&  
 
The 50 mL M9 preculture was grown for 16 hours at 37°C with agitation at 
120 rpm. The cells were then resuspended in 1 L of M9 minimal medium 
again using the above equation to determine a starting OD600 of 0.05 for 
the 1 L culture. The culture was then grown at 37°C for 6-8 hours or until it 
reached an OD600 between 0.6-0.8. Protein expression was then induced 
by supplementing the culture with IPTG (final concentration in culture 1 
mM). After induction the culture was grown at 20°C for 16 hours. The 
culture was then centrifuged at 5000 RCF for 20 minutes to pellet the cells. 
Cell pellets were either stored at -20°C or lysed immediately.  
 
2.1.6 Protein expression in LB 
 
When protein constructs were not required to be labelled for NMR studies, 
protein expression was carried out in LB. A pre-culture of 20 mL of 
LB/kanamycin was inoculated and grown for 16 hours at 37°C with 
agitation at 120 rpm. The optical density was measured, and the volume 
required for a starting OD600 of 0.05 for 1 L of LB was centrifuged and cell 
pellet was resuspended and transferred to the 1 L LB culture. The culture 
was grown for 4 hours or until it reached an OD600 of 0.6-0.8 and induced 
with IPTG, after induction the culture was grown at 20°C for 16 hours. The 
cell culture was then centrifuged at 5000 RCF for 20 minutes to pellet the 
cells. Cell pellets were used as described above.  
 
2.1.7 Assessment of protein expression and solubility  
 
To investigate protein expression and solubility, 50 mL cultures of protein 
constructs were grown as above. Cell pellets were resuspended in lysis 
buffer. Dependent on the method of lysis (chemical or sonication) the lysis 
buffer for chemical lysis was also supplemented with 1 mg/mL of hen egg 
lysozyme (Sigma) and Triton X-100. Gel samples were made of total 
protein before centrifugation, the supernatant and centrifuged cell pellet 
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resuspended in the same volume of lysis buffer. Samples were then 
examined by SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel 
electrophoresis) for protein expression and solubility.  
 
2.1.8 Large scale protein purification  
 
1L cultures of His-MBP tagged protein constructs were grown as above, 
cell pellets were resuspended in lysis buffer as described above and lysed 
using sonication. Sonication of samples were carried out on ice with 3 
minutes total sonication (3s on, 3s off, power level 5.5) carried out twice 
with a short incubation on ice in between (Sonicator 3000 Misonix). The 
lysate was then centrifuged for 30 minutes at 50,000 RCF, the supernatant 
was stored on ice prior to loading over a 5 mL nickel affinity column 
(HisTrap HP GE) equilibrated with Ni-IMAC binding buffer. Bound His-MBP 
tagged protein was then eluted with a Ni-IMAC elution buffer. The eluted 
protein was then buffer exchanged into Ni-IMAC binding buffer using a 
desalting column (HiPrep 26/10 GE). The concentration of the buffer 
exchanged eluted protein was then calculated by UV spectrophotometry 
using the hypothetical extinction coefficients identified by ProtParam 
calculated by the number of tryptophan’s, tyrosine’s and phenylalanine’s 
present in the protein (https://web.expasy.org/protparam/).  
 
Table 2.1 UV extinction coefficients of TRBP constructs 
 
Protein construct Molecular 
weight (kDa) 
ε280 (cm-1M-1) 
TRBP-D1 8.9 2980 
TRBP-D2 8.4 6990 
TRBP-D12 22.9 9970 
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The His-MBP solubility tag was cleaved from the eluted protein using His-
tagged HRV 3C protease (York TF) added in a ratio of 1 mg of protease 
per 50 mg of eluted protein at 4°C for 16 hours. Dithiothreitol (DTT) was 
added to the eluted protein to give a final concentration of 1 mM prior to 
the addition of the 3C protease.  After cleavage a second nickel affinity 
purification was carried out to separate the protein from the His tagged 
solubility tag. 
 
The eluted protein of interest was then concentrated to a volume below 1 
mL using a spin column with a 5 kDa MWCO (VivaSpin 20), which was 
them passed over a S75 Superdex 16/600 column (GE healthcare) 
equilibrated in size exclusion buffer at a flow rate of 1 mL/min. Eluted 
fractions were investigated by SDS-PAGE and fractions containing the 
pure protein of interest were pooled and concentrated (VivaSpin 6). Protein 
samples were then dialysed in the buffer required for the different 
experiments. 
 
2.1.9 Media and buffers for protein production and 
purification 
 
LB medium 
Component Concentration (g/L) 
Tryptone 10 
Yeast Extract 5 
NaCl 10 
Agar (for plates) 15 
 
M9 Base 1 L 
Component Concentration (g/L) 
Na2HPO4 (anhydrous) 6 
KH2PO4 3 
NaCl 0.5 
NH4Cl or  15NH4Cl 1 
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1 L M9 medium 
Component Volume 
M9 base 1 L  
20% D-Glucose or 99% [U-13C] D-
glucose 
10 mL 
1 M MgSO4 1 mL 
100 mM CaCl2 1 mL 
100 mM MnCl2 1 mL 
50 mM ZnSO4 1 mL 
100 mM FeCl3 0.5 mL 
100x Vitamin cocktail (Gibco) 10 mL 
50 mg/ mL Kanamycin 1 mL 
 
Lysis buffer (pH 7.5) used for sonication 
Component Concentration 
HEPES 50 mM 
KCl 100 mM 
MgCl2 10 mM 
CaCl2 10 mM 
Imidazole 10 mM 
Glycerol 10 % 
DNase 20 µg/mL 
Leupeptin 1 µg/mL 
Pepstatin 1 µg/mL 
 
Ni-IMAC binding buffer pH 7.5 
Component Concentration 
Tris-HCl pH 7.5 20 mM 
NaCl 500 mM 
Imidazole 20 mM 
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Ni-IMAC elution buffer pH 7.5 
Component Concentration 
Tris-HCl pH 7.5 20 mM 
NaCl 500 mM 
Imidazole 500 mM 
 
Size exclusion buffer 
Component Concentration 
Tris-HCl 23.5 mM 
KCl 100 mM 
MgCl2 10 mM 
DTT 5 mM 
 
2.2 RNA production methods 
 
Two pre-miRNAs were used in this study. Pre-miR 155 which was based 
on hsa-miR-155 stem loop (miRbase accession code:MI0000681). Pre-let-
7a sequence was based on has-let-7a-1 (miRbase accession 
code:MI0000060). The 5’ and 3’ ends of the RNAs were modified for the 
inclusion of 2 guanines on the 5’ end to aid transcription initiation and the 
3’ end to base pair with the modified 5’ end. 
 
2.2.1 DNA template production 
 
Double stranded DNA templates for RNA production were designed with a 
T7 promoter sequence and created by annealing two oligonucleotides 
(Appendix). The two oligonucleotides, a forward and reverse primer, 
required for the dsDNA template were annealed in DNA annealing buffer 
by heating a mixture of the two primers at 95 °C for 5 minutes and then 
letting the mixture cool at room temperature for 20 minutes. DNA templates 
were then investigated by gel electrophoresis. 100 ng of DNA in 2x loading 
buffer was loaded on an agarose gel and run for 100 Volts for 50 minutes.  
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2.2.2 RNA production 
 
RNAs of interest were produced through an in vitro transcription (IVT) 
reaction. DNA templates were incubated with components required for IVT 
for 4 hours at 37°C, the reaction was stopped by the incubation of the 
reaction at -20°C. 
 
50 µL IVT reactions 
Components Volume (µL) 
rATP (100 mM) 2 
rUTP (100 mM) 2 
rGTP (100 mM) 2 
rCTP (100 mM) 2 
GMP (100 mM) 2 
MgCl2 (100 mM) * 
T7 RNA polymerase (40ug/ul) 1.3 
10x T7 buffer 5 
Nuclease free H20 * 
DNA template (500 ng/ µL) 3.5 
*Volume depends on the specific MgCl2 concentration required for the 
dsRNA 
 
10X T7 buffer 
Components Concentration 
Tris-HCl pH 8 400 mM 
Spermidine 10 mM 
DTT 50 mM 
Triton X-100 1% 
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2.2.3 Large scale RNA purification 
 
RNA IVT reactions were purified by anion exchange chromatography. 1 mL 
of the reaction was passed over a 1 mL MonoQ HR 5/50 GL column (GE 
Healthcare) equilibrated with Anion exchange Buffer A. Bound RNA was 
then eluted using a gradient of Anion exchange Buffer B. An initial elution 
gradient from 0-100% per mL was carried out to determine the elution 
volume of the RNA of interest. The elution gradient was then optimized 
according to the RNA purified. Contents of eluted fractions were then 
analysed by gel electrophoresis using a 15% urea denaturing gel to check 
for pure RNA fractions. 
 
2.2.4 3’ RNA labelling 
 
RNAs were labelled at the 3’ end with fluorescein 5-thiosemicarbazide 
(FTSC). 0.5 nmoles of RNA was labelled in a 50 µL reaction volume. The 
labelling strategy uses two steps (Zearfoss and Ryder 2012). First the 3’ 
terminal ribose sugar is oxidized forming a reactive aldehyde. This oxidized 
sugar is then conjugated to an aldehyde-reactive chemical tag (FTSC). 
Oxidation is carried out by sodium periodate and as this requires vicinal 
hydroxyls, the reaction is specific to RNAs and only modifies the 3’ terminal 
ribose.  
 
Step 1- Oxidation of the terminal ribose sugar 
The reaction was assembled as described below and reacted for 90 
minutes at room temperature. The RNA was then precipitated by adding 
2.5 µL of 5 M NaCl, 1 µL of 20 mg/ml glycogen and 100 µL of 100% ethanol. 
Incubated at -20°C for 20 minutes and spun at 16,000x g for 25 minutes.  
 
Reagent Volume (µL) 
Sodium acetate pH 5.2 (0.5 M) 10  
RNA (100 µM) 5 
NaIO4 10 
H2O 25 
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Step 2 -Labelling of the reactive aldehyde 
The pelleted RNA from the previous reaction was resuspended in FTSC 
labelling solution and incubate at 4°C overnight in the dark. 
FTSC labelling solution 
Reagent Volume (µL) 
Sodium acetate pH 5.2 (0.5 M) 80 
FTSC (200 mM) 3 
H2O 317 
 
 
Step 3-RNA clean up 
The labelled RNA was precipitated as mentioned above and resuspended 
in 20 mM Tris-HCl pH 7.5. The RNA was then further purified using a 
centrifuge spin column (Bio-Spin 6,Bio-rad) equilibrated in 20 mM Tris-HCl 
pH 7.5. 
 
Successfulness of labelling was determined by running labelled product on 
a 15% urea denaturing gel and visualising the gel on an Amersham 
Typhoon (GE) based on the excitation and emission of the dye (Ex492: 
Em:516). 
2.2.5 Buffers for RNA production 
 
DNA annealing buffer 
Component Concentration 
Tris-HCl pH 8.0 10 mM 
NaCl 50 mM 
EDTA 1 mM 
 
Anion exchange Buffer A 
Component concentrations 
Tris-HCl pH 7.0 20 mM 
NaCl 100 mM 
MgCl2 10 mM 
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Anion exchange Buffer B 
Components concentrations 
Tris-HCl pH 7.0 20 mM 
NaCl 1000 mM 
MgCl2 10 mM 
 
2.3 Gels  
 
2.3.1 SDS PAGE 
 
Gel components 
Component 15% resolving gel 4% stacking gel 
30% Acrylamide (40:1) 4.9 mL 650 µL 
1.5 M Tris-HCl, pH 8.8 2.5 mL - 
0.5 M Tris-HCl pH 6.8 - 1.25 mL 
10% SDS 100 µL 50 µL 
Distilled H20 2.5 mL 3.05 mL 
10% APS 100 µL 50 µL 
TEMED 10 µL 5 µL 
 
Running buffer 
Component Concentration 
Tris 3 g/L 
Glycine 14 g/L 
SDS 1 g/L 
 
Sample buffer 
Component  
1M Tris-HCl pH 7.2 1 mL 
Distilled H20 3 mL 
10% SDS 10 mL 
Bromophenol blue 0.06 g  
Glycerol 12 g 
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Staining 
1 L Coomassie stain  
Component  
Ethanol 450 mL 
Acetic Acid 100 mL 
Distilled H20 450 mL 
Brilliant Blue R 2.5 g 
 
1 L Destain 
Component  
Ethanol 100 mL 
Acetic Acid 100 mL 
Distilled H20 800 mL 
 
2.3.2 Agarose gel 
 
Components for 2% gel 
Component  
Agarose 2 g 
1XTBE 100 mL 
Sybr™ Safe DNA gel stain 10 µL 
*Running buffer 1XTBE 
 
2.3.3 Urea denaturing gel 
 
Components for 15% gel 
Component  
40% Acrylamide 9.4 mL 
10X TBE 2.5 mL 
Urea 10.5 g 
APS 10% 100 µL 
TEMED 10 µL 
H2O 5.6 mL 
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2.3.4 Native Gel for EMSA 
 
10% Native gel 
Component Volume 
40% Acrylamide 3 mL 
10X TBE 1 mL 
APS 10% 100 µL 
TEMED 10 µL 
H2O 9 mL 
 
*Running buffer 1XTBE 
 
Running buffer 1X TBE made from 10x TBE used for both native and 
urea denaturing gels 
10XTBE components   
Tris base 108 g 
Boric acid 55 g 
EDTA, sodium salt 7.5 g 
 
Staining of RNA for EMSAs and urea denaturing gels were carried out 
using Sybr™ Gold. Gels were incubated in 40 mL of 1xTBE with 4 µL of 
stain. 
 
Molecular weight ladders used 
Ladder Gel Company 
Precision Plus Protein™ SDS page gels Bio-Rad 
Low range ssRNA ladder Urea denaturing 
gels  
BioLabs Inc 
dsRNA ladder Urea denaturing 
gels 
BioLabs Inc 
Low molecular weight 
ladder 
Agarose gel BioLabs Inc 
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2.4 Biophysical methods 
 
2.4.1 SEC-MALS 
 
SEC-MALS is the combination of size exclusion chromatography with 
multi-angle light scattering analysis. This technique enables 
characterisation of protein properties such as size and oligomerisation 
state. The measurement of light scattered by a molecule into a plurality of 
angles is used to determine the absolute molar mass and average size of 
a molecule in solution. The light scattered by a molecule such as a protein 
is proportional to both the mass concentration and molecular weight of the 
protein (Wyatt 1993). 
 
100 µL of purified protein sample at 3 mg/ml was passed over a Superdex 
75 10/30 analytical gel filtration column (GE Healthcare), pre-equilibrated 
in SEC-MALLS buffer at a flow rate of 0.5 mL/min. The light scattering, and 
refractive index measurements were recorded using in-line Wyatt Dawn 
HELEOS-II and Wyatt rEX Optilab detectors. The measurements were 
then analysed using ASTRA software version 5.3.4.12 (Wyatt Technology).  
 
SEC-MALLS buffer pH 6.5 
Component Concentration 
Phosphate buffer 23.5 mM 
KCl 100 mM 
MgCl2 10 mM 
DTT 5 mM 
 
2.4.2 Circular dichroism 
 
Circular dichroism (CD) uses the calculated difference between the 
absorption of left-handed circularly polarised light and right handed 
circularly polarised light dependent on a molecule that contains one or 
more chiral chromophores. Measurements of molecules are carried out in 
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the visible and ultra-violet (UV) region. The molecule of interest containing 
chiral chromophores will absorb one circular polarised light (CPL) state 
more than the other and the CD signal over the corresponding wavelength 
will be non-zero. The CD signal is either positive or negative depending on 
which CPL state is absorbed to a greater extent. A positive CD signal is 
given if the left CPL is absorbed greater than the right CPL and a negative 
signal is given if the left CPL is absorbed less than the right CPL 
(Greenfield 2007). 
 
The absorption of L-CPL and R-CPL can be used in structural biology to 
evaluate the secondary structure, folding and binding properties of proteins 
(Greenfield 2007). The chromophores in the amides of the polypeptide 
backbone of proteins are used in CD spectroscopy and different structural 
elements in proteins have characteristic CD spectra. Proteins with α-helical 
structures have negative bands at 222 nm and 208 nm and a positive band 
at 193 nm. Proteins with β-pleated sheets have negative bands at 218 nm 
and positive bands at 195 nm (Greenfield 2007). Unstructured proteins 
have low ellipticity above 210 nm and negative bands at 195 nm. 
Therefore, CD spectroscopy is a useful tool to determine the structural 
characteristics of proteins. 
 
CD of the protein of interest was carried out on a JASCO J-810. A CD curve 
of the buffer alone was taken before a CD curve of the protein to normalise 
the CD signal of the protein.  CD spectroscopy was carried out on a 400 
µL sample of protein at a concentration of 0.1 mg/mL in a 1 mm pathlength 
cuvette.  
 
CD data in millidegrees for each protein construct were extracted and the 
molar ellipticity for the protein constructs was calculated from the original 
CD data given in millidegrees using the equation below.  
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(𝜃) = 𝑚° ×𝑀10 × 𝐿 × 𝐶 
 
θ = molar ellipticity (deg*cm2dmol) 
m° = millidegrees 
M= average molecular weight (g/mol) 
L= path length of cell (cm) 
C= concentration (mg/mL) 
 
CD buffer 
Component Concentration 
Bis-Tris propane 23.5 mM 
KCl 100 mM 
TECEP 1 mM 
 
2.5 Nuclear magnetic resonance spectroscopy 
 
Nuclear magnetic resonance (NMR) is a specific spectroscopy technique 
on nuclei used in far reaching applications throughout the biological 
sciences (Marion 2013). NMR utilizes a large superconductive magnet to 
probe the intrinsic spin properties of atomic nuclei and uses 
electromagnetic waves in the radio frequency range to manipulate spins 
alignment.  
The principle of NMR is based on the quantum-mechanical property of a 
nuclei also known as spin, which depends on the organisation of the 
protons and neutrons of the nuclei. Atomic nuclei with an even number of 
protons and neutrons have zero spin and atomic nuclei which contain an 
odd number of protons and neutrons have a non-zero spin and have a 
magnetic dipole moment. Nuclei such as 1H,13C,15N, 31P and 19F are useful 
in NMR as their spin of value ½ make their behaviour in a magnetic field 
easy to predict, in contrast with other non-zero spin value and are almost 
exclusively used. The magnetic moment of these nuclei forces the spin to 
behave as tiny bar magnets (dipole) (Levit. 2008). 
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As described above NMR takes advantage of nuclei with ½ spin as they 
can only exist in one of two possible states in an applied magnetic field. 
The spin will naturally line up either parallel (low energy state) or 
antiparallel (high energy state) to the direction of an external magnetic field. 
This alignment can be perturbated by applying a secondary oscillatory 
magnetic field in the form of a radio wave of frequency specific to the 
observed nucleus and the static magnetic field (Larmor frequency). As the 
nuclei spin returns to its low energy state, energy is emitted by the nuclei 
in the form of a RF radiation at a frequency close to the excitation frequency 
depending both on the static magnetic field and the local magnetic field 
perceived by the atom. The relaxation of the nucleus to its equilibrium state 
in a magnetic field can be measured using coil probes placed in close 
proximity to the sample to give an NMR signal also known as the free 
induction decay (FID) which can be processed by Fourier transform to yield 
an NMR spectrum of the nuclei. 
The relaxation of a nucleus to its equilibrium state is related to its resonant 
frequency. The resonant frequency of the relaxation is dependent on the 
local magnetic field perceived by the nucleus, this field is affected by the 
chemical environment and neighbouring nuclei. Therefore, the chemical 
environment of a specific nucleus can be derived from its resonant 
frequency. This can allow for different nuclei in a molecule to be 
distinguished and create distinguished peaks in the NMR spectrum. The 
difference between the radiation frequency of a reference nuclei (methyl 
protons of DSS in my experiment), and the observed frequency of a nuclei 
in its environment is the chemical shift of this specific nucleus and is 
measured in parts per million (ppm). 
 
NMR spectroscopy can be a powerful tool in obtaining structural and 
dynamic information of proteins.  In proteins NMR spectroscopy the most 
commonly probed nuclei are 1H,15N and 13C, these nuclei can be found in 
the backbone of proteins or the side chain groups of amino acids.  
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Fast time-scale local motions of proteins can be obtained by NMR 
spectroscopy by investing specific spin relaxation times. Spin relaxation 
methods of proteins most commonly probe the amide 15N spin which will 
elucidate the motion of the protein backbone (Jarymowycz and Stone 
2006; Kleckner and Foster 2011).  
 
2.5.1 2D Nuclear magnetic resonance spectroscopy 
 
(1H-15N) HSQC is one of the most common experiments for the study of 
proteins by NMR as it displays the proton and nitrogen chemical shifts of 
the backbone amide groups of proteins. A HSQC spectrum gives a 2D 
spectrum with one axis for the proton and one axis for the nitrogen and the 
spectrum contains a peak for each unique proton attached to a nitrogen. 
Therefore, an amide in the protein backbone will yield a peak in the HSQC 
spectra and displays a fingerprint of the protein backbone.  
 
(1H-15N) Transverse relaxation-optimized spectroscopy (TROSY) is 2D 
NMR technique most commonly used to study larger proteins. (1H-15N) 
TROSY experiments were used for analysis of the double domain protein 
construct, TRBP-D12.  
 
2.5.2 3D Triple resonance backbone assignment 
 
The assignment of a protein amide cross peak in a (1H-15N) HSQC/TROSY 
experiment can be carried out by using 3D triple resonance experiments 
where a third nucleus is probed (13C) (Ikura et al. 1990). 3D triple 
resonance experiments can probe the side chain carbons or carbonyls 
directly linked to an amide in an amino acid or the carbons of the preceding 
amino acid. For example, a 3D HNCO experiment reports on the carbonyl 
group of the preceding amino acid. A 3D HNCACO experiment reports on 
the carbonyl group of the amino acid probed and the carbonyl group of the 
preceding amino acid. Using these experiments, the NH cross peaks of 
amino acids can be sequentially linked helping with the backbone 
assignment. Additional experiments such as a HNCA and HNCOCA 
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experiment can be used in the same manner which probe the Cα, to 
sequentially link (1H-15N) cross peaks. Once sequentially linked the type of 
amino acid the NH cross peak represents can be elucidate by the side 
chain carbon chemical shifts elucidated from HNCACB or HNCOCACB 
experiments. These give chemical shifts for the Cα and Cβ linked to the 
NH group. The sequentially linked NH cross peaks can then be assigned 
with the protein sequence.  
 
Spectra of triple resonance assignment experiments were analysed, and 
backbone assignment of proteins were carried out using CcpNMR Analysis 
version 2.4 (Vranken et al. 2005). 
 
2.5.3 15N relaxation experiments 
 
T1 relaxation experiments determine the rate at which magnetization 
returns to the thermodynamic equilibrium along the z-axis. T1ρ is 
characterized by the decay of magnetisation spin-locked by a radio 
frequency field. T1p can be converted into giving spin-spin relaxation time 
(T2), which is the decay constant for the component of magnetization that 
is perpendicular to the external field. (1H-15N) heteronuclear NOE 
experiments provide information about the motion of individual N-H bonds 
residues which have a faster motion than the overall tumbling of the 
molecule, show a decreased NOE intensity compared to the residues in 
structured regions. All three relaxation experiments are affected by the 
local motion of a protein and can shed light on the dynamics of a protein 
(Palmer 2004; Kleckner and Foster 2011). 
 
2.6 NMR experimental set up 
 
For all NMR samples purified protein were prepared with 10% D20 and 0.05 
mM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) and loaded either in 
a 5 mm thin wall NMR tube (Wilmad) or a 5 mm thin Shigemi tube (Shigemi 
Inc). NMR data collection was carried out on two spectrometers (Table 
2.2). 
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Table 2.2 NMR spectrometer details 
Spectrometer Field (MHz) Probe Abbreviation 
Bruker Avance II 700 Triple 
resonance 
cryoprobe 
700_York 
Bruker Avance I 800 Triple 
resonance 
cryoprobe 
800_Shef 
 
 
2.6.1 (1H-15N) HSQC 
 
HSQC experiments were carried out in Tris-HCl pH 6-7.5 20 mM, 100 mM 
KCl,10 mM MgCl2 and 5 mM DTT all carried out on the 700_York using the 
pulse sequence hsqcetf3gpsi. Nitrogen and proton offsets used were 118 
ppm and 4.7 ppm respectively, the spectral widths used were 28 ppm for 
nitrogen and 16 ppm for proton. Most (1H-15N) HSQC experiments were 
recorded with 2048 real and imaginary points in the proton dimension and 
128 real and imaginary points in the nitrogen dimension.  
 
HSQC spectra were processed using TopSpin version 3.5 pl 7. An 
apodization function, zero filling, Fourier transformation and phase 
correction (if required) were carried out. A gaussian function was applied 
to in the 1H and the indirect dimension.  
 
2.6.2 Assignment of WT TRBP-D12 and TRBP-D12Mut 
 
Assignment of WT-TRBP D12 was carried out on 0.5 mM sample of [15N-
13C] labelled sample in 20 mM Tris-HCL pH 6.5, 100 mM KCl, 10 mM 
MgCl2, 0.5% Glycerol, 5 mM TECEP, 10% D20, 0.05 mM of DSS at pH 7.0. 
Experiments were recorded on the 800_Shef at 4°C. Experimental 
parameters are described below. 
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Table 2.3 Experimental parameters for assignment of WT-TRBP-D12 
and TRBP-D12Mut 
Pulse sequence Nucleus Offset 
(ppm) 
Spectral 
width 
(ppm) 
No of points 
(real & 
imaginary) 
Trosyetf3psi.2 1H 
15N 
 
4.7 
117 
12.5 
36 
4096 
256 
Trhncogp3d 1H 
15N 
13C 
4.7 
117.5 
173 
12.5 
30 
14 
2048 
60 
80 
 
Trnhncacogp3d 1H 
15N 
13C 
4.7 
117.5 
173 
12.5 
30 
14 
2048 
48 
80 
Trnhncacbgp3d 1H 
15N 
13C 
4.7 
117.5 
41 
12.5 
30 
70 
2048 
48 
180 
Trnhncocacbgp3d 1H 
15N 
13C 
4.7 
117.5 
41 
12.5 
30 
70 
2048 
48 
180 
Trnhncaetgp3d 1H 
15N 
13C 
4.7 
117.5 
52 
12.5 
30 
28 
2048 
48 
180 
Trnhncocaetgp3d 1H 
15N 
13C 
4.7 
117.5 
52 
12.5 
30 
28 
2048 
48 
180 
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2.6.3 Backbone assignment of TRBP-D1 Q56P and TRBP-
D2 P186Q 
 
Assignment of TRBP-D1 Q56P and TRBP-D2 P186Q was carried out on 
~1-1.5 mM sample of [15N-13C] labelled sample in 20 mM Tris-HCl pH 6.5, 
100 mM KCl, 10 mM MgCl2, 0.5% Glycerol, 5 mM TECEP, 10% D20, 50 
uM of DSS at pH 7.0. Experiments were recorded on the 700_York. 
 
Table 2.4 Experimental parameters for assignment of TRBP-D1 Q56P 
and TRBP-D2 P186Q 
Pulse sequence  Offset 
(ppm) 
Spectral 
width 
(ppm) 
No of points 
(real & 
imaginary) 
B_trosyetf3psi.2 1H 
15N 
 
4.7 
117 
12.5 
36 
4096 
256 
B_trhncagp3d.2 1H 
15N 
13C 
4.7 
118 
53.2 
13.7 
26 
30 
 
1024 
128 
200 
B_trhncacbgp3d.2 1H 
15N 
13C 
4.7 
118 
42.5 
13.7  
26 
65 
1024 
160 
180 
B_trhncocacbgp3d.2 1H 
15N 
13C 
4.7 
118 
42.5 
13.7  
26 
65 
1024 
160 
180 
B_trhncacogp3d.2 1H 
15N 
13C 
4.7 
118 
173.5 
13.7 
35 
14 
1024 
160 
180 
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2.6.4 15N relaxation experiments of WT TRBP-D12 and 
TRBP-D12Mut 
 
15N T1, T1ρ and (1H-15N) Heteronuclear NOE relaxation experiments were 
recorded using the Sheffield_800 spectrometer at 4°C on a ~0.35 mM [15N] 
labelled sample of WT TRBP-D12 and a ~0.35 mM [15N] labelled sample 
of TRBP-D12Mut. The buffer used was 20 mM Tris-HCl pH 7.0, 100 mM 
KCl, 10 mM MgCl2 and 5mM TECEP at pH 7.0. T1 experiment were 
recorded with randomly ordered relaxation delays of 
0,80,240,400,640,800,1200,1760,2400 (ms) with a repeated relaxation 
delay of 400ms. T1ρ experiment were recorded with randomly ordered 
relaxation delays of 1,20,30,40,60,90,110,150,200 (ms) with a repeated 
relaxation delay of 20ms. (1H-15N) Heteronuclear experiments were carried 
out using a recycle delay of 10 seconds.  
 
The exact same buffer conditions and experimental parameters were used 
for calculating 15N relaxation rates for WT TRBP-D2 and TRBP-D2 P186Q. 
All relaxation experiments were carried out on the 800_Shef. 
 
Relaxation data was processed using Felix NMR, the first dimension 1H 
and the indirect dimension (15N) were processed with a sine-bell function 
and phase shifted. Zero filling and baseline corrections were applied. The 
data was then referenced to DSS, which has a peak at 0 ppm in the one-
dimensional 1H spectrum. 
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Table 2.5 Experimental parameters for 15N relaxation experiments  
Pulse sequence Nucleus Offset 
(ppm) 
Spectral 
width (ppm) 
No of points 
(real & 
imaginary) 
Trosyetf3gpsi.2 1H 
15N 
 
4.7 
117 
12.5 
36 
4096 
256 
T1N15_tr.nl 1H 
15N 
 
4.7 
117.5 
12.5 
30 
2048 
260 
T1rhoN15_tr.nl 1H 
15N 
 
4.7 
117.5 
12.5 
30 
2048 
260 
N15HetNoe_tr.nl 1H 
15N 
 
4.7 
117.5 
12.5 
30 
2048 
260 
 
 
2.6.5 15N Relaxation data analysis 
 
CCPN analysis version 2.4 was used to transfer cross peak assignments 
to the relaxation data. T1 and T1ρ values were obtained from a two-
parameter exponential decay to zero model (Equation below). The errors 
in the relaxation rates calculated using the bootstrap error method on 
CCPN analysis 2.4. 𝐼(@) = 𝐼(0)	exp	(− 𝑡𝑇G,GI) 
I(t) =Intensity of peak at time point (t) 
I(0) =Intensity of peak at 0 
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(1H-15N) Heteronuclear-NOE values were calculated from the ratio of peak 
intensities from the proton saturated (Sat) and non-proton saturated 
experiment (ref).  
 𝑁𝑂𝐸	𝑣𝑎𝑙𝑢𝑒 = 	 𝑆𝑎𝑡	𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦𝑅𝑒𝑓	𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 
 
                     𝐸𝑟𝑟𝑜𝑟 = 𝑎𝑏𝑠	(𝑣𝑎𝑙𝑢𝑒) ×	R(S TU@	VWXYZTU@	XV@ZVYX@[\] + ( _Z`	VWXYZ_Z`	XV@ZVYX@[)]) 
 
 
2.6.6 T1ρ conversion to T2 
 
T1ρ rates calculated were converted to T2 values using the equation below 
(Lakomek et al. 2012). It uses T1 and T1ρ values to calculate T2 value. T1 
and T1ρ were first converted to R1 and R1ρ, using these values and the 
equation below R1ρ rates were converted to R2. 
 𝑅] = ((𝑅GI −	𝑅G)𝑐𝑜𝑠]𝜃)𝑠𝑖𝑛]𝜃  
 
 θ = W1/ΔW 
ΔW = spin lock frequency offset (9528.99) – 15N shift in Hz 
W1= spin lock field strength = 1866 
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2.7 RNA protein interaction studies 
 
2.7.1 Electrophoretic mobility shift assay 
 
Electrophoretic mobility shift assay (EMSA) is a commonly used 
electrophoresis technique used to study the interaction of protein with 
nucleic acids (Fried 1989). It can identify if a protein binds to a nucleic acid 
or even the binding affinity of a protein for a specific nucleic acid. It can 
also determine if one or more protein molecules are involved in binding. 
EMSA depends on the migration of the complex compared to the free 
molecule in a native acrylamide gel. Complex formation dependent on 
protein concentration can be used to determine the binding affinity of a 
protein.  
 
A constant concentration of RNA was incubated with an increasing 
concentration of protein in EMSA binding buffer (20 mM Tris-HCl pH 6.5, 
200 mM NaCl, 5% Glycerol) and run on an 10% native gel. The gel was 
run at 100 volts for 2 hours at 4°C. The free RNA and RNA-protein complex 
was then visualised by Sybr™ Gold staining, a fluorescent stain that 
detects nucleic acids. The gels were then imaged using BioRad Gel Doc™ 
EZ gel documentation system. The estimated affinity of the protein 
construct for the dsRNA was calculated by analysis the disappearance of 
the free RNA band. 
 
2.7.2 Fluorescence anisotropy to measure RNA: protein 
binding affinities 
 
Fluorescence anisotropy is a principle where light emitted by a fluorophore 
has unequal intensities across different axes of polarization. The 
anisotropy can describe the tumbling rate of a molecule the fluorophore is 
attached to. This principle can be used to measure binding constants of 
complexes by measuring the change in anisotropy caused by the change 
in rotational time when a molecule is bound to a partner molecule. Binding 
is calculated by using the difference in anisotropy of the free, partially 
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bound and fully bound molecule. It can be used to monitor protein-nucleic 
acid interactions (Pagano et al. 2011). 
 
Titrations were performed using increasing concentrations of protein with 
50 mM 3’ fluorescin labelled RNAs in 200 uL volumes. The reaction buffer 
contained 20 mM Tris pH 7.5, 200 mM KCl, 5 mM TECEP and 5% glycerol. 
Fluorescence readings were taken in a black flat-bottom 96-well plate 
(NUNC) at 25°C in a BMG POLARstar Optima plate reader with the 
detector gain set on 50 mM of labelled RNA.  
 
2.7.3 Determination of binding model for the interaction of 
RNA: protein 
 
When fitting a model to the binding isotherm obtained from the 
fluorescence anisotropy, to give an assessment of the binding behaviour 
of the RNA-protein interaction, there are few things that have to be 
considered. A sensible binding model would have to consider parameters 
such as stoichiometry of the reacting molecules.  In previous research on 
TRBP interacting with pre-miRNAs, it has been identified that two double 
domain constructs can bind to one pre-miRNA, which also allows for four 
single dsRBDs to bind one pre-miRNA (Benoit et al., 2013). The RNA: 
protein stoichiometry of 1:4 for our reactions makes the fitting of the 
saturation curve obtained from fluorescence anisotropy complicated.  
Although we suspect that each site is a single independent binding site, 
each domain binding to the RNA will have a different macroscopic binding 
affinity. Due to when each site on the pre-miRNA is continuously filled by 
a dsRBD it reduces the number of free sites available on the pre-miRNA 
for the subsequent binding domain. The macroscopic binding constants or 
the stepwise equilibrium constant of each domain binding to the RNA 
cannot be identified from this RNA: protein interaction study as the 
distinctive binding steps of the RNA being saturated (1:1, 1:2, 1:3 or 1:4 
RNA: protein complexes) cannot be extracted from the fluorescence 
anisotropy data. Fluorescence anisotropy lacks the precision for this.  The 
binding isotherm produced cannot be reliably fitted to a model with four 
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different binding constants. Therefore, the most appropriate approach to fit 
the binding isotherms is to fit the data to an equation of single identical 
independent binding sites, which will estimate the overall binding constant. 
Although this model cannot precisely define the stepwise binding constants 
of each single domain it will provide us with a global affinity of the four 
domains binding to one pre-miRNA. This model can still aid in comparing 
the binding properties of the various protein constructs and discover the 
most interesting constructs for further informative investigation. 
 
The dissociation constants for the RNA protein complexes were 
determined by fitting the binding curves with the equation below in Prism 
(GraphPad). The equation is based on a one site binding model. 
 
 
                               𝑌 = cdUe	×	f	ghi	f                                 
 
 
Y= Change in anisotropy 
Bmax= maximum change in anisotropy 
X= protein concentration  
KD= is the dissociation constant.  
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Chapter 3- Analysis of protein and RNA 
constructs produced in this study 
 
3.1 Production of recombinant TRBP domains 
 
3.1.1 Introduction 
 
Recombinant proteins are used throughout the biological sciences and the 
production of proteins for scientific studies is a biotechnological process. It 
can be accomplished by the manipulation of gene expression in organisms 
or using cell free expression systems. Chemical synthesis of proteins is not 
viable for most proteins due to their size and their complexity; therefore, 
cells and their cellular machinery are used to produce proteins from 
modified genetic templates. The most commonly used cellular expression 
systems are bacterial cells, insect cells and mammalian cells. Each system 
has its own advantages and disadvantages, ranging from yield, protein size 
capabilities and post-translational modification of proteins. Bacterial protein 
expression systems contain advantages such as effortlessness of culture 
growth and the production of high yields of recombinant protein. 
Studies required milligram quantities of highly purified protein, occasionally 
specific isotope labelled, therefore expression of TRBP constructs were 
carried out in E. coli. TRBP is a multi-domain protein with three dsRBDs 
separated by long flexible linkers. The two N-terminal dsRBDs interact with 
dsRNA whereas the C-terminal dsRBD interacts with protein cofactors of 
TRBP (Gatignol et al. 1991; Laraki et al. 2008; niels et al. 2009). Interested 
in the RNA binding properties of TRBP, the third domain (TRBP-D3) was 
disregarded and protein constructs from the RNA binding portion of TRBP 
were produced (Table 3.1). Each protein construct was flanked by a His-
MBP affinity and solubility tag to aid with the solubility and purification of 
the protein. 
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3.1.2 Solubility test of protein constructs using different 
lysis methods 
 
To determine the best method of cell lysis for protein solubility, two 
methods were tested with protein constructs TRBP-D2 and TRBP-D12.  50 
mL cultures of E. coli BL21 (D23) cells expressing the protein of interest 
were grown, split into two and centrifuged. Cell pellets were either lysed by 
using a buffer with lysozyme or by sonication. Gel samples were made of 
the: total cell content after lysis, supernatant after centrifugation and the 
cell pellets (Figure 3.1). 
 
 
 
 
 
 Residue 
number 
No of amino 
acids 
Predicted 
molecular 
weight (kDa) 
Molecular 
weight with 
tag (kDa) 
TRBP-D1 19-99 80 8.9 51.9 
TRBP-D2 157-228 71 8.4 51.4 
TRBP-D12 19-228 209 22.9 65.9 
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Figure 3.1 Lysis test of TRBP constructs to check for solubility. 
15% SDS-PAGE gel of the lysis tests and solubility of TRBP-D2 and TRBP-
D12. For each test; 3 lanes were run: Total protein before centrifugation 
(T); Supernatant after centrifugation (S); and pellet resuspended after 
centrifugation (P). Lane (L) is the protein ladder, with masses in kDa. The 
band seen around 15 kDa in the lysis buffer lanes is lysozyme. TRBP-D2 
is the overexpressed band at around 50 kDa. TRBP-D12 protein band is 
around 75 kDa. 
 
The lysis test results show that both methods can extract soluble protein 
from cells. TRBP-D1 was not tested but due to its similarity in domain 
structure would be anticipated to behave similarly to the TRBP-D2 
construct. Sonication was taken forward for future purifications of proteins 
due to the ease of this method with large-scale cultures with smaller cell 
suspension volumes. Sonication is also advantageous in the breakdown of 
nucleic acids without the need of DNase and RNase which can affect 
downstream assays. 
 
 
 
TRBP-D12 
TRBP-D2 
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3.1.3 Scale up of protein expression and purification of 
TRBP constructs 
 
1 L cultures of the His-MBP tagged TRBP constructs were grown in either 
M9 minimal medium containing (15N) labelled ammonium chloride or both 
(15N) labelled ammonium chloride and (13C) labelled glucose for NMR 
related studies or in LB for higher yields and non-NMR related studies. 
 
Following lysis of the cell pellet by sonication, several steps were carried 
out to purify the protein of interest and obtain pure protein. The protein of 
interest was purified form the endogenous E. coli proteins using nickel 
immobilized metal affinity chromatography (Ni-IMAC). Once purified, the 
protein was cleaved away from its affinity tag (His-MBP) by the protease 
3C and a second nickel IMAC purification step was carried out to remove 
the cleaved protein construct from the affinity tag (Figure 3.2). 
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Figure 3.2 Purification of TRBP constructs by Ni-IMAC 
15% SDS-PAGE gel analysis of Nickel IMAC purification of TRBP constructs. A) SDS-
PAGE of TRBP constructs after the 1st Nickel IMAC purification and cleavage.  For each 
TRBP construct four lanes were run: Protein sample pre Ni-IMAC (PH); Flow-through 
from Ni-IMAC purification (FT); Elution of bound protein from Ni-IMAC (E); protein 
construct after dialysis and 3C protease cleavage (AC); White astericks are used to 
highlight the protein of interest. B) Example of 2nd Ni-IMAC purification of TRBP-D1 after 
cleavage of the affinity tag. 15% SDS page gel accompanied by the 2nd Ni-IMAC 
purification profile.  
TRBP-D12
TRBP-D1 &D2
His-MBP
**
*
TRBP-D1
His-MBP
Elution volume (mL)
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Following the 2nd Ni-IMAC purification, fractions containing the protein of 
interest were first concentrated and then purified using SEC (Figure 3.3). 
 
 
 
Figure 3.3 Size Exclusion chromatography of TRBP constructs.  
A) TRBP-D1 and TRBP-D2 SEC profiles (B) TRBP-D12 SEC profile. 5 mL fractions 
of the single dominant peaks seen for each protein construct were run on a 15% 
SDS-PAGE gel for analysis, displayed next to the SEC profiles. Protein ladder (L) 
Black lines on the SEC profiles represent the absorbance at A260. SE was carried 
out on Superdex S75 (16/600) 
 
mL 
mL 
mL 
TRBP-D1 &D2 
TRBP-D12 
 
 
78 
Size exclusion chromatography was carried out on all protein constructs to 
remove the contaminants that can be seen in the input lane of the SDS-
PAGE gels (Figure 3.3). All protein constructs show single dominant peaks 
in their respective chromatogram. 
 
3.1.4 Summary 
 
The purity of TRBP constructs seen after the final SEC purification step 
was determined to be sufficient for downstream studies. Single purified 
bands were seen on SDS-PAGE gels at the correct size for TRBP-D1 and 
TRBP-D2 (Figure 3.3A). TRBP-D12 can be seen to run at a slightly higher 
molecular weight than expected on the SDS-PAGE gel. This phenomenon 
has been seen for this protein construct before, regardless TRBP-D12 
appears to be pure with no contaminant proteins after size exclusion 
chromatography (Figure 3.3B). 
 
3.2 Characterisation of the RNA binding portion of TRBP 
 
To determine whether the protein constructs purified were folded and to 
test their oligomerization characteristics, various biophysical techniques 
were conducted. Previous research in the literature has highlighted certain 
characteristics of these dsRBDs (Benoit et al., 2013; Yamashita et al., 
2011).Therefore, it is important to determine whether the purified 
constructs to be used here have the same properties, so downstream 
investigations can align with results obtained in the literature. 
 
3.2.1 SEC-MALS shows that the dsRBDs of TRBP are 
monomeric 
 
TRBP-D1 and TRBP-D2 were examined by SEC-MALS, which is used to 
determine the absolute molar mass and average size of molecules in 
solution. A size exclusion step is carried out prior to the multi-angle light 
scattering procedure to separate the protein of interest from protein 
aggregates. 
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SEC-MALS of the two N-terminal dsRBDs of TRBP confirms that both 
dsRBDs are monomeric in solution (Figure 3.4A & 3.4B). Both constructs 
eluted at a similar volume and the calculated molecular weight by SEC-
MALS of TRBP-D1 and TRBP-D2 are 8.9 kDa and 8.8 kDa respectively. 
These values are consistent with the monomeric molecular mass of each 
construct (Table 3.1). 
Figure 3.4 SEC-MALS of TRBP-D1 and TRBP-D2 constructs.                                             
The refractive index is shown as a black line with the calculated molecular mass in red. 
A)SEC-MALS of TRBP-D1 B) SEC-MALS of TRBP-D2. 
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3.2.2 NMR spectroscopy of TRBP constructs shows that the 
proteins are folded 
 
All three TRBP constructs were grown in minimal media containing (15N) 
labelled ammonium chloride, which will allow for two-dimensional nuclear 
magnetic resonance spectroscopy (2D NMR) on the proteins to 
characterise the protein fold. The 2D NMR technique carried out was 
heteronuclear single-quantum correlation spectroscopy (HSQC), which 
detects correlations between nuclei of two different types connected by a 
single covalent bond. In this study, the two bonded nuclei probed are (1H-
15N), as each residue within a protein apart from proline has a proton 
attached to nitrogen in the peptide bond.  Therefore, each amide produces 
a cross peak in the HSQC spectrum representing a specific residue 
(Marion 2013). 
 
Analysis of the three TRBP constructs by 2D (1H, 15N) HSQC suggests that 
all constructs are folded as evidenced by the high dispersion of cross peaks 
in the proton dimension. Moreover, the majority of cross peaks can be 
individually distinguished (Figure 3.5). In the TRBP-D12 2D HSQC 
spectrum, overlapping peaks can be seen around the middle of the 
spectrum. This is most likely due to the long unstructured linker region 
found between the two dsRBDs (TRBP-D1 and TRBP-D2) (Figure 3.5C). 
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Figure 3.5 2D (1H,15N) HSQC of TRBP constructs.  
2D HSQC spectra of A) TRBP-D1. B) TRBP-D2.C) TRBP-D12. (D) Overlay of TRBP-
D1, TRBP-D2 and TRBP-D12. All protein samples were in NMR buffer with a pH of 7.0 
(Tris 23.5 mM, KCl 100 mM, MgCl2 10 mM, DTT 5 mM, D2O 10% and DSS 50 uM). 
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3.2.3 Summary 
 
SEC-MALS and NMR studies have shown that the RNA binding portions 
of TRBP (D1 and D2) form stable monomeric proteins. SEC-MALS data is 
not available for the double domain construct (TRBP-D12) but interpreting 
the SEC data one can assume the protein is a monomer in solution from 
its elution volume (Figure 3.3B). NMR data shows all three protein 
constructs are folded in solution, in the buffer conditions tested.  Consistent 
with previous NMR analysis of these dsRBDs, the NMR data suggests the 
two dsRBDs do not interact with each other in the TRBP-D12 construct as 
the cross peaks from the individual dsRBDs overlay nicely with TRBP-D12 
with no large shifts in cross peaks (Figure 3.5D) (Benoit et al. 2013; Benoit 
and Plevin 2013). 
 
These results are consistent with previous biophysical work carried out on 
TRBP and its dsRBDs. 
 
3.3 Biophysical approach to analysing TRBP-D1 
folded/unfolded equilibrium 
 
3.3.1 Introduction 
 
Previous NMR studies of TRBP-D1 have shown that the dsRBD exists in 
a state of equilibrium between a folded and unfolded protein (Benoit. 2013). 
This phenomenon was characterised by the observation that the number 
of non-side chain cross peaks observed was almost two times the number 
of peaks expected. Two sets of peaks could be distinguished based on 
their intensities; one minor set of cross peaks with low intensities clustered 
around the middle of the spectrum suggesting an unfolded species of 
protein being present and a major set of cross peaks with high intensities 
dispersed across the proton dimension belonging to the folded species. 
Previous work into this phenomenon with EXSY experiments detected an 
exchange between the two sets of peaks, demonstrating that TRBP-D1 
exists in equilibrium of folded and unfolded protein. 
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The phenomenon could not be explained and a solution to get rid of this 
state of equilibrium was never determined. It is important to address this 
issue since downstream characterisation of this dsRBD requires the 
correct concentration of folded and active protein for accurate analysis as 
proteins require a specific structure and conformation for their function.  
 
3.3.2 NMR suggests the folded/unfolded equilibrium of 
TRBP-D1 is affected by pH 
 
A set of 2D (1H-15N) HSQC spectra of TRBP-D1 were collected across a 
pH range from 6.0 to 7.5. At pH 6.5 the approximate number of non-side 
chain cross peaks seen in the spectrum was significantly higher than the 
number of cross peaks expected (79 cross peaks) (Table 3.2). With an 
increase in pH, the number of cross peaks in the spectrum decreases, the 
set of cross peaks that disappear with an increase in pH are mostly located 
in the middle of the spectrum suggesting the concentration of the unfolded 
species of TRBP-D1 diminishing (Figure 3.6). The reduction in the number 
of peaks in the middle of the spectrum seen with an increase in pH 
suggests a move into only a single folded species of the protein being 
present. 
 
Table 3.2 TRBP-D1 – Number of peaks seen in the 2D (1H-15N) HSQC 
spectra at different pH. 
pH of buffer Number of peaks 
6.0 140 
6.5 135 
7.0 100 
7.5 85 
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Figure 3.6 2D (1H,15N) HSQC experiments of TRBP- D1 to analyse the effect 
of pH on the protein stability. 
2D  (1H,15N) HSQC of A) TRB-D1 at pH 6.0, B) TRBP-D1 at pH 6.5. C) TRBP-
D1 at pH 7.0. D) TRBP-D1 at pH 7.5.  2D (1H,15N) HSQC experiments were 
carried out on a single sample with altering the pH of the sample after the 2D 
(1H,15N) HSQC was recorded at each pH.  Starting concentration of TRBP-D1 
was 0.65 mM; the protein concentration changed only minimally as buffering of 
the sample was achieved with highly concentrated acid and base. 
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Figure 3.7 Analysis of the folded/unfolded equilibrium of TRBP-D1 using 
NMR spectroscopy.          
A) Cross peaks were picked from the major species (M) and minor species (m) 
based on the cross-peak intensity. B) Intensity of cross peaks from both the 
major and minor set species C) Average peak intensity of all the cross peaks 
in both the major and minor set. 
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The cross peaks in the 2D (1H,15N) HSQC experiments that disappear with 
an increase in pH can be distinguished from other cross peaks in the 
spectrum as they have lower intensities across the whole pH range (Figure 
3.7B). The low intensity peaks in the spectrum are denoted as a set of 
minor species of cross peaks, which represent the residues in the unfolded 
state of the protein. The high intensity peaks are denoted as the major 
species of cross peaks representing the protein in the folded state (Figure 
3.7A). 
 
To semi-quantitatively investigate the effects of buffer pH on the 
unfolded/folded equilibrium phenomenon seen for TRBP-D1, a set of cross 
peaks in both major and minor set were picked, which represent amino 
acids in both the folded and unfolded state (Figure 3.7A). NMR 
spectroscopy of TRBP-D1 suggests that an increase in the pH of the NMR 
buffer reduces the concentration of the unfolded state of the protein being 
present, seen in the 2D (1H-15N) HSQC experiments. The intensity of the 
cross peaks in the minor species decreases with an increase in pH and at 
pH 7.0 the minor set of cross peaks picked as residues in the unfolded 
state have much lower intensities compared to the cross peaks in the 
folded state (major set of cross peaks). At pH 7.5 the NMR spectrum 
displayed no peaks that correspond to residues in the minor species of 
cross peaks, suggesting that at this pH the protein may exist fully in the 
folded state. This data suggests that TRBP-D1 can be shifted into the 
folded state of the folded/unfolded equilibrium with an increase in the pH 
of the buffer. A caveat to this analysis is that only a few cross peaks were 
picked to represent the folded/unfolded state of the whole protein. Another 
problem that the NMR analysis of the TRBP-D1 phenomenon encounters 
is the NH groups in the unfolded state will exchange with the buffer with an 
increase in pH more readily than the NH groups in the folded state. What 
may be observed is the protein not being shifted into the folded state of 
equilibrium but rather not being able to visualise the minor cross peaks in 
the spectrum due to exchange. Therefore, further analysis of this 
phenomenon is required by another approach. 
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3.3.3 Characterisation of the unfolded/folded equilibrium of 
TRBP-D1 by CD spectroscopy 
 
Previous NMR studies and the results here indicated that TRBP-D1 exists 
in a folded/unfolded equilibrium. NMR analysis suggested that at pH 7.5 
TRBP-D1 is found in its folded state. To check if this phenomenon and 
result can be seen with another technique, circular dichroism spectroscopy 
was carried out. 
 
CD has many applications but most interestingly for this study it can be 
used to estimate the secondary structure of proteins and the folding 
properties (Greenfield, 2008). The near UV CD spectrum of proteins 
provides information on the tertiary structure; the different types of regular 
secondary structures found in proteins give rise to characteristic CD 
spectra. Circular dichroism (CD) uses circularly polarized light and 
depends on the absorption of left and right-handed light by structures within 
proteins. Different structural elements within proteins have characteristic 
CD spectra, α-helical proteins have negative bands at 222 nm and 208 nm 
and a positive band at 195 nm. β helices have negative bands at 218nm 
and positive bands at 195 nm. Therefore, CD spectroscopy can be used to 
determine the protein fold by analysing the ellipticity. Disordered proteins 
have low molar ellipticity above 210 nm, using this property the 
folded/unfolded equilibrium of TRBP-D1 will be investigated by CD 
spectroscopy. 
 
Circular Dichroism spectroscopy was conducted on TRBP-D1 with a pH 
ranging from 5.6 to 7.6. CD spectra were recorded for TRBP-D1 at each 
pH (Figure 3.8). CD spectroscopy was also conducted on TRBP-D2 as a 
control. The molar ellipticity of the proteins at 223 nM was calculated, which 
will give an indication of the fold of the protein. TRBP-D1 can be seen to 
have a lower molar ellipticity at 223 nM at pH 5.6 and as the pH of the 
buffer increases the molar ellipticity of the protein increases, suggesting a 
shift into a more ordered protein conformation (folded state) (Figure 3.8E). 
The molar ellipticity at 223 nm plateaus after pH 7.0, this plateau suggests 
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no further changes in the ratio of folded/unfolded protein. The change in 
molar ellipticity for TRBP-D2 with pH is not as considerable as TRBP-D1. 
 
Figure 3.8 Characterisation of the folded/unfolded equilibrium of TRBP-
D1 using circular dichroism. 
 A) Full CD spectra collected of TRBP-D1 in buffer with a pH ranging from 5.6 
to 7.6  B) Zoomed in CD spectra of TRBP-D1 to highlight the change in CD 
wavelength at each pH. C) Full CD spectra collected of TRBP-D2 at various 
pHs. D) Zoomed in CD spectra ofTRBP-D2 to highlight the change in CD 
wavelength at each pH. E) Molar elipticity of TRBP-D1 at 223 nM to 
distinguish protein stability at each pH range. F) Molar elipticity of TRBP-D2 
at 223 nM to distinguish protein stability at each pH range.  
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3.3.4 Summary 
 
TRBP-D1 has been shown to exist in equilibrium between folded and 
unfolded protein. To compare the binding activity and study the properties 
of TRBP-D1 compared to other dsRBDs such as TRBP-D2. TRBP-D1 is 
required to be in its folded and most ordered protein conformation. Through 
NMR and CD spectroscopy, it has been shown that the equilibrium 
between folded and unfolded protein is affected by the pH. With a pH 
greater than 7 in the buffers tested TRBP-D1 exists as a folded species. 
Therefore, RNA binding studies of TRBP-D1 will be carried out at pH 7.5 
to be certain that work will be carried out with an active and folded protein, 
with no contribution of the unfolded state on RNA binding. 
 
3.4 Characterisation of TRBP mutant constructs 
 
3.4.1 Introduction 
 
To study the RNA binding properties of the dsRBDs found in TRBP, mutant 
TRBP constructs were created to understand the importance of amino acid 
sequence in RNA binding regions (Figure 3.9). The residues chosen to 
study this are found in RNA binding region 2, the research focused on 
trying to elucidate how specific residues in this region played a role in the 
structure of the region and its RNA binding property of both dsRBDs. 
 
To check whether point mutations targeted the correct amino acids in a 
mutant protein construct and to check if the mutation has not disrupted the 
overall fold and structure of the protein 2D (1H,15N) HSQC experiments 
were carried out. 
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Figure 3.9 Schematics of mutant TRBP dsRBD constructs 
Diagram highlighting the point mutations introduced in TRBP-D1 
and TRBP-D2 for characterisation of RNA binding region 2. 
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3.4.2 NMR analysis suggests mutations in RNA binding 
region 2 do not disrupt the fold of the protein 
 
15N labelled TRBP wild type (WT) and mutant constructs were produced 
and purified at an appropriate concentration for NMR spectroscopy (Fig 
3.10). 
 
2D (1H,15N) HSQC experiments of TRBP- D1 WT and the mutant 
constructs show that the protein constructs are folded due to the dispersion 
of peaks in the protein dimension and mutations have not disrupted the 
overall fold of the protein domain (Figure 3.10). The experiments were 
collected with a buffer at pH 7.0 to reduce the effects of unfolded state seen 
for TRBP-D1, which was still seen in the mutant constructs. The specific 
pH of 7.0 was used to reduce chemical exchange of the amide groups of 
flexible regions of the folded protein specifically at the site of the mutations. 
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2D (1H,15N) HSQC experiments of TRBP- D2 wild type and the mutant 
constructs show the protein is folded which can be seen by the dispersion 
of peaks in the proton dimension (Figure 3.11). Difference in cross peak 
positions can be seen for the mutants compared to the wild type protein in 
only a few positions indicating the mutation has affected the residue of 
interest and the surrounding residues, with not much effect on the whole 
protein itself, this is to be expected as the mutations carried out are in a 
flexible loop between two β-strands. 
Figure 3.10 2D (1H,15N) HSQC spectra of TRBP-D1 WT and mutant constructs.  
2D (1H,15N) HSQC spectra of A) TRBP-D1 WT B) TRBP-D1 Q56P C) TRBP-D1 H58A.  
 
 
93 
 
Figure 3.11 2D (1H,15N) HSQC spectra of TRBP-D2 wt and mutant constructs.  
2D (1H,15N) HSQC spectra of A) TRBP-D2 WT B) TRBP-D2 P186Q C) TRBP-D2 
H188A. D) TRBP-D2 R189Q E) TRBP-D2 K190P. 
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3.4.3 Summary 
 
NMR analysis of each construct indicates that although mutations have 
been carried out, the protein maintains its overall fold.  All mutant 
constructs show well dispersed cross peaks in the 2D (1H,15N) HSQC 
spectrum, which is ideal for further in-depth NMR studies of these protein 
constructs. Further examination on the impact of the mutations on the 
protein requires assignment of the cross peaks to precisely identify the 
structural regions affected. 
 
3.5 Production of RNAs for RNA binding studies 
 
3.5.1 Introduction 
 
There are various methods for producing RNA, using organic chemistry 
reactions or enzymatic reactions to produce RNA. The most commonly 
used method is an enzymatic reaction that employs the use of an RNA 
polymerase to transcribe RNA strands from a template DNA strand. This 
method is cheap and efficient in producing high yields of RNA. Three 
commonly used polymerases with high specificity for their 23 base bair 
promoter are SP6, T3 and T7 RNA polymerases. After production of RNAs 
in vitro, purification of the RNA away from contaminants such as free 
nucleotides, the DNA template and the polymerase is required. Which can 
be carried out using simple RNA clean up kits or more advanced 
techniques such as anion exchange for higher purity. 
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3.5.2 DNA template production 
 
In vitro transcription requires pure linear DNA template containing a 
promoter region for the polymerase enzyme. Consequently, DNA 
templates were prepared from two oligonucleotides annealed together to 
form a dsDNA template, each DNA template was flanked with the T7 
polymerase initiation sequence. The two oligonucleotides were mixed in 
DNA annealing buffer and heated for 5 min at 95°C and then incubated at 
RT for 30 minutes for hybridization of the oligonucleotides to occur (Figure 
3.12) 
 
 
Figure 3.12 DNA template production 
2% Agarose gel of DNA templates for in vitro transcription produced 
by annealing two oligonucleotides. 
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3.5.3 In vitro transcription of RNAs 
 
To determine the best conditions for RNA production through in vitro 
transcription using T7 polymerase, the concentration of MgCl2 required for 
a reaction was tested. Small-scale reactions were set up with varying 
concentrations of MgCl2 to determine the best concentration required for 
increased yields of RNA production. 
 
The RNA band of interest can be seen as the over stained band around 
the 50 nt marker for 155 WT and 155 modified (155 mod) and 80nt for let7a 
WT and let7a modified (let7a mod) (Figure 3.13). The best MgCl2 
concentration for each RNA construct was determined by identifying the 
highest yield of RNA production from the intensity of the RNA band on the 
denaturing gel. 
 
 
Figure 3.13 MgCl2 concentration test for IVT reactions.  
15% urea denaturing gel analysis of RNA yield dependent on MgCl2 
concentration. A) Gel of Pre-miR 155 and Pre-miR 155 mod small scale in vitro 
transcription reactions B) Gel of Pre-let7a and Pre-let7a mod RNAs small scale 
in vitro transcription reactions. The concentration of MgCl2 used is noted on top 
for each lane. (L) is the RNA ladder used to check the RNA produced is the 
correct size.  
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Following determination of appropriate concentration of MgCl2, 5 mL 
reactions of each RNA construct were carried out. IVT reactions were 
incubated in a water bath at 37°C for 4 hours. To increase RNA yield, extra 
T7 polymerase and MgCl2 were added at two hours into the reaction. 
Reactions were stopped by freezing the reaction at -20 °C. Large scale 
purification of dsRNAs were then carried out using anion exchange 
chromatography (Figure 3.14). 
Figure 3.14 Large scale purification of in vitro produced Pre-let7a. 
 A) Anion exchange profile for Pre—let7a B) 15 % urea denaturing gel of 1.5 
mL fractions eluted from the anion exchange purification. Anion exchange was 
carried out on a Mono Q 5/50 GL column. The black line represents the 
absorbance at A260 nm. The green line represents the concentration of Buffer 
B (Tris-HCl pH 7.0 20 mM, MgCl2 10 mM and 1 M NaCl). 
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Table 3.3 DsRNA constructs 
DsRNA structures were predicted using Mfold. 
 
 
 
 
 
 
 
 
dsRNA Number 
of 
nucleotides 
MgCl2 
conc 
for IVT 
(mM) 
Structure 
Pre-miR-
155 
61 21 
 
Pre-miR-
155 mod 
65 21 
 
Pre-let-7a 73 21 
 
Pre-let-7a 
mod 
73 21 
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3.5.4 End labelling of dsRNAs 
 
Scientific studies of nucleic acids to determine the function and to study 
their properties often require labelling of the nucleic acid with chemical tags 
or radioisotopes. Labelling of oligonucleotides can be carried out during 
synthesis or post synthesis using an enzyme-catalysed reaction. They can 
be end labelled or nucleotides can be internally modified. For downstream 
studies to investigate the RNA binding properties of the dsRBDs found in 
TRBP, dsRNAs investigated were labelled on the 3’ end through post-
synthetic conjugation of a chemical tag (Zearfoss and Ryder, 2012). Figure 
3.15 shows successful labelling of Pre-let7a and Pre-miR 155 constructs 
that were used for downstream RNA binding assays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 3’ end labelling of dsRNAs with fluorescein 5-
thiosemicarbazide.  
15% urea denaturing gel of dsRNA constructs visualised two ways. 
A) Detection of dsRNA using SYBR Gold B) Detection of the 
fluorescent label FTSC. 
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Chapter 4- Characterisation of the type-A 
dsRBDs of TRBP by NMR spectroscopy 
 
4.1 Introduction 
 
The unique structure of a protein is determined by its amino acid sequence; 
however, proteins carry the ability to occupy ensembles of conformations 
and are not strictly static entities.  Local motion within a protein may be 
essential for its function and investigations into protein dynamics can be 
crucial to understanding the mechanism of protein function (Yang et al. 
2014). This chapter will explore the protein dynamics and local motions of 
the type-A dsRBDs of TRBP. 
 
NMR spectroscopy has been widely used to study dsRNA-binding proteins, 
from the singular dsRBDs of a protein to the whole multi-domain protein. 
NMR spectroscopy has been used to elucidate solution structures, 
molecular dynamics and molecular interaction regions of dsRBDs and 
linker regions found in dsRBPs (Stefl et al. 2010a) Bycroft et al., 1995; Lu 
and Hall, 1997; Gabel et al., 2006; Nanduri et al., 2000; Masliah et al., 
2018; Kharrat et al., 1995; Mueller et al., 2010; Benoit et al., 2013; Benoit 
and Plevin, 2013; Chiliveri and Deshmukh, 2014). Motional dynamics of 
dsRBDs have been shown to play an important role in their function 
(Agarwal and Barnwal 2009). For example, the interferon-inducible antiviral 
kinase PKR (PKR) has been shown through NMR spectroscopy to contain 
two dsRBDs that exhibit a difference in motional flexibility on a millisecond 
timescale, which has been suggested to be the reason for a difference in 
RNA binding activity seen between the two dsRBDs. The motionally more 
flexible PKR-dsRBD1 has a higher RNA binding activity compared to PKR-
dsRBD2 (Yang et al. 2014). 
 
To date only minimal dynamic data has been elucidated for TRBP 
especially for the dsRNA binding regions. Previous work by Benoit et al 
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highlighted through (1H-15N)  heteronuclear NOE experiments that the type-
A dsRBDs of TRBP confer similar rigidity across each dsRBD. However, 
further analysis of the data displayed a difference in flexibility in the loop 
region between β1-β2 in the dsRBDs (Benoit et al. 2013). Interestingly this 
region is vital for RNA binding of the dsRBD and what was seen is that 
TRBP-D2 has a more rigid β1-β2 loop compared to TRBP-D1. This led to 
questioning how this difference between these two dsRBDs exists and 
what role does this phenomenon play in the binding of dsRNAs. To find 
answers for these questions and further study the dynamics of the dsRBDs 
in TRBP, mutagenesis of this loop region and in-depth NMR dynamics 
experiments were carried out.  
 
NMR spectroscopy is a powerful tool for studying proteins; compared to 
other structural techniques such as X-ray crystallography and electron 
microscopy, NMR provides information on the protein structure in the 
solution state therefore it can be employed to obtain vital information about 
the dynamics of a protein. NMR spectroscopy permits the analysis of 
specific residues and atoms (Palmer 2004) . 
 
15N NMR relaxation studies can provide information relating to the 
dynamics and motions within a protein on a ps to ms timescale. NMR 
relaxation experiments are influenced by the global tumbling of a molecule 
but also by local motional dynamics within the protein structure (Palmer 
2001; Jarymowycz and Stone 2006).To study dynamic motions within a 
protein, accurate measurement of various relaxation parameters is 
required. NMR relaxation experiments were collected at a single magnetic 
field strength of 800Mhz to analyse the motional properties of the type-A 
dsRBDs found in TRBP.  Spin-lattice relaxation (T1), Spin-spin relaxation 
time in the rotating frame (T1ρ) and (1H-15N) Heteronuclear-NOE 
experiments were collected.  
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4.2 Backbone assignment of TRBP-D12 
 
To examine the structure and dynamics of proteins using NMR 
spectroscopy it is first important to acquire resonance assignment of 
proteins, to distinguish which chemical shift in a spectrum corresponds to 
which atom within a protein sequence. Therefore, this chapter will begin by 
discussing the attempt to assign the NMR spectrum of the double domain 
protein construct TRBP-D12, the difficulties that were encountered and 
how they were solved to produce a partially assigned NMR spectrum of 
TRBP-D12. 
 
The backbone assignment of proteins is commonly carried out using 3D 
triple resonance experiments where three nuclei are probed 1H, 13C,15N. 
Triple resonance experiments have the ability to transfer the magnetization 
over the peptide bond to probe the amide, carboxyl group and the side 
chain carbons of an amino acid but also the carbonyl groups preceding that 
specific amino acid (Ikura et al. 1990). Hence, triple resonance 
experiments can be carried out to sequential link each (1H-15N) cross 
peaks. Triple resonance experiments such as HNCACB can then be used 
to identify corresponding cross peaks to a specific amino acid in the protein 
sequence by analysing the chemical shifts of Cα and Cβ cross peaks linked 
to a (1H-15N) cross peak. 
 
 
 
 
 
 
 
 
 
 
 
 
103 
Table 4.1 Triple resonance experiments carried out for backbone 
assignment of TRBP-D12 
Experiments Nuclei probed 
i :nuclei’s connected 
to NH group of amino 
acid 
i-1 :nuclei’s connected 
to NH group of 
previous amino acid 
HNCO X CO 
HN(CA)CO CO CO 
HNCACB CA,CB CA,CB 
HN(CO)CACB X CA CB 
HNCA CA CA 
HN(CO)CA X CA 
 
 
 
Following initial protein stability tests of TRBP-D12 in different buffer 
conditions and temperatures, [13C, 15N] labelled TRBP-D12 was prepared 
at ~0.5 mM and a standard set of triple-resonance backbone assignment 
experiments was recorded (Table 4.1). 
 
The 2D (1H-15N) TROSY experiment at pH 6.5 of TRBP-D12 contained 
approximately 290 cross peaks, which is much higher than the expected 
number of cross peaks of 194 (Figure 4.1). The extra peaks are due to the 
previously seen effect of TRBP-D1 existing in equilibrium between two 
states in chapter 3.  The presence of TRBP-D1 in two states complicated 
the interpretation of the NMR spectra for TRBP-D12 but does not hinder 
the assignment procedure as the two states could be distinguished as a 
major and minor species of peaks as seen previously for TRBP-D1. NMR 
assignment experiments were carried out at pH 6.5 to help identify and 
assign the maximum number of chemical shifts possible for the protein.  
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Assignment of specific nuclei probed in the triple resonance backbone 
assignment experiments, HNCA, HNCACB, HNCO, HCOCAB were 
attempted for TRBP-D12.  The set of minor cross peaks seen (unfolded 
state of TRBP-D1) in the 2D (1H,15N) TROSY experiments did not possess 
corresponding cross peaks in all triple resonance experiments carried out.  
Interestingly in the major set of cross peaks not all contained corresponding 
cross peaks in the HNCACB or HNCOCACB experiments. Most of them 
contained cross peaks for the Cα in the HNCA experiments but additional 
magnetization transfer via the Cβ led to a significant loss of detectable 
signal in the HNCACB experiments. The cross peaks in the 2D (1H,15N) 
TROSY expected to be from the structured dsRBDs elucidated from the 
overlap of the single dsRBDs with TRBP-D12, displayed no NMR signals 
in the 3D HNCACB triple resonance experiments. A potential reason for 
not being able to see cross peaks in the 3D triple resonance experiments 
Figure 4.1 2D (1H, 15N) TROSY of WT TRBP-D12.  
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could be due to the poor signal to noise ratio of the experiments. The poor 
signal to noise observed for these experiments is most likely due to the fast 
decay of NMR signals due to the slow tumbling of the large protein in 
solution (~22 kD). Several approaches could have been attempted to 
overcome the problems with the signal to noise seen for TRBP-D12. For 
example, deuterium labelling of the protein, which improves the signal-to-
noise by decreasing the relaxation rate of the 13C and 15N spins (Sattler 
and Fesik 1996). However, another approach was conducted, which was 
to carry out assignment experiments on the single domains and then 
assign the linker region using the original TRBP-D12 triple resonance 
experiments. To assist with the backbone assignment of the double 
domain protein TRBP-D12, single dsRBDs proteins with single point 
mutations between the β1-β2 loops were produced. 
 
4.2.1 Backbone assignment of TRBP-D1 Q56P  
 
 [15N,13C] labelled TRBP-D1 Q56P was prepared at a concentration of ~1.1 
mM and 3D HNCOCACB, HNCACB and HNCA triple-resonance backbone 
assignment experiments were recorded. TRBP-D1 Q56P is a mutation 
carried out in RNA binding region 2 of the dsRBD to mimic the amino acid 
composition of TRBP-D2 for downstream studies of this region. 
 
Figure 4.2 presents an assigned (1H,15N) TROSY of TRBP-D1 Q56P. It 
contains 110-120 peaks including side chain amides, marginally higher 
than the number of peaks predicted from the sequence, which is due to the 
two-state phenomenon seen for TRBP-D1. The peaks in the unfolded state 
could be distinguished from the peaks in the folded state by comparing the 
intensities of the peaks. 83% of backbone amide resonances in the folded 
state were assigned, with 83% of Cα spins and 82% of Cβ spins. 
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Figure 4.2 Assigned 2D (1H,15N) TROSY spectrum of TRBP-D1 Q56P 
Assigned cross peaks are labeled with the residue number and the amino 
acid type.  
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The secondary structure of TRBP-D1 Q56P can be predicted from the 
NMR chemical shifts of H,N,CO, Cα and Cβ  using TALOS-N(Shen and 
Bax, 2013).  TALOS-N can predict dihedral angles from the chemical shifts 
it is presented using a database of measured or predicted chemical shifts 
from X-ray structures.  The TALOS-N secondary structure prediction 
(Figure 4.3) is in good agreement with secondary structures of TRBP-D1 
based on crystallographic and NMR data, which suggests that it adopts the 
same fold and that the assignment of TRBP-D1Q56P was successful 
(Yamashita et al. 2011; Masliah et al. 2018).  
 
The N-terminal region of TRBP has recently been shown to contain a small 
alpha helix preceding the canonical αβββα fold of dsRBD (Masliah et al. 
2018; Paithankar et al. 2018). The TALOS-N prediction has also 
highlighted this structure in the protein construct of TRBP-D1 used this 
study (Figure 4.3). 
 
 
 
 
 
 
 
Figure 4.3 TALOS-N prediction of TRBP-D1 Q56P       
Secondary structure prediction by TALOS-N using HN, Cα and Cβ chemical 
shifts. Coloured bars show the prediction confidence for each structure type. 
Above the graph is the secondary structure from a known NMR structure (PDB 
accession 5N8M) 
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4.2.2 Backbone assignment of TRBP-D2 P186Q 
 
 [15N,13C] labelled TRBP-D2 P186Q was prepared at a concentration of 
~1.2mM and a standard set of triple-resonance backbone assignment 
experiments were recorded, 3D HNCOCACB, HNCACB and HNCA 
experiments. TRBP-D2 P186Q is a mutation carried out in RNA binding 
region 2 of the dsRBD to mimic the amino acid composition of TRBP-D1 
for downstream studies of this region. 
 
Figure 4.4 presents an assigned 2D (1H,15N) TROSY spectrum of TRBP-
D2 P186Q. It contains ~90 peaks including side chain amides, close to the 
number of peaks predicted from its sequence. 93% of backbone amide 
resonances were assigned, with 92% of Cα spins and 91% of Cβ spins. 
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Figure 4.4 Assigned 2D (1H,15N) TROSY spectrum of TRBP-D2 P186Q 
Assigned cross peaks are labeled with the residue number and the amino acid 
type.  
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Using TALOS-N the secondary structure of TRBP-D2 P186Q was 
predicted from the Cα and Cβ chemical shifts collected. The TALOS-N 
secondary structure prediction (Figure 4.5) is in good agreement with the 
secondary structure based on crystallographic and NMR data for TRBP-
D2, which suggests that the assignment of TRBP-D2 P186Q was 
successful (Yamashita et al. 2011; Masliah et al. 2018). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 TALOS-N prediction of TRBP-D2 P186Q 
  Secondary structure prediction by TALOS-N using HN, Cα and Cβ chemical 
shifts. Coloured bars show the prediction confidence for each structure type. 
Above the graph is the secondary structure from a known NMR structure of 
TRBP-D2 (PDB accession 5N8M). 
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4.2.3 Backbone assignment of TRBP-D12 WT 
 
With the aid of cross peak assignments from the single dsRBDs, most of 
the chemical shifts of the dsRBDs in the TRBP-D12 spectrum were 
assigned (Figure 4.7). However, due to peak overlap in the TRBP-D12 
spectrum transfers of peak assignments were difficult and not all the peaks 
in each dsRBD were assigned in TRBP-D12. The initial triple resonance 
experiments of TRBP-D12 helped to identify and assign some of the linker 
peaks but due to the bad signal to noise not all peaks were assigned. The 
percentage of peaks assigned for D1, D2 and the linker were 
67%,90%,26% respectively. Figure 4.6 identifies the peaks that have been 
assigned for TRBP-D12. 
 
 
 
 
 
 
 
 
Figure 4.6 Cross peaks assigned for TRBP-D12  
 Representation of TRBP-D12 peaks that were assigned using TRBP-D12 assignment 
experiments and transfer of assignments from the single dsRBDs, TRBP-D1 Q56P and 
TRBP-D2 P186Q. In red are residues which have not been assigned.                     
TRBP%D1%(GPAMI(EQMLAAN(PGKT(PISLLQEYGTRI(GKTP(VYDLLKA(EGQAHQP(NFTFRVT(VGDT(SCTGQ(GP(SKKAAKHKAAEVALKHLKG(
(
(
LINKER%((((GSMLEPALEDSSSFSPLDSSLPEDIPVFTAAAAATPVPSVVLTRSPPMELQPPVSPQQSECN((
(
(
TRBP%D2%(PVGALQELVVQK(GWRL(PEYTVTQE(SGPAHRKE(FTMTCR(VERF(IEIGS(GTS(KKLAKRNAAAKMLLRVHTV(
α0# β1#α1#
α1#
β2# β3# α2#
α2#β1# β2# β3#
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Figure 4.7 Assigned 2D (1H,15N) TROSY spectrum of TRBP-D12 WT 
Assigned peaks are labeled with the residue number and the amino acid type. Bottom panel is 
the centre of the spectrum enlarged. The minor set of cross peaks belonging to the unfolded 
state of TRBP-D1 were not assigned. 
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4.3 Characterisation of TRBP mutant dsRBDs by NMR 
spectroscopy 
 
2D (1H,15N) HSQC experiments were carried out on mutant dsRBD 
constructs of TRBP to examine whether point mutations in the dsRBD has 
affected the overall fold of the protein construct. Compound chemical shift 
differences between the amide groups of the WT and mutant constructs 
were calculated, which will identify the amino acids affected by each single 
point mutation. Assignments were transferred from the wild type protein to 
the mutant constructs where possible. Compound chemical shift 
differences were calculated using the Equation below (Williamson 2013).  
 (∆𝛿 = [∆𝛿𝐻] + (∆𝛿𝑁/6.5)]]G/]   
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4.3.1 Characterisation of TRBP-D1 mutants 
 
Compound chemical shift differences were calculated between TRBP-D1 
WT and the mutant constructs TRBP-D1 Q56P and TRBP-D1 H58A 
(Figure 4.8). Chemical shift values where the matching residue in the 
mutant spectra could not be assigned because of an unidentifiable shift of 
the peak were given an arbitrary value of below zero. Chemical shift 
differences seen between the WT TRBP-D1 and TRBP-D1 Q56P 
highlighted major chemical shift differences concentrated around the β1- 
β2 loop, around the site where the glutamine residue was mutated for a 
proline (Q56P). This can be perceived through a chemical shift difference 
value of 0.3 and higher. Major chemical shift differences could be seen for 
TRBP-D1 H58A in the β1- β2 loop, perceived through not being able to link 
matching peaks in the mutant construct without assigning TRBP-D1 H58A.  
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Figure 4.8 Chemical shift differences between TRBP WT and mutant 
constructs.                        
  (A) Compound chemical shift differences of TRBP-D1 Q56P. (B) Compound 
chemical shift differences of TRBP-D1 H58A. Shift in cross peaks that were not 
able to be distinguished were given an arbitrary value of below 0. 
(A) 
(B) 
TRBP-D1 
Q56P 
TRBP-D1 
H58A 
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4.3.2 Characterisation of TRBP-D2 mutants 
 
Major chemical shift differences in the TRBP-D2 mutant constructs can be 
observed in the residues surrounding the single point mutation for each 
construct as expected. Large chemical shift differences can be seen for 
mutants TRBP-D2 P186Q (Figure 4.8A) and TRBP-D2 K190P (Figure 
4.8D) in the β1- β2 loop compared to the other mutant constructs, which 
could be due to the removal of a proline residue in the P186Q mutation and 
an addition of a proline residue in the K190P mutant, changing the 
backbone structure or dynamics and therefore the chemical environment 
of the residues in this loop region.  
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Figure 4.9 Chemical shift differences between TRBP-D2 WT and 
mutant constructs 
(A) Compound chemical shift differences of TRBP-D2 P186Q. (B) 
Compound chemical shift differences of TRBP-D2 H188A (C) TRBP-D2 
R189Q (D) TRBP-D2 K190P. Shift in cross peaks not distinguishable were 
given an arbitrary value of below 0. 
(A) 
(B) 
(C) 
(D) 
TRBP-D2 
P186Q 
TRBP-D2 
H188A 
TRBP-D2 
R189Q 
TRBP-D2 
K190P 
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Interestingly a large chemical shift difference can be visible for a residue 
not close in the amino acid sequence for example threonine 208. From 
inspection of the structure of TRBP-D2, this residue may not be close in 
sequence but is close in proximity to the loop region in the structure (Figure 
4.10). There could be different possibilities for why Thr-208 may be 
affected by the changing of the β1- β2 loop, one could be that the 
modification in loop residues changes the structure of the loop and 
therefore decreases the distance between the residues in the loop region 
and 208Thr, affecting the chemical environment of the NH group of 208Thr. 
Another explanation could be that the residues found in the β1- β2 loop 
could be interacting with 208Thr and therefore changing the amino acid 
composition of the loop by mutagenesis would affect this interaction.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 4.10 Structure of TRBP-D2 highlighting chemical shift changes due to 
mutagenesis.           
   A) Structure of TRBP- D2, residues affected largely by mutagenesis in the β1- β2 loop 
are coloured red B) Zoomed image orientated on the β1- β2 loop region highlighting 
residues affected largely by mutagenesis of TRBP-D2. Images created in Pymol using 
PDB accession 3ADL. 
(A) 
 
(B) 
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4.4 15N relaxation analysis of the type-A dsRBDs in TRBP 
 
4.4.1 NMR 15N relaxation analysis of TRBP-D12 shows variations in 
motional dynamics between the two dsRBDs 
 
15N NMR relaxation analysis has previously shown that the two type-A 
dsRBDs of TRBP contain similar dynamics between the structural features 
of the dsRBDs such as the alpha helices and beta strand but interestingly 
(1H-15N) Heteronuclear NOE data identified that the loop region between 
β1-β2 in the two dsRBDs displayed a difference in flexibility (Benoit et al. 
2013). This loop region was shown to be more flexible in TRBP-D1 
compared to TRBP-D2. To further study this phenomenon the analysis of 
this loop region was enhanced with additional 15N NMR relaxation data, the 
longitudinal relaxation time T1 and the transverse relaxation time T2 
calculated from the relaxation in the rotating frame T1ρ. 
 
15N T1 times were calculated for WT TRBP-D12 (Figure 4.11A). Regions 
with high flexibility have lower T1 values, for example the values measured 
in the linker region connecting the two dsRBDs.  Analysis of the T1 
relaxation times of the residues within the dsRBD shows that alpha helices 
and beta strands are rigid in structure and the regions connecting the alpha 
helices and beta strands also display similar rigidity, excluding the loop 
joining β1-β2, which expresses the highest flexibility within the dsRBDs.  
 
Regions within proteins with high T2 values exhibit higher flexibility, which 
is visible within the linker regions connecting the two dsRBDs (Figure 
4.11B). Similar to the T1 data the T2 relaxation times indicate that the alpha 
helices and beta strands confer particular rigidity. Similar to the T1 
relaxation times for the amino acids in the β1-β2 loop, the T2 relaxation 
times indicate a much more rigid loop in TRBP-D2 compared to TRBP-D1. 
Interestingly the β1-β2 loop in TRBP-D2 has lower T2 values compared to 
the structured regions, which is not indicative of a flexible loop, this 
phenomenon will be discussed further later.  
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The (1H-15N) heteronuclear NOE values calculated for TRBP-D12 further 
prove the rigidity seen with the structured regions (high noe values) of the 
protein and the flexibility seen within the loop regions (low noe values) 
(Figure 4.11C). Following the trend seen for the T1 and T2 relaxation 
experiments, the β1-β2 loop region between the two dsRBDs again 
displays a difference in rigidity in the (1H-15N) Heteronuclear noe 
experiment.  
 
The three relaxation parameters calculated for WT TRBP-D12 have 
highlighted some interesting variation between the two dsRBDs in the 
multi-domain protein. Most of the structured regions between the two 
dsRBDs show similar rigidity but the β1-β2 loops show different dynamic 
properties. The 15N relaxation experiments indicate that the β1-β2 loop in 
TRBP-D2 is more rigid than the loop of TRBP-D1. This will be further 
explored by investigating the difference in amino acid composition of the 
β1-β2 loop between the two dsRBDs. 
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 Figure 4.11 15N relaxation parameters of WT TRBP-D12  
 (A) T1 relaxation values (B) T2 relaxation values (C) (1H-15N) HET-NOE values for TRBP-D12 WT. 
Coloured regions correspond to the structured regions of the protein (Green-TRBP-D1, Blue TRBP-
D2) 
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4.4.2 Characterisation of the dsRNA binding regions of the type-A 
dsRBDs by NMR spectroscopy  
 
Like many type-A dsRBDs, the N-terminal dsRBDs of TRBP each contain 
three canonical dsRNA binding regions. Region 1 is located in the first α helix, 
with the second region in the loop adjoining β1 and β2 strands, and the third 
region on the N-terminal tip of the α2 helix (Figure 4.12).   
 
 
Comparison of the 15N relaxation times between TRBP-D1 and TRBP-D2 
within TRBP-D12, revealed differences of the two domains within the β1-β2 
loop. Interestingly this is one of the three dsRNA-binding regions of canonical 
dsRBDs (Figure 4.12). DsRNA binding region 2 in TRBP-dsRBD1 shows 
increased flexibility compared to TRBP-dsRBD2. This phenomenon is most 
pronounced in the T2 relaxation parameter. The other two RNA binding regions 
have more similar relaxation rate profiles between the two dsRBDs (Table 4.2 
& 4.3). 
 
Table 4.2 Average 15N relaxation values of the RNA binding regions in 
TRBP-D1 
 TRBP-D1 
 R1 R2 R3 
 33S, 36Q,37E 55G, 57A,58H 80K,81K,84K 
T1 (ms) 1463.4 ±158.2 1098.8 ±261.4 1378.4 ±159 
T2 (ms) 16.7 ±0.5 26.9 ±8.2 20.1 ±6.3 
15N{1H} NOE 0.83 ±0.01 0.50 ±0.18 0.69 ±0.07 
Figure 4.12 Amino acid composition the two N-terminal dsRBDs of TRBP.                            
  Sequence of TRBP dsRBDs with the three RNA binding regions annotated. 
Essential RNA binding amino acid residues are labeled by an * over the residue.   
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Table 4.3 Average 15N relaxation values of the RNA binding regions in 
TRBP-D2 
 TRBP-D2 
 R1  R2 R3 
161V,162G, 
165Q 166E 
185G, 187A, 
188H, 189R 
210K,211K, 
213A,214K 
T1 (ms) 1410.8 ±38.6 1114.4 ±159.8 1322.6 ±94.7 
T2 (ms) 17.6 ±1.3 12.8 ±4.6 20.6 ±3.5 
15N{1H} NOE 0.81 ±0.03 0.71 ±0.18 0.82 ±0.04 
 
 
Sequence comparison between the two dsRBDs highlighted differences in 
RNA binding region 2 (Figure 4.12). For instance, two positively charged 
residues (R189,K190) found in TRBP-D2 and not present in TRBP-D1. 
Additionally, dsRNA-binding region 2 within TRBP-D2 contains a proline 
residue (P186) preceding the RNA interacting histidine (H188) whereas this is 
a glutamine residue (Q56) in RNA binding region 2 of TRBP-D1. To study the 
contribution of these residue variations may play in dynamics and motion of 
RNA binding region 2, single point mutations probing the proline residue 
difference were carried out. In TRBP-D1, Q56 was mutated to a proline residue 
and in TRBP-D2 P186 was mutated to a glutamine residue. The mutation of 
each dsRBD was applied to the multi-domain protein (TRBP-D12) to produce 
TRBP-D12Mut. Relaxation experiments were carried out on both the WT TRBP-
D12 and TRBP-D12Mut.  Backbone assignments of TRBP-D12Mut were 
obtained by transferring assignments from mutant variants of single dsRBDs 
and WT TRBP-D12 protein.  
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Figure 4.13 T1 relaxation values of TRBP-D12 WT/Mut      
  T1 relaxation values of A) TRBP-D12  (B) TRBP-D12Mut (C) Comparison of T1 relaxation 
between WT TRBP-D12 (black squares) and TRBP-D12Mut (red triangles).               
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Figure 4.14 T2 relaxation values of TRBP-D12 WT/Mut   
   T2 relaxation values of A) TRBP-D12  (B) TRBP-D12Mut (C) Comparison of T2 relaxation 
between WT TRBP-D12 (black squares) and TRBP-D12Mut (red triangles).               
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Figure 4.15 (1H-15N) Heteronuclear-NOE relaxation values of TRBP-D12 WT/Mut 
(1H-15N) HET-NOE  relaxation values of A) WT TRBP-D12 (B) TRBP-D12Mut C) Comparison 
of  15N{1H} NOE relaxation between WT TRBP-D12 (black squares) and TRBP-D12Mut (red 
triangles).               
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Comparison of the relaxation data between the WT TRBP-D12 and TRBP-
D12Mut show that the mutations of the loop region have not altered the 
dynamics of the structured regions of the dsRBDs, but primarily affected the 
residues within the β1-β2 loop (Figure 4.13-15). In TRBP-D1 the substitution 
of the glutamine residue (Q56) for a proline residue has increased the rigidity 
of the β1-β2 loop region, which can be seen across the T1 and T2 relaxation 
experiments. The replacement of the proline residue in the β1-β2 loop of 
TRBP-D2 for a glutamine residue has been shown to affect the dynamics of 
the loop by decreasing the rigidity of this region.  
 
Table 4.4 15N relaxation values of the β1-β2 loop in TRBP-D1 of WT TRBP-
D12 and TRBP-D12Mut 
 
 WT TRBP-D12 TRBP-D12MUT 
55G, 56Q, 58H, 59E 55G,57A,58H 
T1 1098.8 ±261.4 1204.6 ±117.3 
T2 26.9 ±8.2 19.8 ± 8.6 
15N{1H} NOE 0.50 ± 0.18 0.48 ± 0.036 
 
 
Table 4.5 15N relaxation times of the β1-β2 loop in TRBP-D2 of WT TRBP-
D12 and TRBP-D12Mut 
 
 
 
15N relaxation experiments of the dsRBDs in TRBP-D12 exposed a disparity 
in structural dynamics between the two dsRBDs, in the β1-β2 loop, where RNA 
binding region 2 lies. With mutations in the β1-β2 loop of each dsRBD to mimic 
the amino acid composition of the other domain, the relaxation values were 
 WT TRBP-D12 TRBP-D12MUT 
185G,187A,188H, 189R 185G, 187A,188H,189R 
T1 1114.4 ±159.8 914.6 ± 30.5 
T2 12.8 ±4.6 27.8 ± 7.0 
15N{1H} NOE 0.71 ±0.18 0.53 ±0.05 
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essentially exchanged between the two dsRBDs. This suggests the difference 
in a single amino acid between the two loop regions could be the reason for 
the variation in motional dynamics of this loop.  
 
4.4.3 15N relaxation analysis of TRBP-D2 WT & P186Q 
 
To further investigate the structural dynamics of the dsRBDs of TRBP and to 
confirm the results observed in the double domain construct, relaxation 
analysis was carried out on TRBP-D2. Analysis on the single dsRBD should 
be able to solve some of the problems encountered with the double domain 
construct such as the overlapping peaks and extraction of relaxation data on 
the residues in the β1-β2 loop. In addition, it would be interesting to verify the 
T2 relaxation rate phenomenon seen in RNA binding region 2 for TRBP-D2 in 
the double domain construct within the single dsRBD as well.  Focusing on 
RNA binding region 2, relaxation experiments were also conducted on the 
TRBP-D2 P186Q mutant.  
 
The NMR experiments were carried out with the same parameters and 
conditions used for TRBP-D12 WT and three relaxation parameters were 
calculated, T1,T2, (1H-15N) HET-NOE.  The advantage of assessing the single 
dsRBD dynamics is that relaxation data were extracted from more residues in 
the β1-β2 loop than in the double- domain construct.  
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 Figure 4.16 T1 relaxation values of TRBP-D2 WT/P186Q      
 (A) T1 relaxation values of TRBP-D2 (B) T1 relaxation values of TRBP-D2 P186Q 
(C) Comparison of T1 relaxation between TRBP-D2 WT (black squares) and 
P186Q (red triangles).                      
 
(A) 
 
(B) 
 
(C) 
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Figure 4.17 T2 relaxation values of TRBP-D2 WT/P186Q   
(A) T2 relaxation values of TRBP-D2  (B) T2 relaxation values of TRBP-D2 P186Q 
Comparison of T1 relaxation between TRBP-D2 WT (black squares) and P186Q (red 
triangles).                      
 
(A) 
(B) 
(C) 
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Figure 4.18 (1H-15N) HET-NOE relaxation values of TRBP-D2 WT/P186Q         
(A) (1H-15N) HET-NOE  relaxation values of TRBP-D2  (B) (1H-15N) HET-NOE  
relaxation values of TRBP-D2 P186Q Comparison of T1 relaxation between 
TRBP-D2 WT (black squares) and P186Q (red triangles).                      
 
 
(A) 
 
(B) 
 
(C) 
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The 15N relaxation experiments displayed rigidity in the structured regions with 
flexibility in the loop regions of the protein and the N-terminal residues. The T1 
and T2 relaxation experiments show that the dynamics of the β1-β2 loop is 
altered with the removal of the proline residue from TRBP-D2. The T1 and T2 
times indicate that the β1-β2 loop region of TRBP-D2 P186Q is more flexible 
than WT TRBP-D2. However, this difference in dynamics is not clearly 
displayed in the (1H-15N) Heteronuclear NOE studies of the two protein 
constructs. 
 
Table 4.6 15N relaxation times of the β1-β2 loop in WT TRBP-D2 and 
TRBP-D2 P186Q 
 WT TRBP-D2 TRBP-D2 P186Q 
 185G,187A,188H,190K 185G,186Q,187A,188H,189R,190K 
T1 (ms) 846.1  ± 63.1 779.5  ± 35.1 
T2 (ms) 22.9   ± 11.9 40.6    ± 11.11 
15N{1H} NOE 0.63   ± 0.22 0.57    ± 0.07 
 
 
T2 relaxation rates of TRBP-D2 WT and P186Q highlight there is rigidity in the 
structured regions of the dsRBDs and high flexibility seen at the N-terminal 
end of the dsRBD.  Interestingly the T2 relaxation rate phenomenon seen in 
RNA binding region 2 of TRBP-D12 can also be seen in the single dsRBD.  
The T2 relaxation rates for the residues in the β1-β2 loop are significantly lower 
than for residues found in the structured regions not indicative of a flexible 
loop.  With the substitution of the proline residue (P186) the T2 relaxation rates 
of the loop region increase indicating an increase in flexibility. Interestingly Val-
168 also has a low T2 relaxation time compared to the rest of the domain. 
 
A possible explanation for seeing this phenomenon of a low T2 relaxation time 
in a flexible loop could be due to a conformational exchange process occurring 
with the residues in the loop structure, if the spins of the residues are switching 
between two or more states with different chemical shifts, this affects the T2 
relaxation rate by signifying a shorter T2 value. Conformational exchange 
motion has previously been identified for loop regions of dsRBDs (Lu and Hall, 
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1997; Nanduri et al., 2000). Interestingly the removal of the proline residue 
increased the T2 values of RNA binding region 2 specifically the histidine 
residue back to an expected value. This could suggest that the proline residue 
maybe important in the potential conformational exchange of this loop region, 
but further NMR analysis must be carried out to prove this.  
 
4.4.4 Discussion 
 
Investigating dynamics and local motions within a protein could help to further 
understand how a protein functions and carries out its specific role. 15N 
relaxation experiments have been carried out to investigate the dynamics of 
the two type-A RNA binding domains of TRBP to inspect the similarities and 
differences in local motion between the two dsRBDs. Interestingly, differences 
in dynamics were identified between RNA binding region 2 between both 
domains. Therefore, it was important to first investigate how this difference in 
dynamics exists between two highly conserved dsRBDs and then to 
understand how this difference impacts the singular dsRBDs and within the 
multi-domain protein. This led to investigating the amino acid composition of 
this region and carrying out point mutations to find the cause for the difference 
in dynamics. The results indicate that the proline residue (P186Q) found in 
TRBP-D2 which is a glutamine residue in TRBP-D1 may be the cause of the 
difference in dynamics between the two domains in RNA binding region 2.   
 
The investigations suggest that there might be some interesting phenomenon 
of RNA binding region 2 in TRBP-D2. The T2 relaxation experiment of WT-
TRBP-D2 showed residues in the β1-β2 loop region has noticeably lower T2 
values compared to the average T2 value of the dsRBD not indicative of a 
flexible loop region. Which has been seen in other dsRBDs where residues 
required an exchange term for T2 relaxation to be fitted. This requires the 
model-free approach proposed by Lipari and Szabo which calculates the 
exchange contribution to T2 (Rex)((Lipari and Szabo, 1982). Therefore, some 
form of conformational exchange could also be occurring with the residues 
within this loop region, additionally point mutations with the removal of P186 
suggests the ability to eliminate this phenomenon. It was also shown that an 
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insertion of a proline residue in the β1-β2 loop of TRBP-D1 had the ability to 
induce this T2 phenomenon. Although the T2 data for the β1- β2 loop in TRBP-
D2 may be affected by residues experiencing exchange, the other two 
relaxation parameters highlight that this region is more rigid than the β1- β2 
loop found in TRBP-D1.  
 
The flexibility of the β1- β2 loop in dsRBDs has been hypothesized to be critical 
for binding, as the loop is required to rotate toward the dsRNA to interact with 
the 2’hydroxyl groups of the minor groove (Ryter and Schultz 1998; Doyle and 
Jantsch 2002; Masliah et al. 2013). A difference in dynamics between dsRBDs 
within a multi-domain dsRBP has been previously reported for the interferon-
inducible antiviral kinase PKR. Using NMR spectroscopy, it was shown that 
the two structurally similar N-terminal dsRBDs exhibited a difference in 
motional flexibility on a millisecond timescale. It was suggested that the 
difference in backbone dynamics correlates with their differential dsRNA 
binding activity (Yang et al. 2014). Therefore, could the difference in backbone 
dynamics seen for TRBP-D1 and TRBP-D2 in β1- β2 loop region play a role 
in RNA binding of these dsRBDs? The dsRBDs of PKR have been shown to 
bind to structurally variable dsRNAs and PKR-dsRBD1 binds more favourably 
than PKR-dsRBD2. It has been hypothesised that the more dynamic PKR-
dsRBD1 may confer the flexibility required for structurally distorted dsRNA. 
Therefore, could the difference in dynamics between TRBP-D1 and TRBP-D2 
play a similar role in the binding of pre-miRNAs.  
 
This chapter has identified a difference in dynamics between two dsRBDs 
within the same multi-domain protein. The data suggests that the difference in 
dynamics is due to amino acid composition. The next logical step would be to 
try and understand why this difference in dynamics exists between TRBP-D1 
and TRBP-D2 and how changing the dynamics of the dsRBD can change its 
functions such as dsRNA binding. In the case of a dsRBD interacting with 
dsRNA, most of the conserved RNA binding amino acids found in dsRBDs use 
their backbones for interaction. Therefore, backbone flexibility can play a 
critical role in dsRNA binding activity of a dsRBD (Ryter and Schultz 1998; 
Ramos et al. 2000; Wang et al. 2011). 
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Chapter 5- Investigating the dsRNA binding 
properties of TRBP 
 
5.1 Introduction 
 
This chapter will focus on the RNA binding properties of the type-A dsRBDs of 
TRBP and more specifically the characteristics of the second RNA binding 
region of both dsRBDs. The amino acid sequence encompasses the structural 
dynamics and chemical properties of protein structures therefore each specific 
residue in region 2 could play a role in dsRNA recognition. Subsequently this 
will be explored through mutagenesis and investigating the RNA binding 
affinities of WT and mutant dsRBD constructs. 
 
5.2 The RNA binding relationship of the dsRBDs of TRBP 
 
The two type-A dsRBDs of TRBP that bind to dsRNA are connected by an 
unstructured long flexible linker, previous studies have shown that two 
dsRBDs do not interact with each other within the multi-domain protein (Benoit 
et al. 2013). The presence of a linker between dsRBDs can play a role in the 
interaction of the dsRBDs with dsRNA, some proteins require the linker region 
to form an integral part of the recognition surface or tether the dsRBDs to 
restrict local diffusion by defining a maximum distance between dsRBDs in a 
length dependent manner (Mackereth and Sattler 2012). The tethering of 
multiple dsRBDs can yield to an increase in local concentration of one dsRBD 
upon binding of another dsRBD within a multi-domain protein (Shamoo et al. 
1995; Tian et al. 2004). In case of an infinitely long linker the affinity of two 
dsRBDs within a multi-domain protein is additive and in the case of a short 
linker it is multiplicative (Shamoo et al. 1995). Linker length dictating and 
restricting the local concentration of dsRBDs in a multi-domain protein can 
contribute to the interaction of a weak interacting dsRBDs. A high-affinity 
dsRBD can first bind to a substrate and restrict the local concentration of the 
weaker binding domain dependent on the linker length and enhance substrate 
binding.  
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Investigations were carried out to analyse the RNA binding affinities of the 
singular domains (TRBP-D1 & TRBP-D2) and the double domain protein 
(TRBP-D12) with various dsRNAs. The method of choice for analysing binding 
affinities was fluorescence anisotropy; each dsRNA investigated was labelled 
with a fluorophore on the 3’ end. Multiple single dsRBDs and multiple TRBP-
D12 are capable of binding a pre-miRNA. However, fluorescence anisotropy 
binding data were fit to a single site-binding isotherm, with the assumption that 
each binding even is independent. 
The linker between the dsRBDs in TRBP is long and flexible separating the 
dsRBDs therefore the expected binding affinity of TRBP-D12 is to be the sum 
of the dsRBD affinities. However, analysing the RNA binding affinity of TRBP-
D12 we can see that for the dsRNAs tested TRBP-D12 binds to dsRNA 
stronger than the individual TRBP dsRBDs (Figure 5.1). A 2-4-fold increase in 
RNA binding affinity for the double domain construct was seen compared to 
the single dsRBD (Table 5.1). This indicates that although the linker is long 
and flexible it plays a role in RNA binding by increasing the affinity of the single 
dsRBDs by tethering them to each other, possibly by increasing the RNA 
binding surface by positioning of the dsRBDs or by increasing the local 
concentration of one dsRBD when one is already bound.  
 
Table 5.1 RNA binding affinities of TRBP-D1, TRBP-D2 and TRBP-D12 for 
various dsRNAs 
 Pre-miR -155 Pre-Let-7a 
Native modified Native modified 
 KD error KD error KD error KD error 
TRBP-D1 946 190 519 60 777 88 1015 142 
TRBP-D2 914 103 571 59 630 57 824 78 
TRBP-D12 381 58 247 36 292 45 285 38 
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Figure 5.1 Binding curves for TRBP-D1, TRBP-D2 and TRBP-D12 for various dsRNAs 
 (A) Interaction of Pre-miR 155 WT vs. protein constructs (B Interaction of Pre-miR 155 
mod vs. protein constructs (C) Interaction of Pre-let7a vs. protein constructs (D) Interaction 
of Pre-let7a mod vs. protein constructs. Experimental data are averaged from three 
independent fluorescent anisotropy experiments.  
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5.3 The role of dsRNA structure on the dsRNA binding affinity 
of the dsRBDs found in TRBP 
 
The binding of most dsRBDs to precursor microRNAs has been identified to 
be sequence independent (Masliah et al. 2013). Therefore, it has been 
suggested that recognition of dsRNAs by dsRBDs depends on the structural 
features of the dsRNA such as bulges and internal loops (Bevilacqua et al. 
1998; Krol et al. 2004; Heinicke et al. 2011; Liu et al. 2018). To investigate 
how structural features of pre-miRNAs may be recognised by TRBP, modified 
versions of two pre-miRNAs were produced (Pre-miRNA-155 & Pre-let-7a). 
Structural features have been removed to produce a perfect dsRNA duplex of 
the pre-miRNA (Figure 5.2).  Pre-miR-155 contains two 1-nt bulges in the 
middle of dsRNA stem and two G.U wobble base pairs in the dsRNA stem. 
Pre-let7a contains only 1-nt bulge close to the 5’ & 3’ end of the duplex and 
two G/U wobble base pairs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Predicted secondary structure of dsRNAs used in 
RNA binding studies  
(A) Pre-miR 155 WT (B) Pre-miR 155 mod (C) Pre-let7a WT (D) Pre-
let7a mod. Secondary structures of the dsRNAs were predicted using 
Mfold. 
(A) 
(B) 
(C) 
(D) 
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The RNA binding analysis of TRBP-D12 with the wild type and modified 
versions of pre-miRNAs showed that for TRBP-D12 a large difference in RNA 
binding affinities cannot be seen (Table 5.1). However, the single domains of 
TRBP can been seen to interact with a higher affinity (2-fold) for pre-miR-155 
mod compared to pre-miR-155 wt. Interestingly with the removal of structural 
imperfections in pre-let-7a the RNA binding affinity by the single dsRBDs 
increased marginally. Other structured dsRNAs need to be investigated to 
further understand the role of structural imperfections in the dsRNA stem of 
pre-miRNAs. However, the data presented here suggests that the RNA 
binding affinities of the single dsRBDs of TRBP can indeed be affected by 1-
nt bulges and non- Watson-Crick base pairing. The RNA binding data also 
implies that structural features of dsRNAs do not only impede RNA binding but 
can also enhance the affinity as seen by pre-let-7a and its modified version. 
Hence, the position of structural features on the dsRNA could possible play a 
role in dsRNA recognition.  
 
It was expected for the dsRBDs of TRBP to bind to both modified version of 
the pre-miRNAs with similar binding affinities, but this was not the case as pre-
let-7a mod has ~1.5-2-fold weaker binding affinity for the single dsRBDs 
compared to pre-miR-155 mod. A potential explanation for this could be due 
to the length of the dsRNA stem, the Mfold structures reveal that Pre-miR-155 
mod has a 25 bp stem whereas Pre-let-7a mod has a 21 bp stem (Figure 5.2). 
This is in agreement with data indicating that the binding affinity of TRBP 
increases with RNA duplex length (Acevedo et al. 2015). 
 
5.4 Investigating the amino acid composition of RNA binding 
region 2 in TRBP-D1 & TRBP-D2 
 
As discussed in Chapter 1 RNA binding region 2 of dsRBDs is highly 
conserved and important for the interaction between dsRBDs and dsRNA. 
Therefore, this part of the chapter will focus on understanding the importance 
of the residues in this region in the dsRBDs of TRBP. Interestingly the two 
type-A dsRBDs of TRBP have a different amino acid composition in this 
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specific region. Analysing the difference in amino acid composition of RNA 
binding region 2 of TRBP-D2 compared to TRBP-D1 will expose how each 
residue functions in RNA binding of this region and help to further elucidate 
how this region interacts with dsRNA. NMR analysis of RNA binding region 2 
of the dsRBDs in TRBP in the previous chapter has highlighted differences in 
dynamics between the two dsRBDs. It was shown that a single point mutation 
Q56P and P186Q in TRBP-D1 and TRBP-D2 respectively can alter the 
flexibility. This will be further investigated to understand how dynamics of this 
region plays a role in dsRNA binding of each dsRBD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Schematic of TRBP constructs 
created by mutagenesis for RNA binding 
studies. 
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5.4.1 Investigating RNA binding region 2 in TRBP-D2 by EMSA 
 
Individual residues in the β1- β2 loop of TRBP-D2 were mutated to mimic the 
amino acid composition of TRBP-D1 and tested to determine whether 
mutations alter the RNA binding (Figure 5.3). The sequence alignment 
highlighted differences in residues between the regions of the TRBP domains. 
The first difference that was investigated is the presence of a Proline residue 
preceding the RNA interacting histidine (GPAHRK) in TRBP-D2, TRBP-D1 
has a glutamine at the equivalent position. The second difference that was 
investigated in this region is the presence of two positively charged residues 
(GPAHRK) in TRBP-D2 that are either glutamine or a proline residue in TRBP-
D1. The role these differences in amino acid composition play in RNA binding 
was initially investigated through EMSA. 
Gels were analysed, and the estimated dsRNA binding affinities were 
examined by determining the disappearance of the free RNA band at various 
protein concentrations for each protein construct. EMSA results show that a 
single amino acid substitution in RNA binding region 2 can reduce the affinity 
of TRBP-D2 for pre-miRNA (Figure 5.4). This can be seen by the 
disappearance of the free RNA band at a higher protein concentration 
compared to WT TRBP-D2. Mutation of the positively charged residues found 
in TRBP-D2 had little to no effect on the RNA binding affinity suggesting that 
these residues do not interact with the negatively charged backbone of the 
dsRNA. However, the P186Q mutation reduced binding affinity of TRBP-D2 
for both pre-miRNAs tested. 
Although the mutation K190P has introduced another proline residue into the 
β1- β2 loop, this mutation had minimal effect on the binding affinity, which 
suggests the positioning of the proline in TRBP-D2 may be important rather 
than the number of proline residues present.  
The results obtained imply that differences in the residue composition of the 
β1- β2 loop of these dsRBDs may be required for fine-tuning the affinity of the 
two RNA binding dsRBDs in TRBP. These findings suggest a hypothesis that 
the proline residue at the position preceding the histidine may be play a role in 
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interacting with the dsRNA or facilitating other residues such as the histidine 
for RNA binding.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Electrophoretic mobility shift assay of two pre-miRNAs with 
various TRBP wt and mutant constructs for binding analysis. 
 (A) 200 nM of Pre-miRNA 155 incubated with an increasing concentration of 
TRBP-D1, TRBP-D2, TRBP-D2 P186Q, TRBP-D2 R189Q and TRBP-D2 
K190P protein constructs. (B) 200 nM of Pre-let 7a incubated with an 
increasing concentration of TRBP-D1, TRBP-D2, TRBP-D2P186Q, TRBP-D2 
R189Q and TRBP-D2K190P protein constructs. EMSAs were carried out on 
10% native polyacrylamide gels in triplicates 
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5.4.2 Quantitative analysis of the dsRNA binding affinity of 
TRBP-D2 and mutations affecting RNA binding region 2 
To further analyse RNA binding properties region 2 of TRBP-D2, a more 
quantitative analyse of determining the RNA binding affinity was carried out. 
Fluorescence anisotropy was used, and protein binding affinities were 
measured with 3’ FTSC labelled dsRNAs. To further our understanding of RNA 
binding region 2, the histidine residue was mutated to an alanine to analyse 
its importance in RNA binding (Figure 5.3). Similar experiments have been 
conducted on dsRBDs for other proteins, which revealed that mutation 
resulted in a lower affinity or no binding to dsRNA (Bycroft et al. 1995; Krovat 
and Jantsch 1996). The EMSA analyses of the two positively charged amino 
acids in RNA binding region 2 showed that single point mutations at these 
positions did not alter the RNA binding affinity. Therefore, a double mutant 
construct was created to understand how this may affect RNA binding of this 
region (TRBP-D2 RK189QP). 
RNA binding curves obtained through fluorescence anisotropy were fitted with 
a single site-specific binding equation (Figure 5.5). Although it has been shown 
that multiple dsRBDs bind to pre-miRNAs such as pre-miR-155, a single site 
binding equation was used to calculate a global affinity of the multiple binding 
sites, assuming all sites are independent. 
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(A) 
 
(B) 
Figure 5.5 dsRNA binding affinities of WT TRBP-D2 and mutant 
constructs  
(A)Table of binding affinities of WT and mutant constructs of TRBP-D2 for 
various pre-miRNAs produced (B) Bar chart format of binding affinities. Binding 
affinities were calculated from three independent fluorescence anisotropy 
experiments. 
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The fluoresce anisotropy analysis of RNA binding region 2 of TRBP-D2 has 
revealed that mutations to specific residues within this region has an effect on 
the RNA binding affinity of the dsRBD (Figure 5.5). 
For all pre-miRNAs tested, the mutation of the histidine residue for an alanine 
residue did not knock out RNA binding but merely decreased the RNA binding 
affinity of TRBP-D2. This result was unexpected as others have shown that 
the removal of the conserved histidine residue knocks out binding of dsRBDs 
(Krovat and Jantsch 1996; Yamashita et al. 2011). Approximately a 2-fold 
weaker binding affinity was seen for TRBP-D2 H188A compared to TRBP-D2 
WT for all dsRNAs tested (Figure 5.5 & 5.6). 
EMSA results suggested that mutation of the two positively charged residues 
(R189, K190) found in RNA binding region 2 of TRBP-D2 did not affect the 
RNA binding affinity of the dsRBD when mutated individually. However, the 
double mutation to mimic the amino acid composition of TRBP-D1 presents 
that the binding affinity is affected with the modification of both residues in 
TRBP-D2. TRBP-D2 R189Q-K190P shows a 2-3-fold weaker binding affinity 
for the dsRNAs tested compared to WT TRBP-D2 (Figure 5.5 & 5.6). 
Structural analysis of RNA binding region 2 in TRBP-D2 highlighted that the 
proline residue (P186) is required for this region to attain certain rigidity and 
with the removal by substituting this residue for a glutamine residue decreased 
the flexibility of this region. To understand how this change in rigidity affects 
dsRNA binding of this region and the whole dsRBD, dsRNA binding tests were 
carried out with TRBP-D2 P186Q and various dsRNAs.  The fluorescence 
anisotropy data highlighted that for all dsRNAs tested TRBP-D2 P186Q has a 
weaker binding affinity compared to WT TRBP-D2. A 2-fold difference in 
binding affinity can be seen for pre-let-7a and pre-miR-155 mod and slightly 
lower affinities for pre-miR-155 and pre-let-7a mod. The proline residue has 
not been seen to directly interact with dsRNA but the binding studies indicate 
it plays a role in the efficient binding of TRBP-D2 to dsRNAs. Possibly 
maintaining the correct positioning of the RNA interacting histidine residue. 
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Figure 5.6 Binding curves for WT TRBP-D2 and mutant constructs 
 (A) Interaction of Pre-miR 155 WT vs. protein constructs (B Interaction of Pre-miR 155 mod vs. 
protein constructs (C) Interaction of Pre-let7a vs. protein constructs (D) Interaction of Pre-let7a 
mod vs. protein constructs. Experimental data are averaged from three independent fluorescent 
anisotropy experiments. 
TRBP-D2- R189Q-K190P 
TRBP-D2- R189Q-K190P 
TRBP-D2- R189Q-K190P 
TRBP-D2- R189Q-K190P 
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5.4.3 Investigating RNA binding region 2 in TRBP-dsRBD1 
 
Following investigations into RNA binding region 2 of TRBP-dsRBD2, this 
region was investigated in TRBP-D1. As described previously between the two 
dsRBDs there are major differences in amino acid composition in this region 
2, to understand how this difference in amino acid composition affects the 
dsRNA binding capabilities of both dsRBDs, dsRNA binding studies were 
carried out on mutant protein constructs.  
Single point mutations in RNA binding region 2 of TRBP-D1 were carried out 
to partially mimic the amino acid composition of TRBP-D2. To understand how 
the presence of a proline residue at the start of loop region can influence 
dsRNA binding. The conserved histidine residue within region 2 in TRBP-D1 
was also mutated to an alanine to investigate this residues impact on dsRNA 
binding.  
Mutagenesis of RNA binding region 2 in TRBP-D1 has shown that the 
substitution of a proline residue within this region (Q56P) has increased the 
RNA binding affinity of the dsRBD for Pre-miR-155 2-fold compared to WT 
TRBP-D1 (Figure 5.7). For the other dsRNAs tested a difference in binding 
affinities could not be observed. Pre-miR-155 features the most structurally 
non-perfect dsRNA duplex in this study so possibly mutating the glutamine to 
a proline residue in this region, has affected how this dsRBD recognises 
structural imperfection and could potentially help the dsRBD position itself 
around them more efficiently.  This hypothesis requires further testing with 
other dsRNAs.  
Interestingly mutating the histidine 58 to alanine did not reduce the dsRNA 
binding affinity, which was not seen for TRBP-D2 (Figure 5.7). TRBP-D1 H58A 
also reveals that with the removal of the histidine residue the dsRBD binds 
2.5-fold stronger to pre-miR-155 similar to what was seen for TRBP-D1 Q56P. 
This suggests that by changing the amino acid composition of region 2 in 
TRBP-D1 could change how this dsRBD interacts with pre-miRNAs with 
structural imperfections in the dsRNA stem. 
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 For pre-miR-155 mod, pre-let-7a and pre-let-7a mod these results indicate 
that the conserved histidine residue within this loop may not be required for 
the interaction of dsRNA for this dsRBD as removing the conserved histidine 
was shown to have no effect on the RNA binding affinity. However, for pre-
miR-155, a more structurally imperfect dsRNA the removal of the histidine 
residue and changing the glutamine to a proline residue has increased the 
RNA binding affinity of TRBP-D1. This suggests the original amino acid 
composition of the loop region in TRBP-D1 could hinder the dsRBD from 
binding to dsRNAs with more structurally imperfect stems or have no effect on 
dsRNA binding.  
.  
 
Pr
e-
m
iR
-1
55
Pr
e-
m
iR
-1
55
 m
od
Pr
e-
Le
t-7
a
Pr
e-
Le
t-7
a 
m
od
0
500
1000
1500
TRBP-D1
TRBP-D1 Q56P
TRBP-D1 H58A
K
D
 (n
M
)
	
 Pre-miR -155 Pre-Let-7a 
Native modified Native modified 
 KD (nM) error KD (nm) error KD (nm) error KD (nm) error 
TRBP-D1 945 190 519 60 777 88 1015 142 
TRBP-D1 Q56P 430 85 529 120 731 98 957 163 
TRBP-D1 H58A 361 63 648 67 748 125 943 140 
(A) 
(B) 
Figure 5.7 dsRNA binding affinities of WT TRBP-D2 and mutant constructs  
(A)Table of binding affinities of WT and mutant constructs of TRBP-D2 (B) Bar chart 
format of binding affinities. Binding affinities were calculated from three independent 
fluorescent anisotropy experiments.   
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Figure 5.8 Binding curves for WT TRBP-D1 and mutant constructs 
 (A) Interaction of Pre-miR 155 WT vs. protein constructs (B Interaction of Pre-miR 155 
mod vs. protein constructs (C) Interaction of Pre-let7a vs. protein constructs (D) Interaction 
of Pre-let7a mod vs. protein constructs. Experimental data are averaged from three 
independent fluorescent anisotropy experiments. 
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5.5 Discussion 
 
DsRNA binding domains are often found in modular RNA binding proteins, in 
combination with other functional domains or as multiple copies (Mackereth 
and Sattler, 2012). TRBP contains three dsRBDs, two of which bind to dsRNA. 
The results have shown that the two N-terminal dsRBDs of TRBP do in fact 
bind to dsRNA and that the linker connecting the two dsRBD which has been 
shown not to interact with dsRNA, does enhance the interaction of the dsRBDs 
with dsRNA. The linker acts as a tether to potentially increase the RNA binding 
surface of the dsRBDs cooperatively or increasing the local concentration of 
one dsRBD when one is already bound.  Interestingly, the RNA binding studies 
conducted with the separate dsRBDs of TRBP highlighted that both dsRBDs 
have similar RNA binding affinities for the dsRNAs tested, which is contrary to 
previous studies. An explanation for this could be due to the pH of the assay 
conducted, as it has been identified that TRBP-D1 exists in a state of 
equilibrium of folded and unfolded protein and investigating this has shown 
that an increase in pH disrupts this equilibrium between folded and unfolded 
protein. Studies here were carried out at pH 7.5 to ensure TRBP-D1 existed in 
a maximally folded state, which likely corresponds to its active state. 
Therefore, the contribution of the unfolded/folded state of equilibrium will not 
affect RNA binding and the investigation can focus on RNA binding region 2. 
DsRBDs have been shown to bind to dsRNA independent of the dsRNA 
sequence (Masliah et al. 2013). As a result, it has been suggested that the 
dsRBDs found in TRBP recognise pre-miRNA through structural features 
within the dsRNA stem, pre-miRNA stems are highly enriched in bulges or 
non-canonical base pairs (Warf et al. 2011). This property of TRBP was 
investigated by analysing the binding affinity for native and modified pre-
miRNAs sequences. The data showed that there was not a major difference 
in RNA binding between a structured dsRNA compared to a dsRNA with a 
perfect dsRNA stem with no helical defects for TRBP-D12, although a two-fold 
difference in binding affinity was observed for the single domains of TRBP for 
pre-miR-155-wt and its modified version. This suggests that two dsRBDs are 
required together to help facilitate TRBP bind to structurally imperfect dsRNAs. 
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Interestingly, the removal of structural features in pre-let-7a has reduced RNA 
binding affinity of the single dsRBDs of TRBP. This suggests that helical 
defects within a dsRNA stem may not only hinder the RNA binding affinity of 
dsRBDs but also aid. The positioning of the structural feature needs to also be 
taken into consideration.  More dsRNAs need to be tested to further prove this 
but the investigation shows that the single dsRBDs of TRBP are affected by 
the presence of helical imperfections ubiquitous to pre-miRNAs. Yet again no 
difference in binding between pre-let-7a and its modified version was seen for 
TRBP-D12 suggesting the need for a multi-domain protein for the recognition 
of dsRNA. 
RNA binding region 2 of dsRBDs has been well studied in various dsRNA 
binding proteins but the specific amino acid composition of this region and the 
differences seen within this region between dsRBDs has not been extensively 
investigated. How do the highly conserved and non-conserved residues in this 
region in TRBP play a role in dsRNA binding of the protein? Could the 
differences in amino acid composition in this region play a role in fine-tuning 
the dsRNA binding affinity of the dsRBD and therefore RNA binding properties 
of TRBP? Contrary to data surrounding other dsRBDs, the mutation of the 
conserved histidine residue in RNA binding region 2 did not knock out dsRNA 
binding in TRBP-D1 and TRBP-D2. Here it was shown that replacing the 
histidine residue with an alanine in TRBP-D1 had no significant effect on the 
RNA binding affinity for three out of the four dsRNAs tested. In fact, the RNA-
binding affinity was enhanced 2-3 fold for of pre-miR-155. TRBP-D2 H188A 
on the other hand showed a reduction in RNA binding affinity for all dsRNAs 
tested (Figure 5.9). These data suggest that the conserved histidine residue 
in TRBP-D1 may not be involved in RNA binding of this region, as mutating 
this residue has not decreased the RNA binding affinity of the dsRBD, which 
was seen for TRBP-D2. The presence of a proline residue in region 2 of TRBP-
D2 which is absent from TRBP-D1, was also examined. The data suggests 
that the introduction of a proline residue into region 2 of TRBP-D1 did not have 
a significant impact on the dsRNA binding affinity of this dsRBD for three out 
of the four dsRNAs tested. However, mutation of the proline residue in TRBP-
D2 in region 2 (P186Q) did weaken binding affinity of this dsRBD for the 
dsRNAs investigated.  
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The mutational studies of RNA binding region 2 of TRBP-D2 have shown that 
each residue within this region is required for the efficient binding of not only 
this region but the whole dsRBD as point mutations have shown to decrease 
the RNA binding affinity.  
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Figure 5.9 Summary of RNA binding affinities of TRBP constructs with dsRNAs 
(A) Table of RNA binding affinities of TRBP constructs with various dsRNAs. Bar chart 
format of binding affinities for TRBP constructs for (B) Pre-miR-155 (C) Pre-miR-155 mod 
(D) Pre-let-7a (E) Pre-let-7a mod.  
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Chapter 6- Conclusions and Discussion 
 
6.1 The folded/unfolded equilibrium of TRBP-D1 is affected by 
pH 
 
TRBP-D1 has previously been shown to exist in an equilibrium between fully 
folded and unfolded state, whereas TRBP-D2 appeared to be stable (Benoit, 
2013). Further investigation into this phenomenon showed that the equilibrium 
could be shifted towards the folded state by increasing the pH above 7.0. 
Trying to identify a condition whereby the protein is in its fully folded state was 
important, as dsRBDs have been shown to require the canonical fold to 
interact with dsRNA (Ryter and Schultz 1998). This also allowed for the 
investigation to focus on the RNA binding regions of TRBP-D1 with no 
contribution from the folded/unfolded equilibrium on RNA binding. A possible 
reason for pH effecting the protein conformation could be due to properties pH 
can have on ionizable amino acids which have a large influence on protein 
structure and stability (Grimsley et al. 2009). 
The dsRBD (1732-1811) found in Dicer-1 (DCL1) of Arabidopsis thaliana was 
shown to be intrinsically disordered but acquired a folded structure when 
bound to dsRNA (Suarez et al. 2015). It was also seen to be disordered in 
tandem constructs with the other dsRBD found in DCL1. Although the dsRBD 
was intrinsically disordered it was seen to carry out its roles in RNA 
recognition.  Disordered proteins and disordered regions within proteins are 
thought to enable multiple target recognition due their inherent flexibility 
(Dyson 2012). This suggests that the state of equilibrium between 
folded/unfolded in TRBP-D1 could be important for its function in RNA binding. 
Like DCL1-dsRBD, TRBP-D1 also exists in this state of equilibrium in the 
double domain construct (TRBP-D12).  RNA-binding studies of the dsRBDs of 
TRBP have shown that the two dsRBDs interacted with dsRNA with differing 
affinities, however the pH of the experiment was pH 6.5 (Benoit et al., 2013). 
In this study RNA binding studies performed at pH 7.5 (at which TRBP-D1 has 
been determined to be in a folded state) identified that the two dsRBDs bind 
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with similar affinities. This suggests a novel dsRBD feature found in TRBP 
whereby RNA binding of TRBP-D1 can be regulated by pH by altering the 
structure of TRBP-D1. 
6.2 Pre-miRNA recognition by the modular protein TRBP 
 
As presented in section 1.6, dsRBDs are commonly found in modular RNA 
binding proteins, both in multiple copies and in combination with other 
functional domains (Mackereth and Sattler, 2012; Tian et al., 2004). Mutations 
and truncations of single dsRBDs in a multi-domain protein have shown to 
diminish or completely abolish the ability of the protein to interact with dsRNA 
(Schmedt et al. 1995; Krovat and Jantsch 1996). By existing in multiple copies, 
the domains can allow the protein to bind with RNA with higher specificity and 
affinity (Stefl et al. 2006; Benoit et al. 2013). TRBP like other dsRBPs has been 
shown contain dsRBDs that fold independently with no intermolecular 
interaction between the domains (Benoit et al. 2013).  
The RNA binding investigations in this study of the individual domains and the 
tandem domain construct showed that the modular design of the RNA binding 
portion of TRBP is required for a higher dsRNA binding affinity. The double 
domain construct was seen to bind 2-3-fold higher than the single dsRBDs. 
This suggests that tethering of the dsRBDs influences RNA binding of the 
dsRBDs by increasing their affinities for dsRNA.  
A long and flexible linker such as the one found in TRBP between the two type-
A dsRBDs has been suggested to allow modular proteins to recognise a 
diverse set of targets, whereas short linkers between dsRBDs has been 
suggested to predispose the domains to bind to a contiguous stretch of RNA 
(Tian et al. 2004). This could allow for structural features of pre-miRNAs to 
block RNA binding as shorter linkers could restrict the distance between 
dsRBDs required for binding around structural features. Interestingly, PACT 
contains a short linker (25aa) between the two type-A dsRBDs. Could this 
shorter linker play a role in the potential differential dsRNA binding between 
TRBP and PACT? The RNA binding data presented here identified that TRBP-
D12 can bind to pre-miRNA with structural features tighter than the singular 
dsRBDs suggesting that linker is sufficiently long to allow the dsRBDs to bind 
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around the structural imperfections. However, for pre-miRNAs with a perfect 
duplex, a short linker such as the one found in PACT could be advantageous 
as linker length can be directly linked to the affinity of a modular protein. 
Assuming the free energy of individual dsRBDs binding is additive, the affinity 
of a protein with multiple dsRBDs could be as high as the product of the 
affinities of the individual dsRBDs. However, with a long flexible linker 
separating multiple dsRBDs, one dsRBD will bind to the dsRNA and the 
second domains sweeps a volume proportional to the length of the linker 
(Shamoo et al. 1995; Tian et al. 2004). In this volume, the concentration of the 
second dsRBD is different compared to in the free solution. As the linker length 
decreases the affinity of the second dsRBD binding increases due to the 
restricted sweeping volume which favours binding of the second dsRBD. 
Therefore, the affinity of the modular protein increases.  
Linker length could therefore be advantageous or disadvantageous in modular 
proteins such as TRBP and PACT dependent on the substrate they are 
interacting with. Further work determining the RNA binding properties of PACT 
single and double domain constructs could elucidate how the difference in 
linker length contributes to dsRNA binding and why Dicer requires two dsRBPs 
for facilitating miRNA processing.  
6.3 The first two dsRBDs of TRBP have variations in backbone 
dynamics between the two dsRBDs 
 
 15N relaxation studies of the type-A dsRBDs of TRBP have previously and 
with this study have revealed subtle differences in backbone dynamics 
between the two dsRBDs on the ps-ns timescale. Interestingly the difference 
in dynamics localises to RNA binding region 2. Here, the dynamics of the two 
dsRBDs was further investigated and the difference was attributed to the 
amino acid composition of RNA binding region 2. A single amino acid 
difference between the two dsRBDs was able to modify the dynamics of this 
RNA binding region. The native sequence of TRBP-D2 has a proline residue 
at the N-terminus of the loop region where this is a glutamine in TRBP-D1. 
Proline residues within a polypeptide bond can impose conformational rigidity 
compared to other amino acids due to its distinctive cyclic structure.  
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Mutagenesis of the dsRBDs in TRBP-D12 to mimic the amino acid 
composition at region 2 of the other domain (TRBP-D1 Q56P & TRBP-D2 
P186Q) were carried out. The results showed that the introduction of a proline 
residue into the β1-β2 loop in TRBP-D1 increased the rigidity of this loop 
region, while substituting out the proline residue in TRBP-D2 decreases the 
rigidity. The data suggests that dynamics of RNA binding region 2 region can 
be fine-tuned by a single amino acid.  
Differences in the presence of proline residues in RNA binding region 2 seen 
in TRBP-D12 also exists between the type-A dsRBDs of PACT (Figure 6.1). 
Investigating whether a difference in dynamics also exists between the 
dsRBDs of PACT at RNA binding region 2 would determine whether this 
difference in dynamics is a conserved feature of multi-domain dsRBPs 
involved in miRNA biogenesis. 
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6.4 The contribution of amino acid composition of region 2 in 
RNA binding by the type-A dsRBDs of TRBP 
 
Investigating the amino acid composition of RNA binding region 2 in both type-
A dsRBDs of TRBP and the role this plays in RNA binding presented some 
interesting results. Mutagenesis of the conserved histidine residue in region 2 
has shown to have no negative effect on RNA binding for TRBP-D1 and only 
weakened the RNA binding affinity of TRBP-D2 (2-3 fold). Interestingly, 
mutating the histidine residue to an alanine in TRBP-D1 enhanced the binding 
affinity of this dsRBD for pre-miR-155. 
Investigations of region 2 in other dsRBDs has shown the importance of this 
region in RNA binding and its residues, with mutations of the histidine in the 
dsRBD of Xlrbpa knocking out RNA binding of the whole dsRBD (Krovat and 
Jantsch, 1996).  Mutating the histidine residue in region 2 of TRBP-D2 showed 
to have only a small impact on the RNA binding affinity of this dsRBD. For all 
dsRNAs tested the RNA binding affinity decreased ~2 fold compared to WT-
TRBP-D2. However, in this study the histidine residue in TRBP-D1 has been 
shown to be unnecessary for dsRNA binding. 
Replacing the glutamine residue with a proline residue in region 2 of TRBP-
D1 showed an increase in dsRNA binding affinity for pre-miR-155. Replacing 
the proline residue with a glutamine in RNA binding region 2 of TRBP-D2 had 
a negative effect on dsRNA binding. For all dsRNAs tested the TRBP-D2 
P186Q mutant had a weaker binding affinity compared to WT TRBP-D2.  
Region 2 has been reported to be important in RNA binding specifically the 
conserved histidine residue. However, the binding data in this study has 
suggested that the dsRBDs of TRBP can endure mutations in RNA binding 
region 2 without largely affecting the RNA binding of the dsRBDs. Mutagenesis 
of RNA binding region 2 in TRBP-D1 had no effect on the binding affinity of 
dsRNA with perfect (modified pre-miRNAs) or near perfect (pre-let-7a) dsRNA 
stem. Therefore, could the other two RNA binding regions be the main 
contributors to RNA binding with region 2 fine tuning the RNA binding of the 
dsRBD? 
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The differential binding modes seen for the dsRBDs of TRBP due to RNA 
binding region 2 could be important in fine tuning the affinity of the protein for 
dsRNA.  
 
6.5 DsRNA binding by TRBP is affected by structural features 
of the pre-miRNA 
 
Investigating the role of structural features on dsRNAs can play in dsRNA 
binding of TRBP showed that for pre-miR-155 a dsRNA with two 1-nt bulges 
in the dsRNA stem, the RNA binding affinities of the WT single dsRBD 
constructs were weaker than for pre-miR-155 (mod) with no structural 
imperfections in the dsRNA stem. The data presented here and by others 
suggest that the dsRBDs of TRBP can recognise structural features of pre-
miRNAs (Acevedo et al. 2015). This in turn could help Dicer to discriminate 
between pre-miRNA substrates as Drosophila Dicer-1 has been shown to not 
distinguish or recognise structural features in the stem region of pre-miRNAs 
(Tsutsumi et al. 2011). TRBP has previously been shown to facilitate 
discrimination of pre-miRNA like species by Dicer. TRBP was shown to ensure 
the efficient processing of Dicer for a pre-miRNA in a tRNA crowded 
environment (Fareh et al. 2016). The processing of the pre-miRNA was 
severely hindered when Dicer was present alone. However, when complexed 
with TRBP the processing efficiency was not affected. This has not yet been 
linked to the dsRNA recognition property of TRBP, but one can hypothesise 
that the ability of TRBP in recognising structural features in pre-miRNAs could 
facilitate Dicer binding to pre-miRNAs in an RNA crowded environment.  
TRBP recognition of dsRNA features could help facilitate the positioning of the 
protein on dsRNA and therefore help positioning of Dicer on the pre-miRNA. 
This can influence Dicer cleavage positioning, which would lead to a difference 
in iso-miR production (Lee and Doudna, 2012). TRBP has been shown to help 
tune miRNA length by Dicer dependent on base-mismatches in the pre-miRNA 
stem (Zhu et al. 2018). The data presented in this work supports this proposed 
model of TRBP dsRBDs recognising structural features to help Dicer 
positioning and processing. 
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6.6 The role of loop dynamics on dsRNA recognition 
 
A difference in dynamics between dsRBDs in a multi-domain protein has been 
reported for the dsRBDs of PKR on a millisecond timescale (Yang et al. 2014). 
The study proposed a correlation between the difference in flexibility and 
dsRNA binding affinity and specificity. Here, to draw a link between dynamics 
and RNA binding of TRBP, RNA binding studies were carried out with WT and 
mutant TRBP constructs which altered the dynamics of RNA binding region 2. 
Altering the backbone dynamics of RNA binding region 2 in TRBP-D1 (Q56P) 
by increasing the rigidity has shown to have no substantial impact on the RNA 
binding of this dsRBD for dsRNAs that lack structural features in the dsRNA 
helix. However, for pre-miR-155 a dsRNA with structural features in the dsRNA 
stem, TRBP-D1 Q56P showed a 2-fold increase in RNA binding affinity 
compared to WT- TRBP-D1. Decreasing the rigidity of region 2 in TRBP-D2 
showed that this dsRBD required the β1-β2 loop to attain certain rigidity for a 
higher RNA binding affinity of this dsRBD for the dsRNAs tested.  
The NMR relaxation studies also suggested that residues in the β1-β2 loop in 
TRBP-D2 may be experiencing conformational exchange between states not 
seen in the loop region of TRBP-D1. This phenomeon has not previously been 
reported for the dsRBDs of TRBP. This could be important as multiple 
conformational sub-states of this region may allow binding to various dsRNAs 
substrates. 
The RNA binding and NMR relaxation studies presented here suggest that 
rigidity of RNA binding region 2 may be required in dsRNA recognition of pre-
miRNAs with structurally imperfect dsRNA stems. This is contrary to what has 
been suggested for the dsRBDs of PKR, where one dsRBD with higher 
flexibility has been suggested to be able adapt to a variety of viral dsRNAs 
with imperfect A-form structures (Yang et al. 2014). A caveat for the hypothesis 
made for the dsRBDs of PKR and the dsRBDs of TRBP in this study is the low 
amount of dsRNAs tested against in their investigation. 
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6.7 Contribution of RNA binding region 2 in dsRBDs 
 
RNA binding studies of WT and mutant TRBP-D2 constructs showed that 
amino acid composition of RNA binding region 2 is important for the RNA 
binding activity of this dsRBD but can endure mutations in this region. 
Investigation of the amino acid composition of RNA binding region 2 in TRBP-
D1 showed that replacing the histidine residue with an alanine and altering the 
dynamics enhanced the binding affinity for pre-miR-155 and did not affect the 
affinity for the other dsRNAs tested. This suggests that the native sequence in 
region 2 of TRBP-D1 may hinder the dsRBD from binding to structurally 
imperfect dsRNAs. The results suggest that dynamics and amino acid 
composition of RNA binding region 2 may play a role in sensing imperfections 
in miRNA precursors. However, this assumption requires further investigation 
with RNA binding studies of more dsRNAs. 
The RNA binding studies carried out on TRBP-D1 and TRBP-D2 indicate that 
the contribution of RNA binding region 2 may differ between the two dsRBDs 
dependent on the dsRNA it is binding to. This could be a feature of multi-
domain proteins to be able to recognise and bind to various dsRNAs with 
higher specificity and affinity. 
Although RNA binding region 2 has conserved amino acids between different 
dsRBDs (GPxHxx), the differences in residues, length and dynamics of this 
region in the β1-β2 loop could play a role in the differential RNA binding 
properties of the different dsRBDs. For example, the β1-β2 loop region in the 
dsRBD found in human Dicer has been shown to be three amino acids shorter 
than the canonical length. Dynamics studies into the loop region in Dicer-
dsRBD showed there was only a minimal increase in dynamics compared with 
the rest of the domain and suggested to contribute to the high binding affinity 
of this dsRBD (Wostenberg et al. 2012). This study has shown that the 
dynamics between the dsRBDs of TRBP can also be fine-tuned by a single 
amino acid.  
The dsRBD domain has been found in functionally diverse proteins and must 
recognise a vast amount of RNAs. The data presented in this thesis suggests 
that RNA binding region 2 in the dsRBDs of TRBP can influence the dsRNA 
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properties of a dsRBD. Out of the three RNA binding regions in dsRBDs, most 
of the sequence length variability exists in region 2 (Tian et al. 2004). 
Therefore, the amino acid composition and dynamics of this loop region could 
be different between various dsRBDs to accommodate for the vast amount of 
dsRNA targets.  
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Figure 6.2 Contribution of the residues in the type-A dsRBDs of TRBP in 
structure and the dsRNA binding property of RNA binding region 2.  
(A) Model of RNA binding region 2 in TRBP-D1 and the contribution of amino acid in 
RNA binding and flexibility of region 2 elucidated from the data. (B) Model of RNA 
binding region 2 in TRBP-D2 and the contribution of amino acid in RNA binding and 
flexibility of region 2 elucidated from the data. Created using Pymol. Arrows on the 
dsRBD structure indicate loop region flexibility.  
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Chapter 7- Suggestions for future research  
 
This thesis sets out to further elucidate how TRBP interacts with dsRNAs, with 
the hope of understanding how TRBP interaction with dsRNA links to pre-
miRNA processing by Dicer. This work has created a toolbox of mutants that 
change the RNA binding properties of the dsRBDs in TRBP, which can be 
used to study how dsRNA interaction properties of TRBP govern processing 
of pre-miRNAs by Dicer.  
Changing the flexibility or amino acid composition of region 2 in one or both 
dsRBDs of TRBP and investigating this effect on Dicer processing such as iso-
miR production and the processing rate of Dicer would elaborate on how the 
RNA binding properties of TRBP contribute to Dicer processing. As mentioned 
before a study highlighted that TRBP acts as a substrate gatekeeper for Dicer, 
how this is governed by the RNA binding by TRBP is yet to be elucidated. 
Would weakening the RNA binding affinity of one or both dsRBDs by 
mutagenesis affect the gate keeping property of TRBP? Would changing the 
dynamics of RNA binding regions affect recognition of the correct substrate for 
Dicer? 
TRBP has been shown to diffuse along dsRNAs and a potential property of 
this diffusion is to scan the structure of dsRNAs to find the correct cleavage 
site for Dicer. Therefore, what role do the RNA binding regions in TRBP play 
in the diffusion mechanism and in turn the correct positioning of Dicer? Could 
the difference in dynamics observed for the two dsRBDs play a role in the 
diffusion of TRBP? The results from this thesis suggests dynamics in region 2 
could play a role in recognition of structures within the dsRNA stem of pre-
miRNAs, therefore this region could play a role in diffusion of the protein along 
pre-miRNAs with various structural features. 
Investigations of the RNA binding properties of PACT could further help to 
understand how the RNA binding interaction of dsRBPs play a role in their 
function in miRNA biogenesis. Potential differences seen in the binding of 
dsRNA by TRBP and PACT could help to elucidate why Dicer requires two 
functional dsRBPs for miRNA biogenesis and how each protein carries out its 
differential role in Dicer processing of pre-miRNAs. 
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The studies here were conducted on the single type-A dsRBDs and a multi-
domain construct of just the type-A dsRBD (TRBP-D12). However full length 
TRBP consists of three dsRBDs connected by long flexible linkers. Therefore, 
it would be interesting to investigate the RNA binding properties studied in this 
work in the context of the full-length protein. The data in this thesis highlighted 
that the two dsRBDs in TRBP have different dynamics in RNA binding region 
2. How will switching the dynamics in RNA binding region 2 between TRBP-
D1 and TRBP-D2 affect the dsRNA recognition by the full-length protein; 
furthermore, how will this affect the miRNA processing capabilities of TRBP in 
the miRNA biogenesis pathway? 
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Appendix 
 
Oligonucleotides for DNA templates of dsRNAs 
 
Pre-let-7a 
Forward Primer 
TAATACGACTCACTATAGGAGGTAGTAGGTTGTATAGTTTTAGGGTCAC
ACCCACCACTGGGAGATAACTATACAATCTACTGTCTTCCC 
Reverse Primer 
GGGAAGACAGTAGATTGTATAGTTATCTCCCAGTGGTGGGTGTGACCCT
AAAACTATACAACCTACTACCTCCTATAGTGAGTCGTATTA 
 
Pre-miR-155  
Forward Primer 
TAATACGACTCACTATAGGAATGCTAATCGTGATAGGGGTTTTTGCCTC
CAACTGACTCCTACATATTAGCATTCCCA 
Reverse Primer 
TTTTGGGAATGCTAATATGTAGGAGTCAGTTGGAGGCAAAAACCCCTAT
CACGATTAGCATTCCTATAGTGAGTCGTATTA 
 
Pre-let-7a mod 
Forward Primer 
TAATACGACTCACTATAGGAGGCAGTAGGTTGTATAGTTTTAGGGTCA 
CACCCACCACTGGGAGATAACTATACAACCTACTGCCTCCC 
Reverse Primer 
GGGAGGCAGTAGGTTGTATAGTTATCTCCCAGTGGTGGGTGTGACCCT 
AAAACTATACAACCTACTGCCTCCTATAGTGAGTCGTATTA 
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Pre-miR-155 mod 
Forward Primer 
TAATACGACTCACTATAGGTTAATGCTAATCGTGATAGGGGTTTTTGC 
CTCCAACTGACCCCTATCACGATTAGCATTAAC 
Reverse Primer 
TGTTAATGCTAATCGTGATAGGGGTCAGTTGGAGGCAAAAACCCCTAT 
CACGATTAGCATTAACCTATAGTGAGTCGTATTA 
 
Primers for Mutagenesis of TRBP 
TRBP-D1 Q56P 
Forward Primer 
GAA GGC CGA GGG CCC GGC CCA CCA ACC GAA C 
Reverse Primer 
GTT CGG TTG GTG GGC CGG GCC CTC GGC CTT C 
 
TRBP-D1 H58A 
Forward Primer 
GAA GGC CGA GGG CCA AGC CGC GCA ACC GAA CTT CAC CTT TC 
Reverse Primer 
GAA AGG TGA AGT TCG GTT GCG CGG CTT GGC CCT CGG CCT TC 
 
TRBP-D2 P186Q 
Forward Primer 
CCA AGA GAG CGG CCA GGC ACA TCG CAA GGA G 
Reverse Primer 
CTC CTT GCG ATG TGC CTG GCC GCT CTC TTG G 
 
TRBP-D2 H188A 
Forward Primer 
CAA GAG AGC GGC CCT GCA GCG CGC AAG GAG TTC ACC ATG 
Reverse Primer 
CAT GGT GAA CTC CTT GCG CGC TGC AGG GCC GCT CTC TTG 
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TRBP-D2 R189Q 
Forward Primer 
GAG CGG CCC TGC ACA TCA GAA GGA GTT CAC CAT GAC 
Reverse Primer 
GTC ATG GTG AAC TCC TTC TGA TGT GCA GGG CCG CTC 
 
TRBP-D2 K190P 
Forward Primer 
GCC CTG CAC ATC GCC CGG AGT TCA CCA TGA C 
Reverse Primer 
GTC ATG GTG AAC TCC GGG CGA TGT GCA GGG C 
 
TRBP-D2 RK189QP 
Forward Primer 
CAG GTC ATG GTG AAC TCC GGC TGA TGT GCA GGG CCG CTC 
Reverse Primer 
GAG CGG CCC TGC ACA TCA GCC GGA GTT CAC CAT GAC CTG 
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TRBP Constructs 
 
List of plasmids used for protein expression 
Tag Protein 
His-MBP TRBP-D1 
His-MBP TRBP-D2 
His-MBP TRBP-D12 
His-MBP TRBP-D1 Q56P 
His-MBP TRBP-D1 H58A 
His-MBP TRBP-D2 P186Q 
His-MBP TRBP-D2 H188A 
His-MBP TRBP-D2 R189Q 
His-MBP TRBP-D2 K190P 
His-MBP TRBP-D2 R189Q-K190P 
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DNA Sequence of protein constructs 
6x His with MBP tag and 3C cleavage site 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCATGAAAATCGAAG
AAGGTAAACTGGTAATCTGGATTAACGGCGATAAAGGCTATAACGGTCT
CGCTGAAGTCGGTAAGAAATTCGAGAAAGATACCGGAATTAAAGTCACC
GTTGAGCATCCGGATAAACTGGAAGAGAAATTCCCACAGGTTGCGGCA
ACTGGCGATGGCCCTGACATTATCTTCTGGGCACACGACCGCTTTGGT
GGCTACGCTCAATCTGGCCTGTTGGCTGAAATCACCCGGACAAAGCGT
TCCAGGACAAGCTGTATCCGTTTACCTGGGATGCCGTACGTTACAACG
GCAAGCTGATTGCTTACCCGATCGCTGTTGAAGCGTTATCGCTGATTTA
TAACAAAGATCTGCTGCCGAACCCGCCAAAAACCTGGGAAGAGATCCC
GGCGCTGGATAAAGAACTGAAAGCGAAAGGTAAGAGCGCGCTGATGTT
CAACCTGCAAGAACCGTACTTCACCTGGCCGCTGATTGCTGCTGACGG
GGGTTATGCGTTCAAGTATGAAAACGGCAAGTACGACATTAAAGACGTG
GGCGTGGATAACGCTGGCGCGAAAGCGGGTCTGACCTTCCTGGTTGAC
CTGATTAAAAACAAACACATGAATGCAGACACCGATTACTCCATCGCAG
AAGCTGCCTTTAATAAAGGCGAAACAGCGATGACCATCAACGGCCCGT
GGGCATGGTCCAACATCGACACCAGCAAAGTGAATTATGGTGTAACGG
TACTGCCGACCTTCAAGGGTCAACCATCCAAACCGTTCGTTGGCGTGCT
GAGCGCAGGTATTAAC 
GCCGCCAGTCCGAACAAAGAGCTGGCGAAAGAGTTCCTCG 
AAAACTATCTGCTGACTGATGAAGGTCTGGAAGCGGTTAATAAAGACAA
ACCGCTGGGTGCCGTAGCGCTGAAGTCTTACGAGGAAGAGTTGGCGAA
AGATCCACGTATTGCCGCCACCATGGAAAACGCCCAGAAAGGTGAAAT
CATGCCGAACATCCCGCAGATGTCCGCTTTCTGGTATGCCGTGCGTAC
TGCGGTGATCAACGCCGCCAGCGGTCGTCAGACTGTCGATGAAGCCCT
GAAAGACGCGCAGACTCGTATCACCAAGGGCCTGGAAGT 
TCTGTTCCAGGGACCAGCAATG 
MGSSHHHHHHSSMKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVE
HPDKLEEKFPQVAATGDGPDIIFWAHDRFGGYAQSGLLAEITPDKAFQDKL
YPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPALDKELKAK
GKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGL
TFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYG
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VTVLPTFKGQPSKPFVGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNK
DKPLGAVALKSYEEELAKDPRIAATMENAQKGEIMPNIPQMSAFWYAVRTA
VINAASGRQTVDEALKDAQTRITKGLEVLFQ^GPAM 
 TRBP-D1_19-99 
ATCGAGCAGATGTTAGCCGCCAACCCGGGTAAAACCCCGATTAGCCTG
CTGCAAGAGTACGGTACACGCATCGGCAAAACACCGGTGTATGACTTA
CTGAAGGCCGAGGGCCAAGCCCACCAACCGAACTTCACCTTTCGCGTG
ACCGTTGGTGACACAAGCTGCACCGGCCAGGGCCCTAGTAAGAAGGC
CGCAAAGCACAAGGCCGCCGAAGTGGCCCTGAAACACCTGAAGGGCG
GTAGC 
IEQMLAANPGKTPISLLQEYGTRIGKTPVYDLLKAEGQAHQPNFTFRVTVGD
TSCTGQGPSKKAAKHKAAEVALKHLKGGS 
TRBP-D2_157-228 
GAGTGTAATCCGGTGGGCGCACTGCAGGAACTGGTGGTGCAGAAGGG
CTGGCGCTTACCGGAGTACACCGTGACCCAAGAGAGCGGCCCTGCAC
ATCGCAAGGAGTTCACCATGACCTGCCGTGTGGAGCGCTTCATCGAGA
TCGGCAGCGGTACCAGCAAGAAGCTGGCCAAGCGCAATGCAGCCGCC
AAGATGCTGCTGCGCGTGCACACAGTG 
ECNPVGALQELVVQKGWRLPEYTVTQESGPAHRKEFTMTCRVERFIEIGS
GTSKKLAKRNAAAKMLLRVHTV 
 
TRBP-D12_19-228 
ATCGAGCAGATGTTAGCCGCCAACCCGGGTAAAACCCCGATTAGCCTG
CTGCAAGAGTACGGTACACGCATCGGCAAAACACCGGTGTATGACTTA
CTGAAGGCCGAGGGCCAAGCCCACCAACCGAACTTCACCTTTCGCGTG
ACCGTTGGTGACACAAGCTGCACCGGCCAGGGCCCTAGTAAGAAGGC
CGCAAAGCACAAGGCCGCCGAAGTGGCCCTGAAACACCTGAAGGGCG
GTAGCATGCTGGAACCGGCCCTGGAGGACAGCAGCAGCTTCAGTCCG
CTGGATAGTAGCCTGCCGGAAGACATCCCGGTGTTCACCGCAGCAGCA
GCCGCAACCCCTGTTCCTAGTGTTGTTCTGACCCGCAGTCCGCCGATG
GAGTTACAACCGCCGGTTAGCCCTCAGCAGAGTGAGTGTAATCCGGTG
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GGCGCACTGCAGGAACTGGTGGTGCAGAAGGGCTGGCGCTTACCGGA
GTACACCGTGACCCAAGAGAGCGGCCCTGCACATCGCAAGGAGTTCAC
CATGACCTGCCGTGTGGAGCGCTTCATCGAGATCGGCAGCGGTACCAG
CAAGAAGCTGGCCAAGCGCAATGCAGCCGCCAAGATGCTGCTGCGCG
TGCACACAGTG 
IEQMLAANPGKTPISLLQEYGTRIGKTPVYDLLKAEGQAHQPNFTFRVTVGD
TSCTGQGPSKKAAKHKAAEVALKHLKGGSMLEPALEDSSSFSPLDSSLPE
DIPVFTAAAAATPVPSVVLTRSPPMELQPPVSPQQSECNPVGALQELVVQK
GWRLPEYTVTQESGPAHRKEFTMTCRVERFIEIGSGTSKKLAKRNAAAKML
LRVHTV 
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Abbreviations 
 
Ago Argonaute 
CD Circular dichroism 
dsRNA Double-stranded RNA 
dsRBD Double-stranded RNA binding domain 
dsRBP Double-stranded RNA binding protein 
DNA Deoxyribonucleic acid 
DSS 4,4-dimethyl-4silapentane-1-sulphonic acid 
DTT Dithiothreitol 
EDTA Ethylenediamineteraacetic acid 
EMSA Electrophoretic mobility shift assay 
EXSY Exchange Spectroscopy 
FA Fluorescence anisotropy  
FTSC Fluorescein 5-thiosemicarbazide 
HEPES 4-(2-hydroxyl)-1-piperazineethanesulfonic acid 
HSQC Heteronuclear Single Quantum Coherence 
IVT In vitro transcription 
miRNA microRNA 
mRNA Messenger RNA 
NMR Nuclear magnetic resonance  
PDB Protein Data Bank 
Pre-miRNA Precursor microRNA 
Pri-miRNA Primary microRNA 
RISC RNA induced silencing complex 
RNA Ribonucleic acid 
RNAi RNA interference 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel 
SEC Size Exclusion Chromatography 
SEC-MALS Size Exclusion Chromatography coupled to Multi-
Angle Light Scattering 
siRNA Short interfering RNA 
TCEP Tris(2-carboxyethel) phosphine 
TROSY Transverse relaxation-optimized spectroscopy 
UTR Untranslated region 
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